data_2kaa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kaa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.435 ' C ' ' HG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG21 ' CD1' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.452 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.481 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.4 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.466 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 118' ' ' LYS . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.409 ' H ' ' CG ' ' A' ' 117' ' ' ASP . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.424 HE22 ' HB ' ' A' ' 69' ' ' ILE . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.424 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.49 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 118' ' ' LYS . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 117' ' ' ASP . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.462 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG21 ' SG ' ' A' ' 129' ' ' CYS . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.496 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.467 ' CZ2' ' HE2' ' A' ' 74' ' ' LYS . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.457 ' CD2' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 98' ' ' TYR . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 120' ' ' ASN . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.412 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.402 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG22 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 67' ' ' TYR . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.497 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.491 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.497 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.427 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.403 HD13 ' CE3' ' A' ' 71' ' ' TRP . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.4 ' HG1' HG13 ' A' ' 94' ' ' ILE . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.49 ' C ' ' HD1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.402 ' H ' ' HG3' ' A' ' 121' ' ' GLN . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.497 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.461 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.419 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.494 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HE2' ' HA2' ' A' ' 12' ' ' GLY . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.418 ' HA2' ' HE2' ' A' ' 9' ' ' LYS . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.481 ' CE2' ' HA3' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.502 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.454 ' HA ' ' CH2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 65' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.497 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 ' CG2' ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HE2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.454 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 51' ' ' ARG . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.417 ' HB ' ' C ' ' A' ' 130' ' ' ASP . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD2' HD12 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 94' ' ' ILE . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.479 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.5 tp-100 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 19' ' ' VAL . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.401 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.484 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.417 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 107' ' ' TYR . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.455 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.41 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.434 ' CE2' HG11 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.448 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.401 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' CD1' HD21 ' A' ' 100' ' ' ASN . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.51 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' C ' ' HG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.416 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.543 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HD2' ' CZ3' ' A' ' 71' ' ' TRP . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' A' ' 33' ' ' LEU . 10.0 t-20 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.484 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.423 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.497 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.501 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.454 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.4 ' HD1' ' HG3' ' A' ' 66' ' ' GLU . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.482 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.409 ' CZ2' HG23 ' A' ' 97' ' ' VAL . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG3' ' HD1' ' A' ' 42' ' ' HIS . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.489 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.403 HD13 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG23 ' CZ2' ' A' ' 52' ' ' TRP . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 2.4 t30 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.463 ' CD1' HD21 ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.456 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.432 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.48 ' CZ2' ' HE2' ' A' ' 74' ' ' LYS . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.415 ' CG ' ' H ' ' A' ' 81' ' ' ASP . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 80' ' ' LYS . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.463 HD21 ' CD1' ' A' ' 33' ' ' LEU . 18.0 t-20 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.425 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.495 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.495 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 67' ' ' TYR . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.543 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.426 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.543 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' HIS . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.466 ' CE3' HD11 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.492 ' CE2' ' HG2' ' A' ' 87' ' ' GLN . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' THR . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.509 ' CB ' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.426 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.558 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.558 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.442 HD21 ' CD1' ' A' ' 65' ' ' TRP . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.442 ' CD1' HD21 ' A' ' 33' ' ' LEU . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.433 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.433 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.497 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 4.8 tp-100 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.604 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.449 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 120' ' ' ASN . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.405 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 7' ' ' ARG . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.451 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.493 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.421 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' HD13 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 129' ' ' CYS . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.535 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.516 ' CD1' HD21 ' A' ' 100' ' ' ASN . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB3' ' HH ' ' A' ' 44' ' ' TYR . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.416 ' CG2' ' H ' ' A' ' 51' ' ' ARG . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' H ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.408 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.535 ' HB ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.429 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.486 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.516 HD21 ' CD1' ' A' ' 33' ' ' LEU . 4.9 t-20 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.5 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.466 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.523 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.447 ' CG1' ' HG1' ' A' ' 112' ' ' THR . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.447 ' HG1' ' CG1' ' A' ' 94' ' ' ILE . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.634 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.528 ' C ' ' HG1' ' A' ' 35' ' ' THR . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 98' ' ' TYR . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG13 HE22 ' A' ' 87' ' ' GLN . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.522 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 7.9 tp-100 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.439 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' C ' ' HG1' ' A' ' 35' ' ' THR . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG21 ' CD1' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.452 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.481 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.478 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.478 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.4 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.466 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 118' ' ' LYS . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' H ' ' CG ' ' A' ' 117' ' ' ASP . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.466 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.424 HE22 ' HB ' ' A' ' 69' ' ' ILE . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.529 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.424 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.49 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 118' ' ' LYS . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 117' ' ' ASP . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.462 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG21 ' SG ' ' A' ' 129' ' ' CYS . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.473 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.441 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.496 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.467 ' CZ2' ' HE2' ' A' ' 74' ' ' LYS . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.457 ' CD2' HG12 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.457 HG12 ' CD2' ' A' ' 98' ' ' TYR . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 120' ' ' ASN . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.412 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.402 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.417 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG22 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB1' ' CE2' ' A' ' 67' ' ' TYR . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CE2' ' HB1' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.497 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.491 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.497 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.427 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.427 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.537 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.403 HD13 ' CE3' ' A' ' 71' ' ' TRP . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.4 ' HG1' HG13 ' A' ' 94' ' ' ILE . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.49 ' C ' ' HD1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.402 ' H ' ' HG3' ' A' ' 121' ' ' GLN . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.497 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.461 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.42 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.544 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.419 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.494 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.565 ' CZ ' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HE2' ' HA2' ' A' ' 12' ' ' GLY . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.418 ' HA2' ' HE2' ' A' ' 9' ' ' LYS . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.481 ' CE2' ' HA3' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.502 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.454 ' HA ' ' CH2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.502 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.481 ' HA3' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 65' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.497 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 ' CG2' ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.428 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HE2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.415 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.498 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.454 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.402 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.428 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 51' ' ' ARG . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.41 ' SG ' ' CG2' ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' HB ' ' C ' ' A' ' 130' ' ' ASP . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD2' HD12 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' HD11 ' A' ' 94' ' ' ILE . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.461 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.479 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.479 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.5 tp-100 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 19' ' ' VAL . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.484 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 107' ' ' TYR . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.452 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.482 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' HB2' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.455 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.411 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' CA ' ' HB2' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.41 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.434 ' CE2' HG11 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.448 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.401 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 111' ' ' MET . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' CD1' HD21 ' A' ' 100' ' ' ASN . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.51 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' C ' ' HG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.416 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.543 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.473 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.482 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.482 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HD2' ' CZ3' ' A' ' 71' ' ' TRP . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' A' ' 33' ' ' LEU . 10.0 t-20 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.484 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.423 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.497 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.432 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.501 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.454 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.4 ' HD1' ' HG3' ' A' ' 66' ' ' GLU . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.482 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.409 ' CZ2' HG23 ' A' ' 97' ' ' VAL . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG3' ' HD1' ' A' ' 42' ' ' HIS . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.489 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.403 HD13 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG23 ' CZ2' ' A' ' 52' ' ' TRP . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HA ' ' CD2' ' A' ' 33' ' ' LEU . 2.4 t30 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.405 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 98' ' ' TYR . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.463 ' CD1' HD21 ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.456 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.432 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.48 ' CZ2' ' HE2' ' A' ' 74' ' ' LYS . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.415 ' CG ' ' H ' ' A' ' 81' ' ' ASP . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' H ' ' CG ' ' A' ' 80' ' ' LYS . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.463 HD21 ' CD1' ' A' ' 33' ' ' LEU . 18.0 t-20 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.425 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.495 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.43 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.495 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.414 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 67' ' ' TYR . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.543 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.426 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.543 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' HIS . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.466 ' CE3' HD11 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' CB ' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.492 ' CE2' ' HG2' ' A' ' 87' ' ' GLN . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 92' ' ' THR . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.509 ' CB ' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.453 ' CE2' HG22 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.426 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.558 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.558 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.449 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.442 HD21 ' CD1' ' A' ' 65' ' ' TRP . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.442 ' CD1' HD21 ' A' ' 33' ' ' LEU . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.433 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.433 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.497 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 4.8 tp-100 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.604 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.449 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 120' ' ' ASN . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.405 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 7' ' ' ARG . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 ' CG2' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.451 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.493 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.421 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CG2' HD13 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.455 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 HG22 ' SG ' ' A' ' 129' ' ' CYS . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.535 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.516 ' CD1' HD21 ' A' ' 100' ' ' ASN . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' HB3' ' HH ' ' A' ' 44' ' ' TYR . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.416 ' CG2' ' H ' ' A' ' 51' ' ' ARG . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' H ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.408 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' HB ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.429 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.486 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.516 HD21 ' CD1' ' A' ' 33' ' ' LEU . 4.9 t-20 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CZ ' HG21 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.499 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.432 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.466 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.523 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.447 ' CG1' ' HG1' ' A' ' 112' ' ' THR . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.447 ' HG1' ' CG1' ' A' ' 94' ' ' ILE . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.634 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 67' ' ' TYR . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 40' ' ' ASP . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.528 ' C ' ' HG1' ' A' ' 35' ' ' THR . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 98' ' ' TYR . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.522 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG13 HE22 ' A' ' 87' ' ' GLN . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.522 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 7.9 tp-100 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.439 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 19' ' ' VAL . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 19' ' ' VAL . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.551 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 4' ' ' VAL . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' HD12 ' A' ' 3' ' ' ILE . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HB3' HD13 ' A' ' 69' ' ' ILE . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.67 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 104' ' ' ALA . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.481 HG21 ' CE2' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CE2' HG21 ' A' ' 50' ' ' ILE . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 56' ' ' ASN . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.463 ' H ' HG12 ' A' ' 54' ' ' VAL . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 64' ' ' LEU . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 99' ' ' ALA . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 27' ' ' GLN . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.493 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 28' ' ' ALA . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.651 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' SER . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' HB3' ' A' ' 93' ' ' PRO . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.487 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.479 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.431 ' CG ' HG23 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.506 ' HB2' HG23 ' A' ' 110' ' ' VAL . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.668 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 19' ' ' VAL . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' HG21 ' A' ' 112' ' ' THR . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' NZ ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.541 ' NZ ' HD23 ' A' ' 10' ' ' LEU . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 4' ' ' VAL . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 2' ' ' PRO . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.491 HE21 ' CG1' ' A' ' 96' ' ' VAL . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.697 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.697 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 54' ' ' VAL . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 57' ' ' CYS . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 64' ' ' LEU . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' CG1' ' A' ' 19' ' ' VAL . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.614 ' CG1' HD23 ' A' ' 64' ' ' LEU . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.516 ' HB3' ' NE2' ' A' ' 106' ' ' GLN . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' A' ' 99' ' ' ALA . 6.2 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.1 m120 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 19' ' ' VAL . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.857 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 4' ' ' VAL . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.731 HG23 ' CE2' ' A' ' 107' ' ' TYR . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.614 ' CG2' HD11 ' A' ' 69' ' ' ILE . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 105' ' ' VAL . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.614 HD11 ' CG2' ' A' ' 23' ' ' THR . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.781 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.502 ' CE3' HD12 ' A' ' 94' ' ' ILE . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CZ2' HG22 ' A' ' 84' ' ' THR . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 17' ' ' PHE . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 33' ' ' LEU . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 21' ' ' VAL . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.857 HG23 HD22 ' A' ' 10' ' ' LEU . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 50' ' ' ILE . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.783 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 20' ' ' ASP . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 19' ' ' VAL . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 16' ' ' PRO . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 6' ' ' CYS . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.822 ' HB2' HG21 ' A' ' 5' ' ' THR . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.555 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 3' ' ' ILE . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 107' ' ' TYR . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 105' ' ' VAL . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 105' ' ' VAL . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.51 HG21 HD21 ' A' ' 100' ' ' ASN . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.746 HD12 HG12 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 94' ' ' ILE . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.404 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 79' ' ' ALA . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 17' ' ' PHE . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 110' ' ' VAL . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 HD12 ' A' ' 64' ' ' LEU . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.671 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.51 HD21 HG21 ' A' ' 63' ' ' ILE . 43.4 t30 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.671 HG23 ' CB ' ' A' ' 98' ' ' TYR . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.66 ' CE2' HG23 ' A' ' 21' ' ' VAL . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 96' ' ' VAL . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.606 HG23 HD22 ' A' ' 10' ' ' LEU . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 128' ' ' LYS . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' ND2' ' A' ' 100' ' ' ASN . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 50' ' ' ILE . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 97' ' ' VAL . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 94' ' ' ILE . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.498 ' CZ2' HG22 ' A' ' 84' ' ' THR . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.498 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.46 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 17' ' ' PHE . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.763 HG12 HD23 ' A' ' 64' ' ' LEU . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.668 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 101' ' ' SER . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.668 HG13 ' CB ' ' A' ' 98' ' ' TYR . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' A' ' 24' ' ' ALA . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 116' ' ' VAL . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.63 ' O ' HD22 ' A' ' 10' ' ' LEU . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 19' ' ' VAL . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.424 HG13 ' H ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' HD11 ' A' ' 69' ' ' ILE . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.688 ' CD ' HD13 ' A' ' 69' ' ' ILE . 48.2 mm-40 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.739 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.635 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 43' ' ' ARG . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.463 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.688 HD13 ' CD ' ' A' ' 27' ' ' GLN . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HA2' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.625 ' CE3' HD12 ' A' ' 94' ' ' ILE . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 84' ' ' THR . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.625 HD12 ' CE3' ' A' ' 71' ' ' TRP . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.523 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 10' ' ' LEU . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 19' ' ' VAL . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 19' ' ' VAL . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD3' HD23 ' A' ' 10' ' ' LEU . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.955 HG21 ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 70' ' ' TYR . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 103' ' ' GLY . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.72 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' C ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.586 HD13 ' CG1' ' A' ' 19' ' ' VAL . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 110' ' ' VAL . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.445 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.738 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 33' ' ' LEU . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.738 HG23 ' CB ' ' A' ' 98' ' ' TYR . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.658 ' HE1' HG23 ' A' ' 110' ' ' VAL . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 96' ' ' VAL . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.619 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' ILE . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 50' ' ' ILE . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.955 ' SG ' HG21 ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 19' ' ' VAL . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 19' ' ' VAL . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 4' ' ' VAL . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.688 HG21 HD11 ' A' ' 69' ' ' ILE . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 96' ' ' VAL . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HA ' HG11 ' A' ' 105' ' ' VAL . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 65' ' ' TRP . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 HG12 ' A' ' 97' ' ' VAL . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.466 ' CD1' HD23 ' A' ' 33' ' ' LEU . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.655 ' N ' HD13 ' A' ' 69' ' ' ILE . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' C ' ' HB3' ' A' ' 38' ' ' SER . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 44.9 tp60 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.408 ' HB ' ' HE3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 17' ' ' PHE . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 64' ' ' LEU . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 116' ' ' VAL . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.54 ' HB3' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.441 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 19' ' ' VAL . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 2' ' ' PRO . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' HG11 ' A' ' 105' ' ' VAL . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.728 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 126' ' ' PHE . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.525 ' HB2' HG12 ' A' ' 54' ' ' VAL . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 52' ' ' TRP . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 64' ' ' LEU . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 57' ' ' CYS . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 24' ' ' ALA . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.613 HG12 HD23 ' A' ' 64' ' ' LEU . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.737 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' OD1' HD13 ' A' ' 33' ' ' LEU . 29.4 t30 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CE2' HG13 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.501 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.602 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 21' ' ' VAL . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 10' ' ' LEU . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.413 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' H ' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.438 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' H ' HG22 ' A' ' 54' ' ' VAL . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.668 ' H ' HG13 ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 97' ' ' VAL . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 94' ' ' ILE . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CE3' HD12 ' A' ' 94' ' ' ILE . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 73' ' ' GLY . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 72' ' ' VAL . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.624 ' HA ' HG13 ' A' ' 110' ' ' VAL . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 64' ' ' LEU . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 106' ' ' GLN . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 99' ' ' ALA . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.409 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.506 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.506 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.525 ' HB2' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HB2' HG12 ' A' ' 21' ' ' VAL . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.642 HG23 HG23 ' A' ' 19' ' ' VAL . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 19' ' ' VAL . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' HG11 ' A' ' 19' ' ' VAL . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 5' ' ' THR . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' THR . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 107' ' ' TYR . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.668 HG22 HD11 ' A' ' 69' ' ' ILE . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 65' ' ' TRP . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.416 ' OH ' HD12 ' A' ' 50' ' ' ILE . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' OH ' ' A' ' 44' ' ' TYR . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.505 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 64' ' ' LEU . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 62' ' ' ALA . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 57' ' ' CYS . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.571 ' CD1' HD22 ' A' ' 33' ' ' LEU . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.668 HD11 HG22 ' A' ' 23' ' ' THR . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 18' ' ' LYS . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.438 ' HB3' ' HD1' ' A' ' 113' ' ' HIS . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.474 HD13 ' CG1' ' A' ' 19' ' ' VAL . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 28' ' ' ALA . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 64' ' ' LEU . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.502 ' CE2' HG23 ' A' ' 21' ' ' VAL . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.414 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 96' ' ' VAL . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 19' ' ' VAL . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 19' ' ' VAL . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HD23 ' A' ' 10' ' ' LEU . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HD2' HG12 ' A' ' 72' ' ' VAL . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 6' ' ' CYS . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' A' ' 69' ' ' ILE . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 126' ' ' PHE . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 56' ' ' ASN . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.736 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' OD1' ' A' ' 20' ' ' ASP . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.613 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' A' ' 18' ' ' LYS . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.613 HD12 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HA ' HG13 ' A' ' 110' ' ' VAL . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 111' ' ' MET . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HA ' HD22 ' A' ' 33' ' ' LEU . 3.9 t-20 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.436 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.62 ' O ' HD22 ' A' ' 10' ' ' LEU . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.526 ' HA ' HG12 ' A' ' 116' ' ' VAL . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 19' ' ' VAL . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 6' ' ' CYS . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 4' ' ' VAL . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' ALA . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.638 HG21 HD11 ' A' ' 69' ' ' ILE . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.401 HD13 ' OD1' ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.748 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 126' ' ' PHE . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 52' ' ' TRP . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' HG12 ' A' ' 54' ' ' VAL . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.547 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 18' ' ' LYS . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 86' ' ' GLN . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' HG13 ' A' ' 82' ' ' VAL . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.599 HD11 ' CD2' ' A' ' 17' ' ' PHE . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.578 HG12 HD12 ' A' ' 64' ' ' LEU . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.401 ' OD1' HD13 ' A' ' 33' ' ' LEU . 34.5 t30 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.42 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.434 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.593 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 3' ' ' ILE . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 19' ' ' VAL . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 19' ' ' VAL . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 5' ' ' THR . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 4' ' ' VAL . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD2' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.515 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 69' ' ' ILE . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HG3' HG22 ' A' ' 69' ' ' ILE . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 41' ' ' PRO . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' VAL . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.504 ' H ' HG13 ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.612 HD23 ' CG1' ' A' ' 97' ' ' VAL . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.788 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CE3' HD12 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HE2' ' CZ2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.861 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HZ2' HG22 ' A' ' 84' ' ' THR . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.51 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.401 ' HA3' ' NZ ' ' A' ' 74' ' ' LYS . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.788 HG22 HD11 ' A' ' 69' ' ' ILE . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 64' ' ' LEU . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.706 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' OD1' HD13 ' A' ' 33' ' ' LEU . 44.6 t30 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 98' ' ' TYR . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 96' ' ' VAL . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.444 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 6' ' ' CYS . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.561 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.56 HG13 ' HA ' ' A' ' 120' ' ' ASN . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.56 ' HA ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 117' ' ' ASP . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.561 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.834 HG23 HG23 ' A' ' 19' ' ' VAL . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' A' ' 103' ' ' GLY . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.438 HG23 ' HE2' ' A' ' 128' ' ' LYS . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.551 ' HB2' HG12 ' A' ' 54' ' ' VAL . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 52' ' ' TRP . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 94' ' ' ILE . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 24.1 tp60 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.76 HD13 ' CG1' ' A' ' 19' ' ' VAL . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 27' ' ' GLN . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 33' ' ' LEU . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.636 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 10' ' ' LEU . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.583 ' HA ' HG12 ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 4.3 tp60 -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 50' ' ' ILE . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.918 ' SG ' HG21 ' A' ' 19' ' ' VAL . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' ALA . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HG3' HG22 ' A' ' 69' ' ' ILE . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 103' ' ' GLY . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 52' ' ' TRP . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.43 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.476 ' CE3' HD12 ' A' ' 94' ' ' ILE . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.469 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 38' ' ' SER . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 82' ' ' VAL . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.516 ' HB ' HD11 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 28' ' ' ALA . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 33' ' ' LEU . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 120' ' ' ASN . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 19' ' ' VAL . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD23 ' HE2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HE2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 4' ' ' VAL . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.683 HG21 HD11 ' A' ' 69' ' ' ILE . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.578 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.646 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 52' ' ' TRP . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 97' ' ' VAL . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 94' ' ' ILE . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.503 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.528 ' HZ2' HG22 ' A' ' 84' ' ' THR . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.528 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 82' ' ' VAL . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 17' ' ' PHE . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 28' ' ' ALA . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG12 HD23 ' A' ' 64' ' ' LEU . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.501 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.714 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.852 ' SG ' HG21 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' HG22 ' A' ' 19' ' ' VAL . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HD3' HD23 ' A' ' 10' ' ' LEU . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 4' ' ' VAL . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD13 ' OD1' ' A' ' 100' ' ' ASN . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.437 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' HA2' ' A' ' 89' ' ' GLY . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.524 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 76' ' ' ALA . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' MET . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 24' ' ' ALA . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' A' ' 33' ' ' LEU . 22.6 t30 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.434 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.561 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 50' ' ' ILE . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 94' ' ' ILE . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.537 HD13 ' ND2' ' A' ' 100' ' ' ASN . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.407 ' CE1' HH21 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.456 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.548 ' O ' HG13 ' A' ' 97' ' ' VAL . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 94' ' ' ILE . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 44.6 tp60 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.734 HD12 ' CE3' ' A' ' 71' ' ' TRP . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.407 HH21 ' CE1' ' A' ' 42' ' ' HIS . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 65' ' ' TRP . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.537 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.688 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 120' ' ' ASN . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.751 ' HA ' HG23 ' A' ' 116' ' ' VAL . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.468 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' VAL . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' CE2' ' A' ' 107' ' ' TYR . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' ND2' ' A' ' 100' ' ' ASN . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 97' ' ' VAL . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.659 ' CE3' HD12 ' A' ' 94' ' ' ILE . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.491 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 38' ' ' SER . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.453 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.659 HD12 ' CE3' ' A' ' 71' ' ' TRP . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 28' ' ' ALA . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 64' ' ' LEU . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.484 ' ND2' HD13 ' A' ' 33' ' ' LEU . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 98' ' ' TYR . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.452 ' CE2' HG23 ' A' ' 21' ' ' VAL . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.486 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 117' ' ' ASP . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 120' ' ' ASN . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.624 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 19' ' ' VAL . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 19' ' ' VAL . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.551 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 4' ' ' VAL . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' HD12 ' A' ' 3' ' ' ILE . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HB3' HD13 ' A' ' 69' ' ' ILE . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.67 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 104' ' ' ALA . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.481 HG21 ' CE2' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CE2' HG21 ' A' ' 50' ' ' ILE . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 56' ' ' ASN . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.463 ' H ' HG12 ' A' ' 54' ' ' VAL . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 64' ' ' LEU . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 99' ' ' ALA . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 27' ' ' GLN . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.493 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 28' ' ' ALA . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.651 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' SER . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' HB3' ' A' ' 93' ' ' PRO . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.487 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.479 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.431 ' CG ' HG23 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.506 ' HB2' HG23 ' A' ' 110' ' ' VAL . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.668 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 19' ' ' VAL . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' HG21 ' A' ' 112' ' ' THR . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' NZ ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.541 ' NZ ' HD23 ' A' ' 10' ' ' LEU . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 4' ' ' VAL . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 2' ' ' PRO . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.491 HE21 ' CG1' ' A' ' 96' ' ' VAL . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.697 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.697 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 54' ' ' VAL . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 57' ' ' CYS . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 64' ' ' LEU . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' CG1' ' A' ' 19' ' ' VAL . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.614 ' CG1' HD23 ' A' ' 64' ' ' LEU . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.516 ' HB3' ' NE2' ' A' ' 106' ' ' GLN . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.516 ' NE2' ' HB3' ' A' ' 99' ' ' ALA . 6.2 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.1 m120 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 19' ' ' VAL . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.857 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 4' ' ' VAL . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.731 HG23 ' CE2' ' A' ' 107' ' ' TYR . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.614 ' CG2' HD11 ' A' ' 69' ' ' ILE . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 105' ' ' VAL . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.614 HD11 ' CG2' ' A' ' 23' ' ' THR . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.781 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.502 ' CE3' HD12 ' A' ' 94' ' ' ILE . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CZ2' HG22 ' A' ' 84' ' ' THR . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 17' ' ' PHE . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 33' ' ' LEU . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 21' ' ' VAL . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.857 HG23 HD22 ' A' ' 10' ' ' LEU . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 50' ' ' ILE . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.783 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 20' ' ' ASP . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 19' ' ' VAL . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 16' ' ' PRO . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 6' ' ' CYS . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.822 ' HB2' HG21 ' A' ' 5' ' ' THR . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.555 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 3' ' ' ILE . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 107' ' ' TYR . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 105' ' ' VAL . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 105' ' ' VAL . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.51 HG21 HD21 ' A' ' 100' ' ' ASN . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.746 HD12 HG12 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 94' ' ' ILE . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.404 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 79' ' ' ALA . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 17' ' ' PHE . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 110' ' ' VAL . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 HD12 ' A' ' 64' ' ' LEU . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.671 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.51 HD21 HG21 ' A' ' 63' ' ' ILE . 43.4 t30 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.671 HG23 ' CB ' ' A' ' 98' ' ' TYR . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.66 ' CE2' HG23 ' A' ' 21' ' ' VAL . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 96' ' ' VAL . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.606 HG23 HD22 ' A' ' 10' ' ' LEU . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 128' ' ' LYS . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' ND2' ' A' ' 100' ' ' ASN . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 50' ' ' ILE . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 97' ' ' VAL . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 94' ' ' ILE . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.498 ' CZ2' HG22 ' A' ' 84' ' ' THR . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.498 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.46 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 17' ' ' PHE . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.763 HG12 HD23 ' A' ' 64' ' ' LEU . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.668 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 101' ' ' SER . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.668 HG13 ' CB ' ' A' ' 98' ' ' TYR . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' A' ' 24' ' ' ALA . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 116' ' ' VAL . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.63 ' O ' HD22 ' A' ' 10' ' ' LEU . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 19' ' ' VAL . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.424 HG13 ' H ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' HD11 ' A' ' 69' ' ' ILE . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.688 ' CD ' HD13 ' A' ' 69' ' ' ILE . 48.2 mm-40 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.739 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.635 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 43' ' ' ARG . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.463 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.688 HD13 ' CD ' ' A' ' 27' ' ' GLN . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HA2' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.625 ' CE3' HD12 ' A' ' 94' ' ' ILE . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 84' ' ' THR . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.625 HD12 ' CE3' ' A' ' 71' ' ' TRP . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.523 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 10' ' ' LEU . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 19' ' ' VAL . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 19' ' ' VAL . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD3' HD23 ' A' ' 10' ' ' LEU . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.955 HG21 ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 70' ' ' TYR . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 103' ' ' GLY . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.72 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' C ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.586 HD13 ' CG1' ' A' ' 19' ' ' VAL . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 110' ' ' VAL . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.445 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.738 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 33' ' ' LEU . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.738 HG23 ' CB ' ' A' ' 98' ' ' TYR . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.658 ' HE1' HG23 ' A' ' 110' ' ' VAL . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 96' ' ' VAL . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.619 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' ILE . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 50' ' ' ILE . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.955 ' SG ' HG21 ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 19' ' ' VAL . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 19' ' ' VAL . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 4' ' ' VAL . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.688 HG21 HD11 ' A' ' 69' ' ' ILE . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 96' ' ' VAL . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HA ' HG11 ' A' ' 105' ' ' VAL . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD23 ' CD1' ' A' ' 65' ' ' TRP . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 HG12 ' A' ' 97' ' ' VAL . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.466 ' CD1' HD23 ' A' ' 33' ' ' LEU . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.655 ' N ' HD13 ' A' ' 69' ' ' ILE . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' C ' ' HB3' ' A' ' 38' ' ' SER . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 44.9 tp60 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.408 ' HB ' ' HE3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 17' ' ' PHE . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 64' ' ' LEU . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 116' ' ' VAL . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.54 ' HB3' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.441 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 19' ' ' VAL . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 2' ' ' PRO . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' HG11 ' A' ' 105' ' ' VAL . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.728 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 126' ' ' PHE . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.525 ' HB2' HG12 ' A' ' 54' ' ' VAL . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 52' ' ' TRP . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 64' ' ' LEU . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 57' ' ' CYS . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 24' ' ' ALA . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.613 HG12 HD23 ' A' ' 64' ' ' LEU . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.737 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' OD1' HD13 ' A' ' 33' ' ' LEU . 29.4 t30 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CE2' HG13 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.501 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.602 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 21' ' ' VAL . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 10' ' ' LEU . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.413 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' H ' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.438 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' H ' HG22 ' A' ' 54' ' ' VAL . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.668 ' H ' HG13 ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 97' ' ' VAL . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 94' ' ' ILE . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CE3' HD12 ' A' ' 94' ' ' ILE . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 73' ' ' GLY . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 72' ' ' VAL . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.624 ' HA ' HG13 ' A' ' 110' ' ' VAL . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 64' ' ' LEU . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 106' ' ' GLN . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 99' ' ' ALA . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.409 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.506 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.506 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.525 ' HB2' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HB2' HG12 ' A' ' 21' ' ' VAL . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.642 HG23 HG23 ' A' ' 19' ' ' VAL . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 19' ' ' VAL . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' HG11 ' A' ' 19' ' ' VAL . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 5' ' ' THR . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' THR . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 107' ' ' TYR . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.668 HG22 HD11 ' A' ' 69' ' ' ILE . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 65' ' ' TRP . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.416 ' OH ' HD12 ' A' ' 50' ' ' ILE . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' OH ' ' A' ' 44' ' ' TYR . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.505 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 64' ' ' LEU . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 62' ' ' ALA . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 57' ' ' CYS . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.571 ' CD1' HD22 ' A' ' 33' ' ' LEU . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.668 HD11 HG22 ' A' ' 23' ' ' THR . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 18' ' ' LYS . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.438 ' HB3' ' HD1' ' A' ' 113' ' ' HIS . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.474 HD13 ' CG1' ' A' ' 19' ' ' VAL . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 28' ' ' ALA . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 64' ' ' LEU . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.502 ' CE2' HG23 ' A' ' 21' ' ' VAL . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.414 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 96' ' ' VAL . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 19' ' ' VAL . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 19' ' ' VAL . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HD23 ' A' ' 10' ' ' LEU . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HD2' HG12 ' A' ' 72' ' ' VAL . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 6' ' ' CYS . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' A' ' 69' ' ' ILE . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 126' ' ' PHE . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 56' ' ' ASN . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.736 ' H ' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' OD1' ' A' ' 20' ' ' ASP . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.613 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' A' ' 18' ' ' LYS . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.613 HD12 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HA ' HG13 ' A' ' 110' ' ' VAL . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 111' ' ' MET . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HA ' HD22 ' A' ' 33' ' ' LEU . 3.9 t-20 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.436 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.62 ' O ' HD22 ' A' ' 10' ' ' LEU . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.526 ' HA ' HG12 ' A' ' 116' ' ' VAL . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 19' ' ' VAL . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 6' ' ' CYS . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 4' ' ' VAL . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' ALA . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.638 HG21 HD11 ' A' ' 69' ' ' ILE . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.401 HD13 ' OD1' ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.748 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 126' ' ' PHE . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 52' ' ' TRP . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' HG12 ' A' ' 54' ' ' VAL . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.547 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 18' ' ' LYS . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 86' ' ' GLN . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' HG13 ' A' ' 82' ' ' VAL . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.599 HD11 ' CD2' ' A' ' 17' ' ' PHE . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.578 HG12 HD12 ' A' ' 64' ' ' LEU . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.401 ' OD1' HD13 ' A' ' 33' ' ' LEU . 34.5 t30 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.42 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.434 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.593 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 3' ' ' ILE . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 19' ' ' VAL . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 19' ' ' VAL . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 5' ' ' THR . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 4' ' ' VAL . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD2' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.515 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 69' ' ' ILE . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HG3' HG22 ' A' ' 69' ' ' ILE . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.485 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 41' ' ' PRO . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' VAL . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.504 ' H ' HG13 ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.612 HD23 ' CG1' ' A' ' 97' ' ' VAL . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.788 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CE3' HD12 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HE2' ' CZ2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.861 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HZ2' HG22 ' A' ' 84' ' ' THR . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.51 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' HA3' ' NZ ' ' A' ' 74' ' ' LYS . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.788 HG22 HD11 ' A' ' 69' ' ' ILE . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 64' ' ' LEU . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.706 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' OD1' HD13 ' A' ' 33' ' ' LEU . 44.6 t30 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 98' ' ' TYR . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 96' ' ' VAL . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.444 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 6' ' ' CYS . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.561 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.56 HG13 ' HA ' ' A' ' 120' ' ' ASN . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.56 ' HA ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 117' ' ' ASP . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.561 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.834 HG23 HG23 ' A' ' 19' ' ' VAL . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' A' ' 103' ' ' GLY . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.438 HG23 ' HE2' ' A' ' 128' ' ' LYS . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.551 ' HB2' HG12 ' A' ' 54' ' ' VAL . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 52' ' ' TRP . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 94' ' ' ILE . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 24.1 tp60 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.76 HD13 ' CG1' ' A' ' 19' ' ' VAL . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 27' ' ' GLN . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 33' ' ' LEU . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.636 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 10' ' ' LEU . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.583 ' HA ' HG12 ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 4.3 tp60 -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 50' ' ' ILE . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.918 ' SG ' HG21 ' A' ' 19' ' ' VAL . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' ALA . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HG3' HG22 ' A' ' 69' ' ' ILE . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 103' ' ' GLY . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 52' ' ' TRP . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.43 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.476 ' CE3' HD12 ' A' ' 94' ' ' ILE . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.469 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 38' ' ' SER . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 82' ' ' VAL . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.516 ' HB ' HD11 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 28' ' ' ALA . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 33' ' ' LEU . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 120' ' ' ASN . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 19' ' ' VAL . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD23 ' HE2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HE2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 4' ' ' VAL . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.683 HG21 HD11 ' A' ' 69' ' ' ILE . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.578 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.646 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 52' ' ' TRP . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 97' ' ' VAL . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 94' ' ' ILE . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.528 ' HZ2' HG22 ' A' ' 84' ' ' THR . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.528 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 82' ' ' VAL . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 17' ' ' PHE . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 28' ' ' ALA . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG12 HD23 ' A' ' 64' ' ' LEU . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.501 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.714 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.852 ' SG ' HG21 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' HG22 ' A' ' 19' ' ' VAL . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HD3' HD23 ' A' ' 10' ' ' LEU . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 4' ' ' VAL . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD13 ' OD1' ' A' ' 100' ' ' ASN . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.437 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' HA2' ' A' ' 89' ' ' GLY . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.524 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 76' ' ' ALA . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' MET . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 24' ' ' ALA . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' A' ' 33' ' ' LEU . 22.6 t30 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.434 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.561 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 50' ' ' ILE . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 94' ' ' ILE . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.537 HD13 ' ND2' ' A' ' 100' ' ' ASN . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.407 ' CE1' HH21 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.456 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.548 ' O ' HG13 ' A' ' 97' ' ' VAL . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 94' ' ' ILE . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 44.6 tp60 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.734 HD12 ' CE3' ' A' ' 71' ' ' TRP . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 HH21 ' CE1' ' A' ' 42' ' ' HIS . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 65' ' ' TRP . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.537 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.688 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 120' ' ' ASN . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.751 ' HA ' HG23 ' A' ' 116' ' ' VAL . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.468 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' VAL . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' CE2' ' A' ' 107' ' ' TYR . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' ND2' ' A' ' 100' ' ' ASN . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 97' ' ' VAL . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.659 ' CE3' HD12 ' A' ' 94' ' ' ILE . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.491 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 38' ' ' SER . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.453 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.659 HD12 ' CE3' ' A' ' 71' ' ' TRP . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 28' ' ' ALA . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 64' ' ' LEU . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' ND2' HD13 ' A' ' 33' ' ' LEU . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 98' ' ' TYR . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.452 ' CE2' HG23 ' A' ' 21' ' ' VAL . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.486 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 117' ' ' ASP . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 120' ' ' ASN . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.624 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 19' ' ' VAL . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 19' ' ' VAL . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.551 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 4' ' ' VAL . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' HD12 ' A' ' 3' ' ' ILE . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HB3' HD13 ' A' ' 69' ' ' ILE . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.67 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 100' ' ' ASN . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.481 HG21 ' CE2' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CE2' HG21 ' A' ' 50' ' ' ILE . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 56' ' ' ASN . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.463 ' H ' HG12 ' A' ' 54' ' ' VAL . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 64' ' ' LEU . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 99' ' ' ALA . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 27' ' ' GLN . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.493 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 28' ' ' ALA . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.651 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.515 HD22 HD13 ' A' ' 33' ' ' LEU . 6.6 t-20 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' SER . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' HB3' ' A' ' 93' ' ' PRO . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.487 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.479 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.431 ' CG ' HG23 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.506 ' HB2' HG23 ' A' ' 110' ' ' VAL . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.668 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 19' ' ' VAL . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' HG21 ' A' ' 112' ' ' THR . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' NZ ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.541 ' NZ ' HD23 ' A' ' 10' ' ' LEU . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 4' ' ' VAL . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 2' ' ' PRO . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.491 HE21 ' CG1' ' A' ' 96' ' ' VAL . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.697 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.697 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 54' ' ' VAL . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 57' ' ' CYS . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 64' ' ' LEU . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' CG1' ' A' ' 19' ' ' VAL . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.614 ' CG1' HD23 ' A' ' 64' ' ' LEU . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 19' ' ' VAL . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.857 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 4' ' ' VAL . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.731 HG23 ' CE2' ' A' ' 107' ' ' TYR . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.614 ' CG2' HD11 ' A' ' 69' ' ' ILE . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 105' ' ' VAL . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.614 HD11 ' CG2' ' A' ' 23' ' ' THR . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.781 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.502 ' CE3' HD12 ' A' ' 94' ' ' ILE . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CZ2' HG22 ' A' ' 84' ' ' THR . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 17' ' ' PHE . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 33' ' ' LEU . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 21' ' ' VAL . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.857 HG23 HD22 ' A' ' 10' ' ' LEU . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 50' ' ' ILE . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.783 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 20' ' ' ASP . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 19' ' ' VAL . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 16' ' ' PRO . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 6' ' ' CYS . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.822 ' HB2' HG21 ' A' ' 5' ' ' THR . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.555 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 3' ' ' ILE . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 107' ' ' TYR . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 105' ' ' VAL . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD13 HD22 ' A' ' 100' ' ' ASN . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.746 HD12 HG12 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 94' ' ' ILE . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.404 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 79' ' ' ALA . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 17' ' ' PHE . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 110' ' ' VAL . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 HD12 ' A' ' 64' ' ' LEU . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.671 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.803 HD22 HD13 ' A' ' 33' ' ' LEU . 10.4 t-20 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.671 HG23 ' CB ' ' A' ' 98' ' ' TYR . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.66 ' CE2' HG23 ' A' ' 21' ' ' VAL . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 96' ' ' VAL . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.606 HG23 HD22 ' A' ' 10' ' ' LEU . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 128' ' ' LYS . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' ND2' ' A' ' 100' ' ' ASN . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 50' ' ' ILE . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG11 ' NE2' ' A' ' 106' ' ' GLN . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 97' ' ' VAL . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 94' ' ' ILE . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.498 ' CZ2' HG22 ' A' ' 84' ' ' THR . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.498 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.46 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 17' ' ' PHE . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.763 HG12 HD23 ' A' ' 64' ' ' LEU . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.668 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 101' ' ' SER . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.668 HG13 ' CB ' ' A' ' 98' ' ' TYR . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.447 ' NE2' HG11 ' A' ' 54' ' ' VAL . 12.4 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' A' ' 24' ' ' ALA . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 116' ' ' VAL . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.63 ' O ' HD22 ' A' ' 10' ' ' LEU . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 19' ' ' VAL . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.424 HG13 ' H ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' HD11 ' A' ' 69' ' ' ILE . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.688 ' CD ' HD13 ' A' ' 69' ' ' ILE . 12.8 mm100 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.739 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.635 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 43' ' ' ARG . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.463 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.688 HD13 ' CD ' ' A' ' 27' ' ' GLN . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HA2' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.625 ' CE3' HD12 ' A' ' 94' ' ' ILE . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 84' ' ' THR . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.625 HD12 ' CE3' ' A' ' 71' ' ' TRP . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.523 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 10' ' ' LEU . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 19' ' ' VAL . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 19' ' ' VAL . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD3' HD23 ' A' ' 10' ' ' LEU . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.955 HG21 ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 70' ' ' TYR . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 103' ' ' GLY . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.72 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' C ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.586 HD13 ' CG1' ' A' ' 19' ' ' VAL . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 110' ' ' VAL . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.445 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.738 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 33' ' ' LEU . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.738 HG23 ' CB ' ' A' ' 98' ' ' TYR . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.658 ' HE1' HG23 ' A' ' 110' ' ' VAL . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 96' ' ' VAL . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.619 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' ILE . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 50' ' ' ILE . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.955 ' SG ' HG21 ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 19' ' ' VAL . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 19' ' ' VAL . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 4' ' ' VAL . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.688 HG21 HD11 ' A' ' 69' ' ' ILE . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 96' ' ' VAL . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HA ' HG11 ' A' ' 105' ' ' VAL . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 HD22 ' A' ' 100' ' ' ASN . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 HG12 ' A' ' 97' ' ' VAL . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.466 ' CD1' HD23 ' A' ' 33' ' ' LEU . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.655 ' N ' HD13 ' A' ' 69' ' ' ILE . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' C ' ' HB3' ' A' ' 38' ' ' SER . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.5 tp-100 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.408 ' HB ' ' HE3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 17' ' ' PHE . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 64' ' ' LEU . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.747 HD22 HD22 ' A' ' 33' ' ' LEU . 20.1 t-20 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 116' ' ' VAL . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.54 ' HB3' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.441 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 19' ' ' VAL . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 2' ' ' PRO . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' HG11 ' A' ' 105' ' ' VAL . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 100' ' ' ASN . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.728 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 126' ' ' PHE . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.525 ' HB2' HG12 ' A' ' 54' ' ' VAL . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 52' ' ' TRP . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 64' ' ' LEU . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 57' ' ' CYS . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 24' ' ' ALA . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.613 HG12 HD23 ' A' ' 64' ' ' LEU . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.737 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.748 HD22 HD13 ' A' ' 33' ' ' LEU . 24.6 t-20 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CE2' HG13 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.501 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.602 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 21' ' ' VAL . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 10' ' ' LEU . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 100' ' ' ASN . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.413 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' H ' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.438 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' H ' HG22 ' A' ' 54' ' ' VAL . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.668 ' H ' HG13 ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 97' ' ' VAL . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 94' ' ' ILE . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CE3' HD12 ' A' ' 94' ' ' ILE . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 73' ' ' GLY . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 72' ' ' VAL . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.624 ' HA ' HG13 ' A' ' 110' ' ' VAL . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 64' ' ' LEU . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 106' ' ' GLN . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.63 HD22 HD13 ' A' ' 33' ' ' LEU . 10.0 t-20 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 99' ' ' ALA . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.409 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.506 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.506 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.525 ' HB2' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HB2' HG12 ' A' ' 21' ' ' VAL . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.642 HG23 HG23 ' A' ' 19' ' ' VAL . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 19' ' ' VAL . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' HG11 ' A' ' 19' ' ' VAL . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 5' ' ' THR . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' THR . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 107' ' ' TYR . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.668 HG22 HD11 ' A' ' 69' ' ' ILE . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 65' ' ' TRP . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.416 ' OH ' HD12 ' A' ' 50' ' ' ILE . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' OH ' ' A' ' 44' ' ' TYR . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.505 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 64' ' ' LEU . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 62' ' ' ALA . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 57' ' ' CYS . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.571 ' CD1' HD22 ' A' ' 33' ' ' LEU . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.668 HD11 HG22 ' A' ' 23' ' ' THR . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 18' ' ' LYS . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.474 HD13 ' CG1' ' A' ' 19' ' ' VAL . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 28' ' ' ALA . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 64' ' ' LEU . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.502 ' CE2' HG23 ' A' ' 21' ' ' VAL . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.414 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 96' ' ' VAL . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 19' ' ' VAL . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 19' ' ' VAL . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HD23 ' A' ' 10' ' ' LEU . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HD2' HG12 ' A' ' 72' ' ' VAL . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 6' ' ' CYS . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' A' ' 69' ' ' ILE . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 126' ' ' PHE . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 56' ' ' ASN . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.736 ' H ' HG12 ' A' ' 54' ' ' VAL . 36.1 t30 -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' OD1' ' A' ' 20' ' ' ASP . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.613 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' A' ' 18' ' ' LYS . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.613 HD12 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HA ' HG13 ' A' ' 110' ' ' VAL . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 111' ' ' MET . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.4 t30 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.659 HE22 HG11 ' A' ' 54' ' ' VAL . 9.8 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.436 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.62 ' O ' HD22 ' A' ' 10' ' ' LEU . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.526 ' HA ' HG12 ' A' ' 116' ' ' VAL . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 19' ' ' VAL . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 6' ' ' CYS . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 4' ' ' VAL . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' ALA . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.638 HG21 HD11 ' A' ' 69' ' ' ILE . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.995 HD13 HD22 ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.748 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 126' ' ' PHE . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 52' ' ' TRP . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' HG12 ' A' ' 54' ' ' VAL . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.547 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 18' ' ' LYS . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 86' ' ' GLN . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' HG13 ' A' ' 82' ' ' VAL . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.599 HD11 ' CD2' ' A' ' 17' ' ' PHE . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.578 HG12 HD12 ' A' ' 64' ' ' LEU . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.995 HD22 HD13 ' A' ' 33' ' ' LEU . 18.0 t-20 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.42 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.434 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.593 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 3' ' ' ILE . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 19' ' ' VAL . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 19' ' ' VAL . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 5' ' ' THR . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 4' ' ' VAL . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD2' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.515 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 69' ' ' ILE . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HG3' HG22 ' A' ' 69' ' ' ILE . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 100' ' ' ASN . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 41' ' ' PRO . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' VAL . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.504 ' H ' HG13 ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.612 HD23 ' CG1' ' A' ' 97' ' ' VAL . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.788 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CE3' HD12 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HE2' ' CZ2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.861 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HZ2' HG22 ' A' ' 84' ' ' THR . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.51 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.401 ' HA3' ' NZ ' ' A' ' 74' ' ' LYS . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.788 HG22 HD11 ' A' ' 69' ' ' ILE . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 64' ' ' LEU . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.706 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.684 HD22 HD13 ' A' ' 33' ' ' LEU . 17.8 t-20 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 98' ' ' TYR . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 96' ' ' VAL . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.444 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 6' ' ' CYS . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.561 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.56 HG13 ' HA ' ' A' ' 120' ' ' ASN . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.56 ' HA ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 117' ' ' ASP . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.561 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.834 HG23 HG23 ' A' ' 19' ' ' VAL . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' A' ' 103' ' ' GLY . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.438 HG23 ' HE2' ' A' ' 128' ' ' LYS . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.551 ' HB2' HG12 ' A' ' 54' ' ' VAL . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 52' ' ' TRP . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 94' ' ' ILE . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 4.8 tp-100 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.76 HD13 ' CG1' ' A' ' 19' ' ' VAL . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 27' ' ' GLN . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 33' ' ' LEU . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.636 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 10' ' ' LEU . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.583 ' HA ' HG12 ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 50' ' ' ILE . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.918 ' SG ' HG21 ' A' ' 19' ' ' VAL . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.48 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' ALA . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HG3' HG22 ' A' ' 69' ' ' ILE . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 103' ' ' GLY . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 52' ' ' TRP . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.43 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.476 ' CE3' HD12 ' A' ' 94' ' ' ILE . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.469 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 38' ' ' SER . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 82' ' ' VAL . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.516 ' HB ' HD11 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 28' ' ' ALA . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 33' ' ' LEU . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 120' ' ' ASN . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 19' ' ' VAL . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD23 ' HE2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HE2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 4' ' ' VAL . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.683 HG21 HD11 ' A' ' 69' ' ' ILE . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.578 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 100' ' ' ASN . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.646 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 52' ' ' TRP . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 97' ' ' VAL . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.412 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 94' ' ' ILE . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.503 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.528 ' HZ2' HG22 ' A' ' 84' ' ' THR . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.528 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 82' ' ' VAL . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 17' ' ' PHE . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 28' ' ' ALA . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG12 HD23 ' A' ' 64' ' ' LEU . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.438 HD22 ' CD1' ' A' ' 33' ' ' LEU . 4.9 t-20 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.501 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.714 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.852 ' SG ' HG21 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' HG22 ' A' ' 19' ' ' VAL . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HD3' HD23 ' A' ' 10' ' ' LEU . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 4' ' ' VAL . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.84 HD13 HD22 ' A' ' 100' ' ' ASN . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.437 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' HA2' ' A' ' 89' ' ' GLY . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.524 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 76' ' ' ALA . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' MET . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 24' ' ' ALA . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.84 HD22 HD13 ' A' ' 33' ' ' LEU . 26.2 t-20 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.434 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.561 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 50' ' ' ILE . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 94' ' ' ILE . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.537 HD13 ' ND2' ' A' ' 100' ' ' ASN . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.407 ' CE1' HH21 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.456 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.548 ' O ' HG13 ' A' ' 97' ' ' VAL . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 94' ' ' ILE . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.778 HG11 HE22 ' A' ' 87' ' ' GLN . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.778 HE22 HG11 ' A' ' 82' ' ' VAL . 7.9 tp-100 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.734 HD12 ' CE3' ' A' ' 71' ' ' TRP . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.407 HH21 ' CE1' ' A' ' 42' ' ' HIS . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 65' ' ' TRP . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.537 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.688 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 120' ' ' ASN . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.751 ' HA ' HG23 ' A' ' 116' ' ' VAL . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.468 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' VAL . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' CE2' ' A' ' 107' ' ' TYR . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' ND2' ' A' ' 100' ' ' ASN . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 97' ' ' VAL . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.659 ' CE3' HD12 ' A' ' 94' ' ' ILE . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.491 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 38' ' ' SER . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.453 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.659 HD12 ' CE3' ' A' ' 71' ' ' TRP . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 28' ' ' ALA . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 64' ' ' LEU . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.484 ' ND2' HD13 ' A' ' 33' ' ' LEU . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 98' ' ' TYR . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.452 ' CE2' HG23 ' A' ' 21' ' ' VAL . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.486 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 117' ' ' ASP . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 120' ' ' ASN . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.624 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.54 -19.02 37.73 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.803 3.002 . . . . 0.0 112.425 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -71.23 123.21 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 O-C-N 120.465 -1.397 . . . . 0.0 110.522 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 19' ' ' VAL . 32.0 m -131.1 -171.89 0.84 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.136 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 19' ' ' VAL . 9.3 p -150.58 127.48 11.06 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 43.6 m -58.96 166.15 2.12 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.841 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.49 56.97 0.52 Allowed Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.526 1.13 . . . . 0.0 111.541 173.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 61.3 Cg_endo -78.92 164.86 24.85 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.305 2.67 . . . . 0.0 110.833 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -108.87 125.44 51.99 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.621 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -85.22 -80.5 0.21 Allowed 'General case' 0 CA--C 1.534 0.342 0 O-C-N 124.477 1.11 . . . . 0.0 109.12 176.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -127.69 34.76 4.6 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.459 1.504 . . . . 0.0 111.323 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.75 -28.08 7.96 Favored Glycine 0 CA--C 1.523 0.534 0 O-C-N 120.506 -1.371 . . . . 0.0 113.597 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -101.21 142.65 32.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.819 0.848 . . . . 0.0 110.882 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -77.3 125.12 28.82 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.957 0.786 . . . . 0.0 109.271 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 ttpp -117.08 136.74 23.42 Favored Pre-proline 0 C--O 1.22 -0.453 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.326 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.9 116.45 3.98 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.847 3.031 . . . . 0.0 111.578 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.551 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.6 114.12 26.3 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 118.885 -0.578 . . . . 0.0 110.399 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.83 112.1 0.39 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.634 1.173 . . . . 0.0 112.787 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 4' ' ' VAL . 11.3 m -150.82 114.67 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 CA-C-O 123.32 1.533 . . . . 0.0 110.62 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' HD12 ' A' ' 3' ' ' ILE . 14.3 p-10 -96.25 132.9 41.22 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 118.879 -2.388 . . . . 0.0 111.139 177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.45 -41.87 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.065 -1.022 . . . . 0.0 112.071 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.83 -62.01 1.67 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.584 0.753 . . . . 0.0 110.546 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.58 -40.25 78.57 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.538 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -54.65 42.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.624 1.17 . . . . 0.0 110.963 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -66.31 -32.22 73.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.713 -1.242 . . . . 0.0 112.29 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.71 77.0 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.969 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HB3' HD13 ' A' ' 69' ' ' ILE . 8.7 pt20 -66.5 -37.91 86.1 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.891 0.769 . . . . 0.0 111.943 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.67 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -67.92 -51.06 52.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.345 0.658 . . . . 0.0 110.607 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HA ' HG11 ' A' ' 105' ' ' VAL . 7.1 tpt180 -63.65 -40.76 97.67 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 118.89 -0.576 . . . . 0.0 111.53 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -61.37 -50.49 72.69 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.736 0.814 . . . . 0.0 111.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.89 -31.3 70.99 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.797 0.686 . . . . 0.0 112.085 177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.78 -167.54 15.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.916 0.77 . . . . 0.0 111.784 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.515 HD13 HD22 ' A' ' 100' ' ' ASN . 1.1 mt -101.42 38.86 1.51 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.578 -0.954 . . . . 0.0 111.352 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.1 p -140.93 118.64 11.66 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 122.806 1.289 . . . . 0.0 111.739 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.6 t -134.1 157.58 45.79 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.313 -0.867 . . . . 0.0 112.46 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.25 -31.91 0.31 Allowed Glycine 0 C--O 1.22 -0.724 0 CA-C-O 118.864 -0.964 . . . . 0.0 113.035 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -47.74 11.18 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.43 1.092 . . . . 0.0 111.456 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 92.8 p -131.54 -64.98 0.78 Allowed 'General case' 0 C--N 1.339 0.126 0 C-N-CA 125.214 1.406 . . . . 0.0 111.634 -176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.17 -25.11 0.05 OUTLIER Glycine 0 C--O 1.225 -0.451 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.37 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.62 146.77 34.71 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.924 0.889 . . . . 0.0 111.344 -176.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.49 179.99 11.73 Favored 'Cis proline' 0 C--O 1.211 -0.871 0 N-CA-C 114.439 0.9 . . . . 0.0 114.439 -4.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.55 151.38 48.96 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 120.571 -1.331 . . . . 0.0 109.106 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 -77.72 121.68 24.34 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 122.893 0.477 . . . . 0.0 109.971 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.64 133.35 35.19 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.016 0.823 . . . . 0.0 108.812 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -128.22 139.34 52.51 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.468 1.107 . . . . 0.0 109.5 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -34.23 100.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.404 1.482 . . . . 0.0 113.243 174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -40.67 0.02 OUTLIER Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.434 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.49 8.47 11.55 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 121.677 0.751 . . . . 0.0 111.427 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.1 m170 55.15 33.99 21.68 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 119.64 -1.912 . . . . 0.0 112.15 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.481 HG21 ' CE2' ' A' ' 52' ' ' TRP . 52.5 mt -93.85 146.83 6.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -119.26 -28.12 5.49 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.048 1.339 . . . . 0.0 113.982 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.481 ' CE2' HG21 ' A' ' 50' ' ' ILE . 74.3 m95 63.69 20.99 12.51 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.278 1.031 . . . . 0.0 112.891 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.22 28.23 26.1 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.861 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 56' ' ' ASN . 73.3 t -127.76 145.56 34.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 118.081 0.941 . . . . 0.0 109.424 -176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.27 -39.8 71.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.709 0.766 . . . . 0.0 112.375 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.463 ' H ' HG12 ' A' ' 54' ' ' VAL . 60.7 t30 -62.25 -54.2 44.15 Favored 'General case' 0 C--O 1.224 -0.245 0 O-C-N 121.527 -0.733 . . . . 0.0 111.949 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.442 ' SG ' HD11 ' A' ' 64' ' ' LEU . 76.4 m -68.99 -39.52 79.33 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-O 116.443 -1.741 . . . . 0.0 112.906 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -43.14 -38.38 2.41 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.942 1.297 . . . . 0.0 113.026 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 42.6 mtmt -40.38 148.67 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.694 1.235 . . . . 0.0 112.294 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.26 -65.64 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.361 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.36 32.26 0.19 Allowed 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 123.076 1.417 . . . . 0.0 112.176 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.12 -175.07 5.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 119.525 -1.984 . . . . 0.0 112.068 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.85 99.24 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.404 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.651 HD13 ' HA ' ' A' ' 99' ' ' ALA . 1.6 mm? -108.67 -177.69 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -144.13 167.87 21.37 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.145 1.378 . . . . 0.0 111.885 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 9.2 pt-20 -149.57 136.19 19.34 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.774 0.83 . . . . 0.0 110.571 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 49.5 t80 -142.88 139.08 16.54 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.251 -0.281 . . . . 0.0 111.583 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 52.2 Cg_endo -71.3 164.52 35.47 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 124.111 3.207 . . . . 0.0 113.359 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 27' ' ' GLN . 10.5 tp -159.91 158.47 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 122.303 1.049 . . . . 0.0 111.491 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.474 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 20.7 m-85 -104.97 116.63 32.29 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.006 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.455 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 9.5 p90 -56.79 -179.4 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 121.853 0.835 . . . . 0.0 112.157 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.67 -43.78 97.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.402 -0.811 . . . . 0.0 112.066 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.2 -37.43 80.44 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 122.227 -0.296 . . . . 0.0 113.232 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -67.7 154.56 41.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 111.206 174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -121.52 39.61 3.8 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.729 1.212 . . . . 0.0 111.092 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -149.81 178.0 9.29 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.476 -1.39 . . . . 0.0 110.744 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -141.96 153.4 44.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.27 0.628 . . . . 0.0 110.814 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.493 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 7.2 t-105 -76.13 143.63 41.1 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.741 0.781 . . . . 0.0 109.826 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.09 174.36 7.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 123.188 1.47 . . . . 0.0 112.394 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.93 -59.64 2.42 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.122 -1.611 . . . . 0.0 111.203 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -90.4 46.73 1.36 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.566 1.174 . . . . 0.0 112.022 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 89.5 t -140.37 114.11 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 O-C-N 120.487 -1.383 . . . . 0.0 109.739 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 ttpt -71.85 167.6 19.66 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.746 176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.4 p -55.88 -31.78 63.12 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.9 p -69.06 -51.21 41.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.626 0.77 . . . . 0.0 113.078 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -68.38 -34.24 75.7 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 123.381 0.672 . . . . 0.0 110.944 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.1 tp-100 -44.32 122.72 3.12 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.13 0.972 . . . . 0.0 111.582 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -99.79 -39.11 8.38 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.632 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -38.79 -53.48 2.44 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 125.035 1.459 . . . . 0.0 112.489 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.07 162.92 10.62 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.838 -0.801 . . . . 0.0 112.975 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.6 143.04 55.34 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.917 3.078 . . . . 0.0 111.602 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.73 115.88 4.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 124.157 0.983 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 58.3 Cg_endo -72.09 -33.92 8.92 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.154 2.569 . . . . 0.0 112.684 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.551 HD11 ' CD2' ' A' ' 17' ' ' PHE . 60.4 mt -65.3 124.09 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 O-C-N 124.114 0.884 . . . . 0.0 109.781 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -131.07 132.26 44.77 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.609 0.763 . . . . 0.0 110.937 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.67 HG21 ' HB2' ' A' ' 28' ' ' ALA . 13.5 p -70.12 130.52 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 122.02 -0.425 . . . . 0.0 111.971 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 41.4 t -114.89 138.15 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 C-N-CA 124.753 1.221 . . . . 0.0 111.056 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -154.87 145.07 21.89 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.487 -174.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.651 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -74.81 157.3 35.39 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.14 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.515 HD22 HD13 ' A' ' 33' ' ' LEU . 6.6 t-20 -66.76 -22.57 66.04 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-O 117.294 -1.336 . . . . 0.0 111.734 173.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 16.0 t 33.48 42.79 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.279 1.431 . . . . 0.0 112.517 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 45.33 57.97 4.48 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.983 -1.073 . . . . 0.0 113.871 -172.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.18 33.63 19.9 Favored Glycine 0 CA--C 1.535 1.324 0 N-CA-C 114.813 0.685 . . . . 0.0 114.813 -174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 101' ' ' SER . . . -146.54 161.89 39.52 Favored 'General case' 0 C--O 1.218 -0.575 0 CA-C-N 118.577 1.188 . . . . 0.0 111.493 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.756 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.3 p -117.05 128.96 74.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 125.801 1.64 . . . . 0.0 110.09 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -108.9 23.87 13.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' O ' ' CG ' ' A' ' 107' ' ' TYR . 7.0 t80 31.86 58.42 0.33 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.311 1.444 . . . . 0.0 109.051 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.429 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 11.9 t -44.06 -36.28 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.793 -1.192 . . . . 0.0 112.726 -177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.73 23.32 Favored Glycine 0 C--O 1.219 -0.814 0 C-N-CA 125.333 1.444 . . . . 0.0 110.287 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 129' ' ' CYS . 0.0 OUTLIER -99.41 133.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 O-C-N 120.424 -1.633 . . . . 0.0 110.044 174.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 24.1 ptt? -110.06 170.12 8.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.152 0.981 . . . . 0.0 109.829 177.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 5.8 t -157.29 167.82 29.2 Favored 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 124.401 1.08 . . . . 0.0 111.646 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' HB3' ' A' ' 93' ' ' PRO . 18.3 m170 -80.81 165.2 22.09 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 120.834 -1.166 . . . . 0.0 111.832 175.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 p -107.3 17.55 22.72 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.039 -1.038 . . . . 0.0 112.542 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.3 tppt? -136.24 74.83 1.52 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.955 -1.091 . . . . 0.0 110.171 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.487 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.2 m -107.33 74.79 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.21 -0.988 0 O-C-N 123.413 0.446 . . . . 0.0 111.206 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -58.0 -75.71 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.676 1.227 . . . . 0.0 112.492 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -133.41 -44.5 0.83 Allowed 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 120.791 -1.193 . . . . 0.0 110.243 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -95.27 15.65 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.957 0.503 . . . . 0.0 112.12 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.4 OUTLIER 48.13 46.87 19.57 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.98 0.912 . . . . 0.0 111.824 179.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -60.49 -73.01 0.1 Allowed 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.819 0.818 . . . . 0.0 109.29 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.479 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 88.56 128.37 3.06 Favored Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 123.895 0.759 . . . . 0.0 112.486 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -126.8 -39.57 1.96 Allowed 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.8 177.01 4.45 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.929 0.768 . . . . 0.0 110.256 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -52.72 175.77 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 122.993 1.377 . . . . 0.0 113.208 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.1 m-85 -98.56 87.86 3.94 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.975 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.1 pp20? -59.95 131.53 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.742 -1.224 . . . . 0.0 111.439 173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.431 ' CG ' HG23 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -63.97 148.05 50.55 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.667 0.787 . . . . 0.0 110.594 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.506 ' HB2' HG23 ' A' ' 110' ' ' VAL . 71.3 m -87.9 162.55 16.86 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.639 0.376 . . . . 0.0 110.565 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 C--O 1.258 1.504 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.668 ' O ' HG12 ' A' ' 21' ' ' VAL . 59.7 Cg_endo -69.05 -15.75 39.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 176.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -93.51 137.65 22.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 120.25 -1.531 . . . . 0.0 110.154 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 19' ' ' VAL . 6.0 m -130.33 178.58 5.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 C-N-CA 124.757 1.223 . . . . 0.0 111.752 176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 p -146.01 114.05 6.56 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 177.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' HB3' HG21 ' A' ' 112' ' ' THR . 11.5 m -56.95 159.9 3.86 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.607 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -109.97 39.04 0.14 Allowed Pre-proline 0 N--CA 1.479 0.984 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 58.5 Cg_endo -66.15 169.21 14.08 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 124.088 3.192 . . . . 0.0 111.435 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -98.45 121.92 40.99 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 122.656 1.217 . . . . 0.0 112.056 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.541 HD23 ' NZ ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -95.36 -78.17 0.46 Allowed 'General case' 0 C--N 1.323 -0.578 0 O-C-N 120.739 -1.226 . . . . 0.0 109.858 176.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.9 35.67 4.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 123.253 1.502 . . . . 0.0 109.805 -173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.37 -33.34 6.3 Favored Glycine 0 N--CA 1.464 0.519 0 O-C-N 119.637 -1.914 . . . . 0.0 113.317 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -98.1 163.01 12.92 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.908 0.883 . . . . 0.0 112.04 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.89 118.8 23.7 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.714 0.634 . . . . 0.0 110.4 177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.541 ' NZ ' HD23 ' A' ' 10' ' ' LEU . 34.3 ttpt -105.83 133.51 20.17 Favored Pre-proline 0 N--CA 1.468 0.452 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.464 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.51 97.76 0.38 Allowed 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 124.549 3.499 . . . . 0.0 112.204 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.13 112.28 16.19 Favored 'General case' 0 C--O 1.214 -0.809 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.34 125.04 13.19 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 117.639 -1.172 . . . . 0.0 111.545 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.813 HG23 HG23 ' A' ' 4' ' ' VAL . 4.7 m -153.66 113.62 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 O-C-N 125.02 1.45 . . . . 0.0 111.823 -178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.3 136.03 39.06 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 120.297 -1.502 . . . . 0.0 110.867 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 2' ' ' PRO . 14.4 p -61.81 -39.56 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.619 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.28 -46.16 62.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.165 0.986 . . . . 0.0 110.56 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.3 m -71.05 -49.59 43.15 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 123.963 0.905 . . . . 0.0 109.387 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.06 -44.99 71.55 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -71.28 -44.96 64.22 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.496 0.718 . . . . 0.0 112.11 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.19 -53.16 57.3 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.123 0.569 . . . . 0.0 110.485 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.491 HE21 ' CG1' ' A' ' 96' ' ' VAL . 18.2 pt20 -63.09 -46.17 88.63 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 123.386 0.674 . . . . 0.0 111.658 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.64 -49.85 71.77 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.516 0.674 . . . . 0.0 110.476 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -69.08 -35.6 76.67 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.628 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -60.06 -47.46 85.79 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.032 0.933 . . . . 0.0 111.482 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.697 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -72.82 -40.53 65.71 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.756 0.822 . . . . 0.0 111.392 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 -163.53 48.0 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 121.731 0.628 . . . . 0.0 112.015 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.7 mt -109.68 37.07 2.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.674 1.189 . . . . 0.0 110.531 -177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 m -149.01 115.54 5.89 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.006 -1.059 . . . . 0.0 110.173 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -124.83 171.42 10.16 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.55 0.74 . . . . 0.0 111.775 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.52 -23.9 0.95 Allowed Glycine 0 C--O 1.221 -0.69 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.941 174.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -38.88 81.26 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 123.818 0.847 . . . . 0.0 111.976 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.9 p -136.83 -67.67 0.5 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.293 1.037 . . . . 0.0 112.881 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -176.85 -26.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.208 -1.329 . . . . 0.0 112.585 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -115.94 143.11 30.2 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.965 0.906 . . . . 0.0 110.337 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.697 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 67.3 Cg_endo -68.09 174.92 32.58 Favored 'Cis proline' 0 C--O 1.211 -0.864 0 N-CA-C 113.757 0.637 . . . . 0.0 113.757 -0.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.4 154.23 33.96 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.026 -1.046 . . . . 0.0 109.579 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.8 mmm-85 -79.68 107.42 12.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.34 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -82.74 107.86 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.278 0.986 . . . . 0.0 108.845 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -106.44 144.84 32.54 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 121.108 -0.995 . . . . 0.0 110.221 172.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -43.93 101.2 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.34 1.056 . . . . 0.0 112.265 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.64 -46.14 0.02 OUTLIER Glycine 0 C--O 1.237 0.296 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.85 136.8 45.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.987 0.899 . . . . 0.0 109.541 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -73.13 56.2 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.087 -1.008 . . . . 0.0 112.634 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -113.21 154.61 14.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 C-N-CA 124.851 1.26 . . . . 0.0 109.664 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.8 109.15 7.84 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.884 1.674 . . . . 0.0 108.725 178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 54' ' ' VAL . 16.2 m95 -86.03 0.05 54.32 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.052 -1.03 . . . . 0.0 112.239 173.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.65 -18.58 2.26 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.191 0.9 . . . . 0.0 113.921 -175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 57' ' ' CYS . 10.0 p -81.28 138.43 19.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.834 0.854 . . . . 0.0 110.923 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.54 -40.36 92.8 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.508 0.671 . . . . 0.0 112.269 177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -52.37 -37.07 55.38 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.639 -0.663 . . . . 0.0 112.095 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.629 ' SG ' HD21 ' A' ' 64' ' ' LEU . 51.1 m -102.55 29.92 4.97 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.55 1.14 . . . . 0.0 112.909 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -118.72 -29.26 5.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.864 1.266 . . . . 0.0 111.609 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 18.2 mmmt -57.33 162.53 2.72 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.758 0.79 . . . . 0.0 110.91 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.38 9.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.846 0.832 . . . . 0.0 111.66 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -92.04 30.0 1.51 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 122.654 1.216 . . . . 0.0 111.784 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.83 169.02 18.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.109 -1.619 . . . . 0.0 111.99 177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.5 mt -130.05 94.97 2.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 123.795 0.838 . . . . 0.0 109.401 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD21 ' SG ' ' A' ' 57' ' ' CYS . 10.3 mp -104.54 178.2 4.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.076 0.941 . . . . 0.0 110.167 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.8 m95 -144.18 148.83 35.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.624 1.169 . . . . 0.0 110.736 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 6.0 pt-20 -125.16 136.45 53.62 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.145 1.378 . . . . 0.0 110.775 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 44.4 t80 -137.15 138.67 26.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.033 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 49.2 Cg_endo -65.56 168.83 13.88 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 124.596 3.531 . . . . 0.0 111.965 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 27' ' ' GLN . 9.4 tt -142.89 170.29 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.329 0.585 . . . . 0.0 111.583 177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 34.2 m-85 -128.69 104.83 7.87 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.846 -1.158 . . . . 0.0 109.823 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.46 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 19.7 p90 -57.16 175.8 0.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.673 0.749 . . . . 0.0 111.857 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.79 -42.3 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.39 -27.74 48.43 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.466 0.555 . . . . 0.0 112.696 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.476 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.6 mttm -80.55 164.11 23.19 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 122.478 1.133 . . . . 0.0 112.124 173.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -132.13 35.26 3.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.767 0.794 . . . . 0.0 111.76 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.5 -178.59 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 120.807 -1.183 . . . . 0.0 110.725 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 24.4 tt0 -138.41 163.99 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.187 0.995 . . . . 0.0 111.229 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 9.0 t-105 -73.01 128.9 36.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.507 0.67 . . . . 0.0 109.501 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -77.61 171.45 14.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 122.379 1.085 . . . . 0.0 112.287 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -80.38 -55.57 4.8 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.279 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.96 47.05 0.95 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.623 1.569 . . . . 0.0 111.397 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 93.1 t -133.38 121.9 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 O-C-N 120.25 -1.531 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -74.95 160.5 30.51 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.902 -0.499 . . . . 0.0 110.159 176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.6 p -48.48 -37.24 16.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.269 1.028 . . . . 0.0 113.543 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.2 t -62.94 -62.02 2.0 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.759 0.824 . . . . 0.0 112.24 175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -55.09 -34.95 64.09 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.682 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.0 tp-100 -39.41 103.12 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.616 1.566 . . . . 0.0 112.041 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -82.2 -43.12 18.07 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.462 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.12 -39.84 3.15 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.601 1.096 . . . . 0.0 113.57 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.68 165.97 11.37 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.414 1.007 . . . . 0.0 111.253 170.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 148.08 68.87 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.727 2.952 . . . . 0.0 111.788 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.69 117.03 4.27 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 123.747 0.819 . . . . 0.0 110.965 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 42.0 Cg_endo -73.5 -40.82 1.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.078 2.518 . . . . 0.0 112.01 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' CG1' ' A' ' 19' ' ' VAL . 51.8 mt -56.5 126.01 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 O-C-N 124.387 1.054 . . . . 0.0 109.391 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -135.37 134.63 39.96 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 123.265 0.626 . . . . 0.0 111.24 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.61 ' HA ' HG12 ' A' ' 110' ' ' VAL . 7.3 p -77.7 133.62 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 C-N-CA 123.064 0.546 . . . . 0.0 111.76 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.614 ' CG1' HD23 ' A' ' 64' ' ' LEU . 21.4 t -109.89 138.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.363 1.078 . . . . 0.0 110.941 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 65' ' ' TRP . 0.5 OUTLIER -148.15 140.51 24.32 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.388 -0.82 . . . . 0.0 110.188 -176.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.23 154.72 21.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.412 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.75 83.66 7.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.624 0.726 . . . . 0.0 110.646 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -100.85 83.25 2.51 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.387 -0.821 . . . . 0.0 109.775 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 59.76 40.15 19.98 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.5 0.667 . . . . 0.0 112.381 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 81.68 -31.04 2.78 Favored Glycine 0 CA--C 1.534 1.258 0 O-C-N 121.391 -0.818 . . . . 0.0 113.633 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.36 142.78 47.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.424 1.107 . . . . 0.0 111.311 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.72 143.45 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.272 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -108.63 18.14 21.19 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.942 -1.028 . . . . 0.0 112.51 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.3 t80 37.23 58.13 1.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.841 0.857 . . . . 0.0 110.191 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 53.7 t -42.9 -36.04 1.39 Allowed 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.474 -0.766 . . . . 0.0 112.718 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.24 159.11 8.54 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -92.54 150.39 3.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 O-C-N 120.545 -1.562 . . . . 0.0 111.185 173.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -128.51 172.92 10.7 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.541 1.136 . . . . 0.0 110.912 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 6' ' ' CYS . 6.7 t -155.49 147.36 23.31 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.86 1.664 . . . . 0.0 111.59 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.462 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 17.6 m170 -68.59 152.19 45.71 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.002 -1.061 . . . . 0.0 111.045 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 t -82.65 -40.8 20.24 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.296 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 101.96 13.6 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 120.081 1.309 . . . . 0.0 111.82 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.82 77.3 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-N 118.902 0.773 . . . . 0.0 111.067 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -59.55 -75.77 0.05 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.533 1.158 . . . . 0.0 112.316 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -135.05 -45.92 0.72 Allowed 'General case' 0 CA--C 1.505 -0.761 0 O-C-N 121.315 -0.866 . . . . 0.0 110.866 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -74.88 -13.62 60.57 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 123.477 0.486 . . . . 0.0 111.814 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 68.53 35.81 3.11 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 122.359 1.076 . . . . 0.0 110.175 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -69.22 179.83 1.82 Allowed 'General case' 0 CA--C 1.534 0.33 0 O-C-N 119.978 -1.701 . . . . 0.0 111.678 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -120.74 106.09 1.12 Allowed Glycine 0 CA--C 1.494 -1.224 0 O-C-N 119.419 -2.051 . . . . 0.0 112.394 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -103.8 -48.14 4.01 Favored 'General case' 0 C--O 1.218 -0.59 0 O-C-N 124.871 0.983 . . . . 0.0 111.695 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -90.5 -179.06 5.49 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.934 0.771 . . . . 0.0 111.797 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.443 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 3.6 p90 -53.88 165.26 0.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.837 1.303 . . . . 0.0 112.475 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.3 m-85 -92.08 114.31 26.82 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.68 1.229 . . . . 0.0 108.452 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.9 mt-10 -86.63 125.61 33.95 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.438 -0.789 . . . . 0.0 109.995 177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -54.98 157.49 3.23 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.142 -0.974 . . . . 0.0 110.501 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 62.9 m -111.19 136.82 49.7 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 124.135 0.974 . . . . 0.0 110.704 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 126.443 1.897 . . . . 0.0 112.162 -177.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 117.003 -1.475 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 72.5 Cg_endo -69.69 -0.04 6.29 Favored 'Trans proline' 0 CA--C 1.545 1.066 0 C-N-CA 124.13 3.22 . . . . 0.0 114.338 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -105.94 109.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.581 1.552 . . . . 0.0 108.829 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 19' ' ' VAL . 3.6 m -109.68 -179.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 124.437 1.095 . . . . 0.0 111.816 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -150.43 116.58 5.65 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -57.34 167.74 0.9 Allowed 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 117.592 0.178 . . . . 0.0 110.941 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtm-85 -108.97 43.21 0.16 Allowed Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.56 147.11 86.22 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.673 2.916 . . . . 0.0 112.331 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -86.0 129.66 34.77 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.005 173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.857 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.14 -88.0 0.34 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 125.159 1.537 . . . . 0.0 110.33 172.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -112.52 39.55 2.45 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.812 2.045 . . . . 0.0 110.336 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.22 -27.06 22.03 Favored Glycine 0 N--CA 1.469 0.84 0 O-C-N 119.179 -2.201 . . . . 0.0 114.345 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -101.42 140.72 35.33 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.467 1.133 . . . . 0.0 111.077 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -73.51 108.1 6.17 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 108.75 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -95.5 139.75 22.08 Favored Pre-proline 0 C--O 1.221 -0.429 0 O-C-N 121.726 -0.609 . . . . 0.0 111.821 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.53 114.9 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.715 2.943 . . . . 0.0 111.448 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -88.53 109.92 20.45 Favored 'General case' 0 C--O 1.219 -0.533 0 O-C-N 121.242 -0.911 . . . . 0.0 110.655 177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -46.24 114.07 0.74 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.813 1.245 . . . . 0.0 112.233 177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.849 HG23 HG23 ' A' ' 4' ' ' VAL . 13.7 m -146.75 136.95 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 122.869 1.318 . . . . 0.0 109.972 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.14 130.97 54.85 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 120.388 -1.445 . . . . 0.0 109.803 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.731 HG23 ' CE2' ' A' ' 107' ' ' TYR . 14.8 p -56.88 -36.62 50.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.466 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.23 -56.06 24.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.746 0.818 . . . . 0.0 109.789 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.614 ' CG2' HD11 ' A' ' 69' ' ' ILE . 53.4 m -62.18 -57.32 11.92 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.14 0.576 . . . . 0.0 110.554 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.67 -53.44 24.41 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.915 0.78 . . . . 0.0 112.16 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -57.1 -46.04 82.89 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.965 1.306 . . . . 0.0 111.19 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.55 -50.89 52.28 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 11.8 mm100 -64.52 -42.52 95.73 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.738 -0.649 . . . . 0.0 112.715 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.25 -58.12 8.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.315 1.046 . . . . 0.0 111.732 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -65.66 -43.94 87.81 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.382 0.673 . . . . 0.0 111.778 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -56.89 -46.11 82.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.706 1.202 . . . . 0.0 111.289 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.14 -41.23 77.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.865 0.866 . . . . 0.0 111.401 176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.14 -164.96 50.24 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.684 0.602 . . . . 0.0 111.995 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 105' ' ' VAL . 5.6 mt -110.97 33.2 4.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.365 1.466 . . . . 0.0 110.686 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.75 115.26 5.91 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.592 0.71 . . . . 0.0 109.685 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -117.55 166.32 12.51 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.064 1.346 . . . . 0.0 111.351 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.72 -15.96 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.427 1.013 . . . . 0.0 114.292 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -55.67 32.12 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.122 1.769 . . . . 0.0 112.059 176.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.4 p -131.92 -56.02 0.99 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.883 0.873 . . . . 0.0 112.699 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.71 -29.94 0.05 OUTLIER Glycine 0 C--O 1.227 -0.317 0 C-N-CA 124.045 0.831 . . . . 0.0 113.218 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.6 OUTLIER -105.18 154.18 39.03 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 177.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 80.5 Cg_endo -64.95 176.66 17.01 Favored 'Cis proline' 0 C--N 1.352 0.716 0 N-CA-C 113.772 0.643 . . . . 0.0 113.772 -6.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -122.13 140.44 52.54 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.784 -1.197 . . . . 0.0 109.316 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 20.3 mmm-85 -70.84 133.81 46.81 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -108.71 106.34 16.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -102.55 -57.69 2.01 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.698 0.799 . . . . 0.0 110.224 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -171.73 171.56 5.21 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.061 1.744 . . . . 0.0 109.931 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.46 -46.04 1.08 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.211 1.386 . . . . 0.0 111.518 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.41 120.22 32.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.831 0.824 . . . . 0.0 109.272 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -70.68 70.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.368 -1.458 . . . . 0.0 112.642 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.0 mt -106.9 164.01 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.841 -1.162 . . . . 0.0 110.327 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -145.82 117.0 7.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 123.361 1.553 . . . . 0.0 107.091 176.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -92.87 -4.17 53.36 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.021 -1.049 . . . . 0.0 111.546 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.33 22.99 66.02 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.31 0.481 . . . . 0.0 113.661 -172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.7 119.14 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -43.45 -38.13 2.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.228 1.411 . . . . 0.0 113.164 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.82 -52.07 53.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.284 1.034 . . . . 0.0 112.801 174.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.83 25.02 0.58 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.615 1.166 . . . . 0.0 113.851 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -122.15 28.95 7.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.493 1.917 . . . . 0.0 111.502 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 16.2 mtpp -112.11 175.61 5.36 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.497 -1.377 . . . . 0.0 111.19 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.32 -41.99 5.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.634 1.174 . . . . 0.0 112.711 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -98.07 30.13 3.21 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.38 1.472 . . . . 0.0 111.361 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.04 157.15 31.3 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 123.112 1.434 . . . . 0.0 112.233 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.64 80.95 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.531 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.3 mp -97.64 -177.12 3.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 122.532 1.158 . . . . 0.0 110.33 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 63.0 m95 -146.62 169.98 17.87 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.571 1.948 . . . . 0.0 111.625 177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -148.32 139.34 23.18 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.597 1.159 . . . . 0.0 111.005 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 63.0 t80 -147.87 132.23 8.71 Favored Pre-proline 0 CA--C 1.539 0.546 0 O-C-N 121.272 -0.892 . . . . 0.0 112.785 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.91 170.48 11.48 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 125.005 3.804 . . . . 0.0 113.795 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.614 HD11 ' CG2' ' A' ' 23' ' ' THR . 4.9 tp -170.46 144.01 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.672 1.225 . . . . 0.0 110.738 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.781 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 18.8 m-85 -86.46 119.12 26.37 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.681 1.192 . . . . 0.0 109.202 175.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.502 ' CE3' HD12 ' A' ' 94' ' ' ILE . 10.6 p90 -62.53 179.22 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.831 0.852 . . . . 0.0 111.974 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.8 t -56.24 -51.09 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.681 0.792 . . . . 0.0 112.612 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.75 -35.17 62.11 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.75 -0.594 . . . . 0.0 113.646 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 37.8 mttm -70.27 155.68 40.32 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.841 0.857 . . . . 0.0 111.289 172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -126.61 31.51 5.33 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.132 1.373 . . . . 0.0 111.737 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -125.81 175.53 7.58 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.653 -1.28 . . . . 0.0 111.095 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -141.69 127.22 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.758 0.79 . . . . 0.0 109.371 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.422 ' CZ2' HG22 ' A' ' 84' ' ' THR . 10.5 t-105 -67.34 111.78 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -60.73 176.74 0.36 Allowed 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.116 0.885 . . . . 0.0 112.295 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -94.69 -65.21 1.0 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.631 1.205 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.62 36.67 0.66 Allowed 'General case' 0 C--N 1.323 -0.584 0 O-C-N 120.618 -1.301 . . . . 0.0 110.401 -176.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 41.4 t -131.13 120.61 47.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 120.549 -1.345 . . . . 0.0 110.677 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.86 157.27 37.79 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.26 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.422 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 52.1 p -39.47 -53.66 2.02 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.149 1.78 . . . . 0.0 114.288 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.8 m -54.27 -62.8 1.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.815 1.246 . . . . 0.0 112.343 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.9 tp60 -53.21 -39.48 63.76 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 116.587 -1.673 . . . . 0.0 112.254 175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -38.61 112.54 0.24 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.905 2.082 . . . . 0.0 112.375 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.83 76.83 1.81 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.591 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -163.14 -45.81 0.02 OUTLIER Glycine 0 N--CA 1.464 0.533 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.898 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.54 157.59 7.26 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 121.314 -1.11 . . . . 0.0 112.987 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 146.42 78.88 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.668 2.912 . . . . 0.0 111.014 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 112.52 3.78 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.193 0.997 . . . . 0.0 110.541 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 39.3 Cg_endo -75.38 -24.32 12.35 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.123 2.549 . . . . 0.0 113.511 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 17' ' ' PHE . 93.5 mt -67.45 117.32 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 124.765 1.226 . . . . 0.0 109.586 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -134.05 128.75 34.91 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.036 0.934 . . . . 0.0 111.139 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.76 135.21 28.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.511 0.725 . . . . 0.0 110.895 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.71 138.75 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 125.339 1.456 . . . . 0.0 109.989 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.5 OUTLIER -146.06 146.45 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 124.413 1.085 . . . . 0.0 110.597 -175.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -96.86 151.37 19.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.346 0.658 . . . . 0.0 110.851 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -95.79 70.72 2.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.627 1.571 . . . . 0.0 110.085 175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -72.84 -66.28 0.69 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.821 0.819 . . . . 0.0 110.593 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -132.26 39.79 3.37 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.893 1.277 . . . . 0.0 113.009 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.18 -38.24 1.57 Allowed Glycine 0 CA--C 1.537 1.407 0 C-N-CA 123.446 0.546 . . . . 0.0 114.084 -174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.05 114.1 14.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.726 -1.455 . . . . 0.0 109.083 172.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG12 HD21 ' A' ' 33' ' ' LEU . 13.1 m -48.92 147.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.126 0.97 . . . . 0.0 110.453 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.7 6.04 29.36 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.089 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.731 ' CE2' HG23 ' A' ' 21' ' ' VAL . 50.5 t80 38.75 60.43 1.39 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.029 0.932 . . . . 0.0 110.987 -171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 40.7 t -44.9 -36.2 3.21 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.33 172.05 19.89 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 125.217 1.389 . . . . 0.0 110.07 167.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 154.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 O-C-N 120.861 -1.376 . . . . 0.0 110.467 175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -134.01 148.74 51.15 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 123.969 0.908 . . . . 0.0 111.105 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.6 t -133.4 144.64 49.68 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 123.805 0.842 . . . . 0.0 110.346 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.417 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.5 m170 -60.12 -15.7 25.87 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.906 0.86 . . . . 0.0 113.226 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t 64.72 28.82 13.01 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 123.002 1.382 . . . . 0.0 113.527 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -148.55 99.47 3.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 121.054 -1.029 . . . . 0.0 113.467 -173.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.857 HG23 HD22 ' A' ' 10' ' ' LEU . 34.1 m -142.06 104.97 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.188 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -105.86 -77.75 0.58 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.112 0.958 . . . . 0.0 109.801 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.44 -8.77 37.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.907 1.283 . . . . 0.0 113.424 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -154.35 118.39 4.73 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.379 1.472 . . . . 0.0 109.608 -176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.433 ' HA ' ' CG1' ' A' ' 116' ' ' VAL . 0.8 OUTLIER -74.51 62.48 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.489 1.116 . . . . 0.0 110.866 176.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -113.57 -22.89 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.505 1.122 . . . . 0.0 111.258 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.415 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 87.58 146.62 11.36 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 122.718 0.199 . . . . 0.0 113.535 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -137.13 -60.62 0.68 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -57.24 172.66 0.29 Allowed 'General case' 0 C--O 1.241 0.629 0 O-C-N 125.385 1.678 . . . . 0.0 111.478 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -51.66 165.19 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 123.183 1.468 . . . . 0.0 112.223 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 50' ' ' ILE . 55.6 m-85 -80.1 126.9 31.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.55 1.167 . . . . 0.0 109.912 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -116.68 112.63 21.51 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.525 1.53 . . . . 0.0 107.323 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.01 126.22 2.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.197 0.599 . . . . 0.0 109.993 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.783 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.6 t -60.16 175.43 0.42 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.61 1.164 . . . . 0.0 110.526 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.7 t0 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.683 1.993 . . . . 0.0 110.756 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 117.681 -1.152 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.23 -31.08 12.29 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.142 2.561 . . . . 0.0 112.788 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 20' ' ' ASP . 9.5 tp -85.45 132.8 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.621 -1.3 . . . . 0.0 109.132 175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 19' ' ' VAL . 4.2 m -128.69 177.07 6.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 125.888 1.675 . . . . 0.0 110.518 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 16' ' ' PRO . 23.5 m -150.4 111.86 4.45 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.751 0.821 . . . . 0.0 109.35 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.505 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m -58.61 168.3 1.22 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -115.54 49.12 0.6 Allowed Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.877 1.671 . . . . 0.0 115.204 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 6' ' ' CYS . 73.9 Cg_endo -69.88 -178.48 2.41 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.075 3.184 . . . . 0.0 112.767 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.4 tttp -115.92 123.31 47.76 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.108 1.363 . . . . 0.0 109.967 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -110.95 -83.03 0.58 Allowed 'General case' 0 C--O 1.218 -0.57 0 O-C-N 125.185 1.553 . . . . 0.0 109.52 176.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -88.98 50.81 2.02 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.835 -1.166 . . . . 0.0 111.758 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 62.96 3.29 5.86 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 124.962 1.267 . . . . 0.0 115.184 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.9 mtm-85 -122.73 142.88 50.22 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.976 2.51 . . . . 0.0 109.023 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -55.86 97.44 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.964 1.705 . . . . 0.0 111.422 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -98.42 125.34 43.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.042 1.337 . . . . 0.0 109.466 -174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.822 ' HB2' HG21 ' A' ' 5' ' ' THR . 71.7 Cg_endo -65.76 121.06 8.34 Favored 'Trans proline' 0 CA--C 1.553 1.469 0 C-N-CA 122.766 2.311 . . . . 0.0 112.716 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.555 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -96.53 108.45 21.03 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 175.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -56.43 129.76 41.97 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.971 1.709 . . . . 0.0 112.377 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.4 m -156.57 108.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.896 1.679 . . . . 0.0 109.627 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 3' ' ' ILE . 7.4 p-10 -87.55 139.13 30.85 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.679 -1.263 . . . . 0.0 110.631 175.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 107' ' ' TYR . 12.5 p -57.53 -40.89 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.965 0.506 . . . . 0.0 112.059 174.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.98 -55.84 17.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.773 1.229 . . . . 0.0 110.34 -176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 85.7 m -61.83 -57.21 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.422 1.089 . . . . 0.0 110.173 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -49.57 30.2 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.433 1.47 . . . . 0.0 114.185 -175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -62.08 -48.89 78.16 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.943 1.697 . . . . 0.0 111.713 173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.45 -47.16 48.46 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.118 0.567 . . . . 0.0 110.615 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -65.1 -49.74 68.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.56 1.144 . . . . 0.0 112.003 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' HG21 ' A' ' 105' ' ' VAL . . . -53.54 -49.81 66.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.223 1.009 . . . . 0.0 112.426 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -66.69 -41.54 87.89 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.238 1.015 . . . . 0.0 112.524 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -56.27 -49.85 73.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.486 1.514 . . . . 0.0 111.069 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.622 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.94 -38.44 69.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.149 0.906 . . . . 0.0 112.706 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.71 -164.83 49.08 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.561 1.077 . . . . 0.0 112.528 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD13 HD22 ' A' ' 100' ' ' ASN . 9.0 mt -103.49 35.58 2.55 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.52 1.528 . . . . 0.0 110.711 177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 m -154.82 135.43 13.49 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.747 -1.221 . . . . 0.0 111.896 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -133.63 158.19 43.86 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.496 1.518 . . . . 0.0 110.674 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.01 39.69 0.02 OUTLIER Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.308 1.432 . . . . 0.0 113.593 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.45 -52.17 1.27 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.223 1.809 . . . . 0.0 110.898 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.3 p -129.04 -48.56 1.22 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 -177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 160.0 -29.43 0.37 Allowed Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.994 1.759 . . . . 0.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.89 158.68 31.31 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 119.581 1.691 . . . . 0.0 113.51 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.622 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -60.6 173.65 11.13 Favored 'Cis proline' 0 C--N 1.35 0.636 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 -14.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.41 142.45 50.0 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.771 -1.206 . . . . 0.0 108.929 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 29.5 mmm-85 -70.63 127.1 31.51 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 173.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -100.99 143.09 31.55 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.112 1.507 . . . . 0.0 107.332 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 43' ' ' ARG . 33.3 m-85 -130.88 136.13 48.34 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.442 1.897 . . . . 0.0 109.349 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -49.96 102.8 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.46 1.104 . . . . 0.0 112.767 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.26 -37.6 0.02 OUTLIER Glycine 0 CA--C 1.532 1.144 0 O-C-N 121.284 -0.885 . . . . 0.0 113.571 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.61 4.5 0.77 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.565 1.546 . . . . 0.0 114.311 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 73.37 42.35 0.42 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.459 1.904 . . . . 0.0 112.401 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mt -125.74 117.32 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 123.912 0.885 . . . . 0.0 110.419 -171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -101.4 -21.64 14.77 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 63.38 11.31 5.4 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.361 1.465 . . . . 0.0 114.88 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.02 23.79 59.83 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.929 -0.928 . . . . 0.0 114.324 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.6 t -132.24 130.56 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.077 1.438 . . . . 0.0 110.034 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -53.78 -40.8 66.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -62.77 -44.13 96.99 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.552 -1.343 . . . . 0.0 111.395 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.9 m -73.63 -44.85 55.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 119.024 -0.512 . . . . 0.0 111.668 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -79.61 32.1 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.507 1.923 . . . . 0.0 113.866 174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.29 176.16 4.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 123.058 1.408 . . . . 0.0 111.959 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.58 81.91 7.51 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 107.012 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.6 t0 60.13 43.82 13.7 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 123.83 1.776 . . . . 0.0 112.567 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.65 167.4 2.71 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 123.862 1.791 . . . . 0.0 114.113 171.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -88.55 89.43 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 113.661 -1.609 . . . . 0.0 107.209 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.746 HD12 HG12 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -99.05 177.77 5.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 122.502 1.144 . . . . 0.0 108.724 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.505 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 58.2 m95 -145.44 170.43 16.38 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.948 2.099 . . . . 0.0 110.631 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -153.11 131.04 11.73 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.397 1.079 . . . . 0.0 111.046 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 49.0 t80 -142.77 132.47 12.04 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 54.3 Cg_endo -64.82 154.16 74.2 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 124.797 3.664 . . . . 0.0 113.388 -176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.9 148.53 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.826 0.822 . . . . 0.0 110.974 -177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 39.2 m-85 -96.87 101.64 13.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.937 1.295 . . . . 0.0 109.492 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.516 ' CE3' HD12 ' A' ' 94' ' ' ILE . 28.9 p90 -56.22 174.41 0.13 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.44 0.696 . . . . 0.0 112.535 173.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.7 t -52.33 -52.53 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -172.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.86 -32.9 81.21 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.508 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.1 mttm -64.55 162.6 15.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.862 1.265 . . . . 0.0 110.465 169.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -129.25 -40.53 1.46 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.477 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -57.75 173.26 0.31 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.721 0.809 . . . . 0.0 112.331 171.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -142.82 150.76 40.36 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.777 1.231 . . . . 0.0 110.76 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 1.7 t-105 -86.45 143.02 27.97 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.877 0.846 . . . . 0.0 109.56 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.404 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -108.59 -178.84 3.7 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.042 0.937 . . . . 0.0 110.366 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -85.15 -57.02 3.26 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.591 -1.318 . . . . 0.0 111.43 177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.29 61.76 3.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.308 1.052 . . . . 0.0 111.558 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG11 ' H ' ' A' ' 79' ' ' ALA . 11.8 p -143.34 110.85 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 123.03 1.395 . . . . 0.0 112.562 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -73.63 168.69 18.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 120.785 -1.197 . . . . 0.0 111.342 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.8 p -57.31 -46.94 82.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.8 t -57.98 -44.03 86.88 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.152 0.981 . . . . 0.0 112.431 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -66.89 -43.5 83.29 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.091 175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.441 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.6 tp-100 -37.57 102.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -93.9 94.7 8.64 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.911 -1.118 . . . . 0.0 110.206 -171.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.33 -32.2 0.45 Allowed Glycine 0 N--CA 1.469 0.866 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 134.01 153.59 7.04 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.375 0.988 . . . . 0.0 112.858 170.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.35 143.51 83.08 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.454 2.102 . . . . 0.0 111.164 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.34 120.46 29.93 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.792 1.237 . . . . 0.0 110.921 174.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.572 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 72.4 Cg_endo -75.67 -26.28 10.04 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.77 2.98 . . . . 0.0 112.133 175.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.555 HD11 ' CG ' ' A' ' 17' ' ' PHE . 90.2 mt -73.63 123.82 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.064 1.346 . . . . 0.0 109.905 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -135.16 121.62 20.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.03 0.932 . . . . 0.0 110.546 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 HG22 ' A' ' 110' ' ' VAL . 7.8 p -63.93 134.64 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.586 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 HD12 ' A' ' 64' ' ' LEU . 27.3 t -118.64 137.01 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 124.18 1.943 . . . . 0.0 111.936 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.671 ' CB ' HG23 ' A' ' 105' ' ' VAL . 2.3 p90 -149.73 148.11 28.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.404 1.482 . . . . 0.0 110.67 -169.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -89.35 165.69 14.21 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.049 0.939 . . . . 0.0 110.566 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.803 HD22 HD13 ' A' ' 33' ' ' LEU . 10.4 t-20 -118.11 26.76 9.42 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.024 2.13 . . . . 0.0 111.827 177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -54.56 -62.41 1.67 Allowed 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.856 -1.152 . . . . 0.0 112.815 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.08 29.14 2.22 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.279 1.432 . . . . 0.0 113.665 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.61 25.25 34.84 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 119.697 1.135 . . . . 0.0 114.89 -175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -146.16 116.87 7.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.274 2.229 . . . . 0.0 107.773 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.671 HG23 ' CB ' ' A' ' 98' ' ' TYR . 2.1 p -38.13 118.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.428 1.491 . . . . 0.0 112.481 167.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -96.93 -11.71 24.33 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.66 ' CE2' HG23 ' A' ' 21' ' ' VAL . 57.5 t80 55.46 65.92 1.35 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 123.672 1.701 . . . . 0.0 111.134 -172.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 23.9 t -51.77 -42.36 62.33 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.866 -1.146 . . . . 0.0 112.275 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.03 169.2 27.23 Favored Glycine 0 C--O 1.221 -0.664 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 96' ' ' VAL . 2.3 t -101.17 147.64 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 O-C-N 120.707 -1.466 . . . . 0.0 111.576 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 22.2 ptt? -122.71 165.21 16.91 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.018 0.927 . . . . 0.0 109.76 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -145.17 155.59 43.37 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.144 1.377 . . . . 0.0 112.085 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 18.4 m170 -75.03 143.5 43.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.53 -0.731 . . . . 0.0 111.727 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 m -87.93 16.04 6.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -138.69 73.27 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.606 HG23 HD22 ' A' ' 10' ' ' LEU . 32.7 m -126.24 59.61 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 C-N-CA 124.285 1.034 . . . . 0.0 111.32 -170.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.445 ' HA ' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -92.46 -80.18 0.37 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -168.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -75.23 -16.8 60.44 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.273 1.429 . . . . 0.0 114.108 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -158.9 136.76 10.36 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 126.991 2.116 . . . . 0.0 109.143 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -71.33 62.95 0.36 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.026 1.73 . . . . 0.0 111.978 175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.77 172.75 6.74 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.014 -1.679 . . . . 0.0 112.729 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.13 138.2 13.77 Favored Glycine 0 N--CA 1.466 0.647 0 O-C-N 120.283 -1.51 . . . . 0.0 109.965 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -136.57 -61.22 0.69 Allowed 'General case' 0 C--O 1.216 -0.659 0 O-C-N 124.57 0.806 . . . . 0.0 111.927 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -73.88 -84.7 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 O-C-N 125.132 1.52 . . . . 0.0 110.421 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -159.87 -175.68 5.26 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.269 1.827 . . . . 0.0 109.307 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.432 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.6 m-85 -107.85 83.51 1.81 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.197 1.799 . . . . 0.0 109.744 -174.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.8 117.99 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 119.787 -1.821 . . . . 0.0 111.1 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -47.74 147.25 1.97 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.858 0.863 . . . . 0.0 111.341 167.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 19' ' ' VAL . 9.4 m -74.92 166.24 23.96 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.681 1.592 . . . . 0.0 111.542 170.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' CG ' ' HZ2' ' A' ' 128' ' ' LYS . 7.7 m-20 . . . . . 0 C--O 1.259 1.591 0 C-N-CA 127.707 2.403 . . . . 0.0 109.412 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.968 0 CA-C-O 117.842 -1.075 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 21' ' ' VAL . 62.0 Cg_endo -69.76 -6.05 17.68 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.213 3.276 . . . . 0.0 114.276 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 tp -92.6 125.68 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.756 1.222 . . . . 0.0 110.154 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 4.3 m -123.24 -177.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.849 176.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.1 p -155.05 121.77 5.4 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.219 0.608 . . . . 0.0 112.538 175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.7 m -66.07 169.25 7.15 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.759 -1.213 . . . . 0.0 109.891 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -114.02 43.11 0.28 Allowed Pre-proline 0 N--CA 1.483 1.183 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.93 -178.16 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.302 3.335 . . . . 0.0 111.36 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -116.38 111.05 19.5 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.761 1.224 . . . . 0.0 113.34 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -96.29 -78.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.147 0.975 . . . . 0.0 109.57 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.52 58.78 0.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.018 1.327 . . . . 0.0 108.608 -167.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.81 14.99 5.83 Favored Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 114.404 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -139.76 162.48 35.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 126.83 2.052 . . . . 0.0 110.878 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -70.59 107.75 4.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.819 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -105.21 127.9 27.72 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.388 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.24 123.37 11.11 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 124.152 3.235 . . . . 0.0 112.022 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.678 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -97.72 110.82 23.31 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.55 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -51.17 116.72 2.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.086 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 3.2 m -147.72 173.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 122.348 1.071 . . . . 0.0 109.734 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.16 120.84 7.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 122.69 1.233 . . . . 0.0 108.806 -176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG23 ' CE2' ' A' ' 107' ' ' TYR . 2.6 p -57.33 -44.5 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.044 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.46 -50.08 72.76 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 124.032 0.933 . . . . 0.0 109.574 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.7 m -59.46 -57.13 14.33 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 124.343 1.027 . . . . 0.0 109.741 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -48.32 -50.74 29.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.16 0.891 . . . . 0.0 113.093 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -57.47 -46.94 83.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.346 . . . . 0.0 111.91 176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.02 -46.01 68.2 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.738 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HB3' ' CE2' ' A' ' 67' ' ' TYR . 14.9 mm100 -64.62 -48.61 74.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.927 0.491 . . . . 0.0 112.144 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.84 -50.15 64.31 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -60.17 -41.91 93.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 118.798 -0.62 . . . . 0.0 111.43 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -63.52 -61.02 2.6 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 117.398 -1.287 . . . . 0.0 111.892 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.36 -45.92 76.49 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 125.372 1.67 . . . . 0.0 110.126 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.23 -171.09 55.1 Favored Glycine 0 C--N 1.341 0.82 0 O-C-N 124.021 0.826 . . . . 0.0 111.309 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 HD13 ' ND2' ' A' ' 100' ' ' ASN . 5.2 mt -102.06 30.27 4.57 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.029 0.932 . . . . 0.0 111.41 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -129.34 119.91 24.71 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 123.656 0.782 . . . . 0.0 110.411 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -136.67 169.93 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.78 -14.64 0.6 Allowed Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.633 -1.093 . . . . 0.0 113.437 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -66.57 0.44 Allowed 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 125.768 1.627 . . . . 0.0 111.695 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.9 p -129.64 -28.47 2.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.907 0.86 . . . . 0.0 113.106 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 152.66 -29.88 0.84 Allowed Glycine 0 CA--C 1.485 -1.803 1 CA-C-O 113.27 -4.072 . . . . 0.0 111.781 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -89.21 134.47 32.99 Favored Pre-proline 0 CA--C 1.564 1.517 0 CA-C-N 120.254 2.027 . . . . 0.0 112.935 174.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 41.9 Cg_endo -71.7 163.13 87.45 Favored 'Cis proline' 0 C--N 1.354 0.853 0 O-C-N 122.555 0.766 . . . . 0.0 111.454 0.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -112.72 140.54 47.41 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 120.325 -1.484 . . . . 0.0 108.668 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 -65.6 138.34 57.96 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.477 -0.765 . . . . 0.0 110.111 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OH ' HD12 ' A' ' 50' ' ' ILE . 5.3 t80 -113.48 126.13 54.99 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.66 1.184 . . . . 0.0 108.742 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -88.07 143.91 26.81 Favored 'General case' 0 C--O 1.202 -1.409 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.9 31.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.067 0 O-C-N 118.89 -2.381 . . . . 0.0 114.248 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.88 13.23 41.61 Favored Glycine 0 N--CA 1.47 0.952 0 O-C-N 120.529 -1.357 . . . . 0.0 113.59 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.61 135.51 33.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -52.9 -17.66 1.52 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.8 mt -40.02 157.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.535 2.334 . . . . 0.0 112.065 167.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -144.59 114.06 7.1 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -92.8 4.18 54.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.984 -1.462 . . . . 0.0 113.317 171.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 21.33 54.57 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.682 0.658 . . . . 0.0 113.47 -173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG11 ' NE2' ' A' ' 106' ' ' GLN . 86.0 t -120.32 115.13 46.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 -174.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -46.16 -40.24 10.82 Favored 'General case' 0 C--O 1.219 -0.519 0 O-C-N 124.787 1.304 . . . . 0.0 112.687 176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -61.9 -52.47 63.98 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 173.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.4 m -60.91 -40.61 93.78 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.186 -0.911 . . . . 0.0 113.061 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -83.43 27.79 0.58 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 123.409 1.576 . . . . 0.0 112.874 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 0.9 OUTLIER -70.86 -178.55 1.93 Allowed 'General case' 0 C--O 1.217 -0.641 0 O-C-N 119.442 -2.036 . . . . 0.0 111.701 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.04 -46.82 4.96 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.843 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -121.1 30.87 6.63 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 124.549 2.119 . . . . 0.0 110.117 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.09 170.37 11.6 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 118.258 -2.776 . . . . 0.0 112.89 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.37 102.37 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 97' ' ' VAL . 7.9 mp -107.03 -175.04 2.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.44 0.696 . . . . 0.0 111.123 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -141.32 172.39 12.75 Favored 'General case' 0 C--O 1.216 -0.686 0 C-N-CA 126.399 1.88 . . . . 0.0 114.024 173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.22 135.25 21.41 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.524 1.53 . . . . 0.0 110.242 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 27' ' ' GLN . 49.0 t80 -144.88 131.08 9.75 Favored Pre-proline 0 C--O 1.216 -0.662 0 CA-C-O 115.861 -2.019 . . . . 0.0 110.765 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 54.9 Cg_endo -68.41 156.36 65.91 Favored 'Trans proline' 0 C--O 1.217 -0.557 1 C-N-CA 126.546 4.83 . . . . 0.0 114.453 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -139.99 160.22 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.807 -1.183 . . . . 0.0 109.838 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.6 m-85 -103.27 109.25 20.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 121.321 -0.862 . . . . 0.0 109.705 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.422 ' CE3' HD12 ' A' ' 94' ' ' ILE . 15.9 p90 -56.68 -178.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.113 1.435 . . . . 0.0 112.955 171.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.05 -50.65 79.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 O-C-N 120.805 -1.185 . . . . 0.0 112.206 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.41 -29.95 32.1 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.448 -0.64 . . . . 0.0 113.826 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 29.3 mttm -77.01 158.43 30.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.733 1.254 . . . . 0.0 113.858 169.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -134.97 44.48 2.61 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.849 -1.157 . . . . 0.0 110.841 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.65 -173.45 4.58 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.791 -0.568 . . . . 0.0 110.595 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.24 169.83 17.01 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.768 1.227 . . . . 0.0 111.778 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.498 ' CZ2' HG22 ' A' ' 84' ' ' THR . 16.5 t-105 -88.36 140.36 29.55 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.206 1.003 . . . . 0.0 109.467 -177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.754 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -78.13 -176.61 4.67 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 112.794 0.665 . . . . 0.0 112.794 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -103.55 -57.79 1.98 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.922 -1.111 . . . . 0.0 111.806 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -91.15 30.64 1.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 124.498 2.094 . . . . 0.0 111.712 178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.8 t -122.2 142.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 118.069 -2.894 . . . . 0.0 109.662 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -83.63 162.78 20.67 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.479 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.498 HG22 ' CZ2' ' A' ' 78' ' ' TRP . 40.6 p -48.94 -46.84 43.8 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.459 -1.401 . . . . 0.0 114.486 172.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.2 t -66.81 -38.95 87.46 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -80.39 4.51 17.78 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 174.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.46 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -85.61 90.74 8.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 120.254 -1.529 . . . . 0.0 109.369 -175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 2.1 mptp? -45.92 -51.96 12.34 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 125.159 1.384 . . . . 0.0 111.589 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -40.9 -41.75 2.68 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 125.648 1.842 . . . . 0.0 113.913 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.92 161.34 10.26 Favored Glycine 0 CA--C 1.521 0.463 0 O-C-N 121.181 -1.187 . . . . 0.0 110.259 167.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.21 144.1 67.36 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.658 2.906 . . . . 0.0 111.904 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.92 6.15 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.274 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.45 -33.9 8.19 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.298 2.665 . . . . 0.0 111.653 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 17' ' ' PHE . 65.0 mt -68.47 121.94 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 C-N-CA 124.82 1.248 . . . . 0.0 110.945 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.523 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 18.5 mtt180 -139.74 136.02 33.72 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 123.684 0.615 . . . . 0.0 111.157 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.71 140.17 18.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 120.782 -1.199 . . . . 0.0 111.766 175.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.763 HG12 HD23 ' A' ' 64' ' ' LEU . 59.2 t -119.22 134.91 61.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 110.668 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.668 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -142.44 160.67 39.81 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 123.748 0.819 . . . . 0.0 109.649 -173.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -92.88 167.67 11.68 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 122.686 0.394 . . . . 0.0 111.919 177.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -118.64 43.84 2.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.33 1.852 . . . . 0.0 110.902 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 104' ' ' ALA . 13.0 p -63.83 96.35 0.13 Allowed 'General case' 0 C--O 1.218 -0.555 0 O-C-N 120.772 -1.205 . . . . 0.0 112.765 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 47.11 29.49 1.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.441 -1.412 . . . . 0.0 114.634 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.46 53.09 3.52 Favored Glycine 0 CA--C 1.54 1.645 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -168.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 101' ' ' SER . . . -145.37 140.44 27.68 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.338 1.569 . . . . 0.0 110.005 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.668 HG13 ' CB ' ' A' ' 98' ' ' TYR . 93.3 t -103.18 129.89 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 O-C-N 124.257 0.973 . . . . 0.0 108.934 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.447 ' NE2' HG11 ' A' ' 54' ' ' VAL . 12.4 pt20 -108.77 8.66 26.85 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.756 -1.116 . . . . 0.0 113.729 176.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.535 ' CE2' HG23 ' A' ' 21' ' ' VAL . 16.4 t80 41.71 60.27 2.23 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.265 0.978 . . . . 0.0 109.211 -172.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 44.8 t -41.83 -34.49 0.66 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.56 174.76 18.07 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 167.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' A' ' 24' ' ' ALA . 1.5 t -96.63 149.43 4.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 O-C-N 120.789 -1.419 . . . . 0.0 111.184 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.565 ' SD ' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -126.41 164.74 20.45 Favored 'General case' 0 CA--C 1.503 -0.838 0 C-N-CA 125.077 1.351 . . . . 0.0 109.599 -178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -152.49 159.22 43.35 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 122.784 1.278 . . . . 0.0 112.781 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 15.7 m170 -85.26 149.88 25.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.856 -1.152 . . . . 0.0 112.139 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.477 ' O ' HG22 ' A' ' 116' ' ' VAL . 5.6 t -70.46 -56.91 5.48 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 124.799 1.312 . . . . 0.0 109.555 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -63.33 103.08 0.46 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.63 ' O ' HD22 ' A' ' 10' ' ' LEU . 8.5 m -146.88 107.04 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.243 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -109.86 -69.13 0.88 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.102 1.43 . . . . 0.0 110.449 178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -125.84 -44.69 1.78 Allowed 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 125.079 1.352 . . . . 0.0 111.545 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -84.41 -33.77 23.66 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.323 -0.86 . . . . 0.0 109.968 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 73.54 38.47 0.63 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.561 1.163 . . . . 0.0 108.574 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -66.05 -67.17 0.47 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.452 -176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.5 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 95.89 117.31 3.24 Favored Glycine 0 C--N 1.34 0.802 0 O-C-N 124.208 0.943 . . . . 0.0 112.879 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -124.66 -41.3 2.14 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.498 1.119 . . . . 0.0 113.353 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -61.84 163.31 7.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -40.66 143.47 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 123.776 1.75 . . . . 0.0 112.166 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -74.38 132.16 41.75 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.313 -178.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -115.36 116.86 28.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 122.013 0.911 . . . . 0.0 108.757 -176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -54.98 134.57 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.206 -0.934 . . . . 0.0 110.707 172.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 91.2 m -67.09 177.76 1.66 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.592 0.757 . . . . 0.0 112.352 168.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.258 1.533 0 C-N-CA 125.062 1.345 . . . . 0.0 112.43 -179.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.43 -0.82 8.76 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.894 3.063 . . . . 0.0 113.933 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 tp -118.09 126.87 75.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 125.943 1.697 . . . . 0.0 109.118 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 19' ' ' VAL . 32.8 m -134.24 -176.61 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.288 0.992 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.599 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -152.39 123.99 7.83 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.38 1.072 . . . . 0.0 113.564 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 19' ' ' VAL . 34.1 m -60.56 164.74 4.26 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.722 -0.612 . . . . 0.0 109.677 -178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -111.64 45.41 0.25 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.039 1.335 . . . . 0.0 113.219 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -64.15 156.38 59.59 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.961 3.107 . . . . 0.0 111.636 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -110.15 129.04 55.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.155 0.982 . . . . 0.0 109.112 176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -81.1 -82.14 0.12 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.536 171.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -127.89 29.22 5.46 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.998 1.319 . . . . 0.0 111.939 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.01 -33.6 3.32 Favored Glycine 0 C--O 1.224 -0.519 0 O-C-N 121.152 -0.968 . . . . 0.0 113.103 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -89.43 153.36 20.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 117.607 0.703 . . . . 0.0 111.436 176.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -92.95 124.53 37.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.955 0.902 . . . . 0.0 109.448 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 tptp -117.72 129.9 25.05 Favored Pre-proline 0 C--O 1.215 -0.722 0 CA-C-O 118.953 -0.546 . . . . 0.0 111.715 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.34 118.06 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.987 2.458 . . . . 0.0 111.542 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -90.7 113.46 25.55 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 118.972 -0.537 . . . . 0.0 110.396 177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -47.27 111.38 0.4 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.243 1.017 . . . . 0.0 111.669 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.804 HG23 HG23 ' A' ' 4' ' ' VAL . 13.2 m -149.22 110.09 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.536 0 C-N-CA 124.599 1.159 . . . . 0.0 110.691 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.6 129.44 37.57 Favored 'General case' 0 C--N 1.314 -0.943 0 O-C-N 120.252 -1.53 . . . . 0.0 111.17 175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.424 HG13 ' H ' ' A' ' 21' ' ' VAL . 1.0 OUTLIER -54.15 -40.38 46.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 123.924 0.89 . . . . 0.0 111.685 176.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.41 63.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.378 1.071 . . . . 0.0 110.361 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 ' CG2' HD11 ' A' ' 69' ' ' ILE . 95.7 m -61.89 -55.87 25.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.969 176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.03 -51.35 53.95 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -48.74 77.3 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.273 1.029 . . . . 0.0 110.63 175.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.44 -51.27 48.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 118.774 -0.632 . . . . 0.0 110.8 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.688 ' CD ' HD13 ' A' ' 69' ' ' ILE . 12.8 mm100 -60.84 -47.28 87.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.579 0.752 . . . . 0.0 112.526 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.54 -55.11 24.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.922 0.889 . . . . 0.0 111.45 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -65.42 -42.24 92.7 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.136 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -53.5 -54.4 37.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 125.147 1.379 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.24 -35.04 75.71 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 123.899 0.749 . . . . 0.0 111.821 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.09 -156.31 48.8 Favored Glycine 0 C--O 1.225 -0.46 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.407 HD12 ' HA2' ' A' ' 103' ' ' GLY . 4.1 mt -116.39 39.81 3.04 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.871 0.869 . . . . 0.0 111.602 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.6 m -149.43 121.59 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.5 t -114.06 164.12 14.26 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.399 0.68 . . . . 0.0 111.784 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.59 -19.23 0.16 Allowed Glycine 0 C--O 1.22 -0.733 0 CA-C-N 116.059 -0.519 . . . . 0.0 114.217 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.88 -61.89 2.0 Allowed 'General case' 0 C--O 1.217 -0.641 0 C-N-CA 125.353 1.461 . . . . 0.0 109.012 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -133.26 -56.39 0.91 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.171 0.986 . . . . 0.0 113.178 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.63 -30.53 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.87 0 CA-C-O 117.883 -1.509 . . . . 0.0 112.821 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.9 p-10 -95.9 144.59 28.09 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-O 121.785 0.802 . . . . 0.0 112.369 178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.739 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.0 Cg_endo -68.09 173.01 39.67 Favored 'Cis proline' 0 C--O 1.222 -0.287 0 N-CA-C 113.491 0.535 . . . . 0.0 113.491 -5.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -123.98 146.09 48.74 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.12 -0.988 . . . . 0.0 109.849 -176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 31.0 mmm-85 -71.53 104.48 3.29 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.0 0.92 . . . . 0.0 110.874 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -85.01 124.78 32.1 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.384 0.674 . . . . 0.0 110.266 176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -77.76 -27.1 50.26 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.431 -0.793 . . . . 0.0 112.895 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . 72.39 24.49 2.96 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 113.314 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.23 17.48 55.71 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.655 0.645 . . . . 0.0 113.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -91.35 35.57 0.93 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.366 1.083 . . . . 0.0 111.117 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 m170 62.75 39.62 10.79 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 119.65 -1.906 . . . . 0.0 112.75 -177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mt -130.78 97.01 2.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -78.25 -19.14 54.32 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.635 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 87.9 m95 62.94 26.53 15.57 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.52 25.03 6.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.12 -0.822 . . . . 0.0 113.897 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 74.2 t -133.27 142.11 42.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 118.767 1.283 . . . . 0.0 108.962 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -66.02 -48.03 72.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -58.14 -47.25 83.89 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.559 0.744 . . . . 0.0 110.825 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.4 m -76.76 23.3 0.17 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -131.72 34.57 3.88 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.588 1.555 . . . . 0.0 112.081 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -129.3 162.61 27.55 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.079 -1.013 . . . . 0.0 111.52 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.54 -40.86 48.62 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 63' ' ' ILE . 1.2 t70 -93.07 43.31 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.09 1.356 . . . . 0.0 109.438 176.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.02 34.02 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.536 -1.352 . . . . 0.0 113.52 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' A' ' 43' ' ' ARG . 4.9 mp 57.85 59.31 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 124.808 1.243 . . . . 0.0 109.557 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.8 mt -78.76 175.0 10.87 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 122.586 1.184 . . . . 0.0 110.313 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.463 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 73.1 m95 -142.96 134.35 26.17 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 124.174 0.99 . . . . 0.0 109.635 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -111.33 143.4 42.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.493 1.117 . . . . 0.0 111.198 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 51.7 t80 -148.22 134.68 10.0 Favored Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 121.745 -0.597 . . . . 0.0 112.256 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 55.2 Cg_endo -68.74 165.16 30.56 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 124.371 3.381 . . . . 0.0 112.488 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.688 HD13 ' CD ' ' A' ' 27' ' ' GLN . 6.2 tp -170.75 142.32 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 122.061 0.934 . . . . 0.0 112.211 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HA2' ' A' ' 90' ' ' GLY . 19.5 m-85 -92.69 133.19 36.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.907 0.883 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.625 ' CE3' HD12 ' A' ' 94' ' ' ILE . 5.0 p90 -69.67 -178.36 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.107 0.563 . . . . 0.0 111.35 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.46 -32.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.423 0.689 . . . . 0.0 111.98 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -58.73 4.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.725 -0.609 . . . . 0.0 113.733 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -54.54 164.69 0.68 Allowed 'General case' 0 C--O 1.218 -0.564 0 O-C-N 121.984 -0.716 . . . . 0.0 111.53 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -132.55 -46.09 0.89 Allowed 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -38.45 139.54 0.39 Allowed 'General case' 0 C--N 1.344 0.356 0 C-N-CA 124.351 1.06 . . . . 0.0 109.84 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -104.82 162.57 13.2 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.482 . . . . 0.0 110.596 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 84' ' ' THR . 7.9 t-105 -97.01 110.94 23.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.517 0.727 . . . . 0.0 109.831 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -63.24 172.07 2.07 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.197 0.998 . . . . 0.0 112.134 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -82.03 -46.98 13.2 Favored 'General case' 0 C--O 1.224 -0.254 0 O-C-N 121.51 -0.744 . . . . 0.0 112.063 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -98.74 45.83 1.0 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 122.292 1.044 . . . . 0.0 111.36 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 86.0 t -143.35 111.9 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 O-C-N 120.547 -1.345 . . . . 0.0 110.592 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 178.62 2.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.082 0.553 . . . . 0.0 111.495 177.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 78' ' ' TRP . 58.2 p -67.9 -62.92 1.18 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.2 t -49.38 -29.29 6.06 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.041 0.936 . . . . 0.0 112.166 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -82.65 -46.46 13.23 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 117.403 -1.284 . . . . 0.0 111.79 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 4.0 tp-100 -44.46 133.09 5.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.952 1.701 . . . . 0.0 110.388 -177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -117.48 91.76 3.66 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 123.537 0.735 . . . . 0.0 109.901 -176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.96 -5.69 8.35 Favored Glycine 0 N--CA 1.463 0.484 0 N-CA-C 114.855 0.702 . . . . 0.0 114.855 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.552 ' HA2' ' CE2' ' A' ' 70' ' ' TYR . . . -108.39 45.08 1.36 Allowed Glycine 0 C--O 1.217 -0.926 0 C-N-CA 125.858 1.694 . . . . 0.0 116.434 172.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.54 5.32 1.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.313 2.008 . . . . 0.0 113.958 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.6 t -45.38 115.37 2.63 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.892 1.277 . . . . 0.0 111.791 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.1 Cg_endo -73.01 -25.26 16.44 Favored 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.211 1.941 . . . . 0.0 112.817 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.625 HD12 ' CE3' ' A' ' 71' ' ' TRP . 63.1 mt -62.58 135.49 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.21 1.004 . . . . 0.0 109.659 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -143.31 123.87 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.797 0.839 . . . . 0.0 112.042 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -63.49 135.87 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 O-C-N 121.692 -0.63 . . . . 0.0 110.354 175.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 20.0 t -113.43 138.81 41.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 126.437 1.895 . . . . 0.0 111.011 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -150.3 148.74 29.21 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.885 1.274 . . . . 0.0 110.932 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -84.04 160.41 20.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.71 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.89 38.24 1.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.927 1.291 . . . . 0.0 111.46 177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -70.33 113.11 7.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.23 -1.543 . . . . 0.0 111.23 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 41.3 36.74 0.53 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.676 -1.265 . . . . 0.0 112.51 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' HA2' HD12 ' A' ' 33' ' ' LEU . . . 74.3 -33.79 0.95 Allowed Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.235 0.921 . . . . 0.0 114.653 -175.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.45 128.94 38.09 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.701 -1.47 . . . . 0.0 112.342 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.7 m -81.28 138.17 20.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.175 177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -99.88 12.72 36.03 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.9 t80 37.22 60.7 1.01 Allowed 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.847 0.859 . . . . 0.0 110.81 -172.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.6 t -43.36 -36.45 1.9 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.65 170.15 13.69 Favored Glycine 0 C--O 1.218 -0.874 0 C-N-CA 124.759 1.171 . . . . 0.0 110.923 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -100.09 152.31 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 O-C-N 121.357 -1.084 . . . . 0.0 111.158 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -129.83 168.02 17.24 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 124.449 1.1 . . . . 0.0 110.26 -178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.9 t -159.76 175.82 12.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.518 0.727 . . . . 0.0 111.978 177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.523 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 12.0 m170 -89.62 157.95 17.81 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.265 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 51.3 p -108.79 21.87 16.67 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.206 1.402 . . . . 0.0 111.721 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 122' ' ' GLY . 14.9 tptp -131.88 53.79 1.97 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 120.335 -1.478 . . . . 0.0 111.97 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.44 ' O ' HD22 ' A' ' 10' ' ' LEU . 16.5 m -86.82 118.55 33.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.921 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.784 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.48 -71.52 0.75 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.082 0.944 . . . . 0.0 110.753 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -111.06 -77.01 0.59 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.552 1.141 . . . . 0.0 111.587 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -83.75 15.37 3.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.253 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 61.36 46.43 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.509 0.724 . . . . 0.0 110.56 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.89 -73.13 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.324 1.05 . . . . 0.0 110.422 -176.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.523 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 79.16 115.18 0.23 Allowed Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.509 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -133.25 -34.14 1.09 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -40.76 -72.8 0.06 Allowed 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 125.057 1.343 . . . . 0.0 111.211 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -170.09 179.89 3.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.026 1.33 . . . . 0.0 110.494 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 19.0 m-85 -98.6 92.96 5.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.408 1.483 . . . . 0.0 110.421 174.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.44 129.87 34.99 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.524 -1.36 . . . . 0.0 111.525 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 125.57 24.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.257 -0.902 . . . . 0.0 110.335 169.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.44 173.78 0.25 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.879 1.272 . . . . 0.0 111.712 169.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.1 t0 . . . . . 0 C--O 1.255 1.36 0 C-N-CA 126.247 1.819 . . . . 0.0 109.934 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 117.12 -1.419 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.97 -5.07 14.79 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.936 3.757 . . . . 0.0 113.921 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -102.05 127.3 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.197 1.399 . . . . 0.0 108.909 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 19' ' ' VAL . 3.2 m -126.85 -175.47 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 124.495 1.118 . . . . 0.0 111.553 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.482 ' HA ' HG22 ' A' ' 19' ' ' VAL . 44.5 p -150.14 121.12 7.67 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 175.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.455 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 59.7 m -57.34 165.22 1.53 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.732 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -109.93 41.38 0.16 Allowed Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.286 1.434 . . . . 0.0 114.478 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 64.6 Cg_endo -67.57 175.67 5.85 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.544 2.83 . . . . 0.0 111.488 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.88 102.45 13.03 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.103 1.361 . . . . 0.0 112.711 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.3 -81.35 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.948 0.88 . . . . 0.0 109.28 174.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.69 56.96 0.67 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 123.533 1.635 . . . . 0.0 109.427 -168.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.64 9.27 9.05 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 120.818 -1.176 . . . . 0.0 114.792 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtp85 -140.65 139.88 34.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 127.377 2.271 . . . . 0.0 107.838 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.75 109.89 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.629 1.172 . . . . 0.0 110.701 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HD3' HD23 ' A' ' 10' ' ' LEU . 64.8 tttt -106.58 128.34 26.41 Favored Pre-proline 0 C--O 1.225 -0.209 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.751 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.98 104.35 0.57 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 124.142 3.228 . . . . 0.0 112.03 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -83.99 113.12 20.77 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 121.061 -1.024 . . . . 0.0 110.354 178.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -48.58 123.71 7.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.053 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.955 HG21 ' SG ' ' A' ' 129' ' ' CYS . 3.2 m -156.44 120.57 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.207 1.403 . . . . 0.0 109.519 -177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -106.04 143.35 34.3 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.699 1.237 . . . . 0.0 110.913 176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.49 -42.55 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.689 176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.58 -48.57 48.63 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 125.387 1.475 . . . . 0.0 109.724 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 70' ' ' TYR . 52.7 m -65.81 -59.98 3.33 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.559 0.744 . . . . 0.0 110.886 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.666 ' HB1' HG21 ' A' ' 110' ' ' VAL . . . -47.32 -56.77 6.18 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -58.97 -47.21 85.97 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.128 1.371 . . . . 0.0 111.599 174.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.56 -51.85 44.37 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.295 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 14.0 mm100 -61.69 -54.04 47.97 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.019 0.928 . . . . 0.0 112.039 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.83 -51.3 57.58 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.276 0.631 . . . . 0.0 112.073 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -59.91 -41.08 90.9 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.726 0.41 . . . . 0.0 110.985 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -61.38 -62.4 1.86 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.443 1.497 . . . . 0.0 111.462 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -61.88 -29.77 70.42 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.179 0.924 . . . . 0.0 112.163 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 -162.35 11.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.845 1.212 . . . . 0.0 111.913 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.453 HD13 ' HA2' ' A' ' 103' ' ' GLY . 2.9 mt -98.08 41.08 1.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.377 -1.073 . . . . 0.0 111.867 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.1 m -149.63 117.87 6.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.489 0.662 . . . . 0.0 110.372 -174.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.4 t -129.91 166.37 20.15 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.538 1.135 . . . . 0.0 111.535 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.9 -18.66 1.24 Allowed Glycine 0 C--O 1.221 -0.677 0 C-N-CA 123.952 0.786 . . . . 0.0 114.005 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -49.28 73.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.988 1.715 . . . . 0.0 111.321 174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.8 p -133.18 -63.61 0.76 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.079 0.952 . . . . 0.0 112.999 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -171.75 -33.07 0.03 OUTLIER Glycine 0 C--O 1.225 -0.429 0 CA-C-O 118.188 -1.34 . . . . 0.0 112.327 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.71 144.21 28.6 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.685 1.194 . . . . 0.0 111.904 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.72 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.8 Cg_endo -67.4 178.53 19.24 Favored 'Cis proline' 0 C--N 1.35 0.658 0 N-CA-C 114.113 0.774 . . . . 0.0 114.113 -2.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.27 145.78 50.66 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.189 -0.945 . . . . 0.0 108.894 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mmm-85 -67.06 118.32 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -90.75 137.17 32.57 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 124.356 1.035 . . . . 0.0 108.263 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -120.65 156.95 30.61 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.876 0.871 . . . . 0.0 111.54 171.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -58.57 -9.34 1.61 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -36.02 -48.15 1.06 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.791 2.138 . . . . 0.0 113.817 171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.27 134.46 56.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 122.366 1.079 . . . . 0.0 111.007 174.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -75.89 52.41 0.69 Allowed 'General case' 0 N--CA 1.472 0.674 0 O-C-N 120.695 -1.253 . . . . 0.0 112.953 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -119.83 145.28 26.31 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.158 1.383 . . . . 0.0 109.082 -172.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 94.38 3.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 124.861 2.267 . . . . 0.0 107.831 -178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 54.4 m95 -65.56 -4.45 6.04 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 118.854 -2.404 . . . . 0.0 113.402 173.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.3 -24.58 2.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 125.708 1.623 . . . . 0.0 112.83 -175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.6 t -69.25 122.48 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -47.25 -39.5 14.42 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 123.999 0.919 . . . . 0.0 112.315 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -66.67 -62.32 1.51 Allowed 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 124.269 1.028 . . . . 0.0 113.405 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 78.2 m -56.49 -26.08 53.18 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.66 -36.32 78.4 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.367 1.867 . . . . 0.0 113.436 172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 10.7 mmmm -44.55 143.72 1.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.362 1.065 . . . . 0.0 112.005 177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -84.44 -50.39 7.81 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.46 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -83.83 25.58 0.78 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.535 1.534 . . . . 0.0 113.368 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -83.76 -178.14 6.92 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 123.746 1.736 . . . . 0.0 112.005 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.9 mt -131.52 100.71 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 120.84 -1.163 . . . . 0.0 108.605 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 179.83 4.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.665 1.222 . . . . 0.0 108.033 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -146.08 152.31 39.11 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.808 1.243 . . . . 0.0 111.392 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -130.04 143.47 50.81 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 125.017 1.327 . . . . 0.0 112.06 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 44.4 t80 -151.3 140.52 13.76 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 121.915 -0.491 . . . . 0.0 112.078 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.453 ' CG ' ' CD2' ' A' ' 78' ' ' TRP . 41.8 Cg_endo -72.8 149.8 48.72 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 124.215 3.277 . . . . 0.0 113.155 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' C ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -132.09 167.72 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 121.1 -1.0 . . . . 0.0 110.557 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 16.3 m-85 -124.25 113.1 17.82 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.347 -0.846 . . . . 0.0 109.156 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.438 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 23.8 p90 -57.83 178.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.629 0.728 . . . . 0.0 112.632 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.5 -42.46 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.199 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.86 -39.23 91.28 Favored Glycine 0 CA--C 1.533 1.168 0 O-C-N 121.789 -0.569 . . . . 0.0 113.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.523 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.1 mttm -64.8 159.75 21.77 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 123.92 0.888 . . . . 0.0 111.13 172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -135.28 30.41 3.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.994 1.718 . . . . 0.0 111.426 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -138.17 178.98 6.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.675 -0.641 . . . . 0.0 110.298 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -141.87 161.68 37.35 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.913 1.285 . . . . 0.0 111.198 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 5.4 t-105 -82.07 124.06 29.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.481 1.134 . . . . 0.0 110.15 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -67.39 172.46 4.89 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.932 1.349 . . . . 0.0 113.102 175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.35 -57.42 3.17 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.992 -1.068 . . . . 0.0 112.354 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.58 44.68 1.11 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.089 1.356 . . . . 0.0 109.578 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 95.9 t -131.31 132.87 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 118.946 -2.346 . . . . 0.0 110.065 176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -83.32 170.53 14.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.787 0.835 . . . . 0.0 111.722 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.5 p -53.11 -63.48 1.13 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -50.42 -52.55 36.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.541 1.136 . . . . 0.0 112.651 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -57.64 -43.11 84.66 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 116.968 -1.491 . . . . 0.0 112.133 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 6.7 tp-100 -37.87 112.12 0.2 Allowed 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 127.544 2.338 . . . . 0.0 111.637 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -90.81 26.08 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.558 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -112.23 -47.5 0.7 Allowed Glycine 0 N--CA 1.449 -0.474 0 O-C-N 122.06 -0.4 . . . . 0.0 112.123 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.43 157.04 7.35 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 117.295 -1.836 . . . . 0.0 111.125 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.69 25.68 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.406 1 C-N-CA 126.825 5.017 . . . . 0.0 113.933 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 t -18.98 109.06 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.283 1.833 . . . . 0.0 113.222 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 38.8 Cg_endo -69.69 -29.7 23.76 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.095 1.196 . . . . 0.0 111.397 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.586 HD13 ' CG1' ' A' ' 19' ' ' VAL . 52.2 mt -67.96 127.44 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.373 1.469 . . . . 0.0 110.387 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -136.01 124.66 23.76 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.696 0.798 . . . . 0.0 111.084 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 110' ' ' VAL . 11.3 p -66.11 143.22 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 123.278 0.631 . . . . 0.0 110.211 175.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.445 HG21 ' CZ2' ' A' ' 52' ' ' TRP . 21.8 t -125.38 142.69 41.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.393 1.477 . . . . 0.0 110.871 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.738 ' CB ' HG23 ' A' ' 105' ' ' VAL . 1.2 p90 -156.17 146.94 21.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.198 0.999 . . . . 0.0 111.615 -173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -77.64 168.1 20.51 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.067 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -113.78 29.84 7.7 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 126.068 1.747 . . . . 0.0 110.632 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.5 p -44.1 90.29 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.055 1.298 . . . . 0.0 112.779 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? 51.85 36.53 18.34 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.759 -1.213 . . . . 0.0 113.914 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.453 ' HA2' HD13 ' A' ' 33' ' ' LEU . . . 73.53 50.51 11.6 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.975 -174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.5 111.01 7.09 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.328 1.051 . . . . 0.0 111.672 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.738 HG23 ' CB ' ' A' ' 98' ' ' TYR . 5.2 p -65.38 123.28 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.008 0.923 . . . . 0.0 110.62 172.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -109.54 18.07 20.72 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.658 ' HE1' HG23 ' A' ' 110' ' ' VAL . 9.4 t80 37.26 59.66 1.13 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.411 1.085 . . . . 0.0 110.847 -172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 53.4 t -47.35 -39.8 15.84 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.438 -0.789 . . . . 0.0 112.69 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.97 163.29 12.27 Favored Glycine 0 C--O 1.221 -0.674 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 96' ' ' VAL . 21.2 t -102.75 147.82 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.892 -1.358 . . . . 0.0 109.056 177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -119.66 177.69 4.85 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.657 1.183 . . . . 0.0 111.664 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.1 t -152.78 163.93 38.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.885 1.674 . . . . 0.0 112.282 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.479 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 25.7 m170 -81.79 151.03 27.6 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.52 -0.737 . . . . 0.0 111.897 173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.5 m -70.52 -53.11 17.48 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-O 118.498 -0.763 . . . . 0.0 111.588 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -75.02 105.76 6.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.996 0.918 . . . . 0.0 110.974 -177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.619 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.4 m -146.25 108.92 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.312 0 C-N-CA 123.8 0.84 . . . . 0.0 110.366 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -117.32 -76.24 0.57 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.601 1.191 . . . . 0.0 110.285 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -117.48 -42.32 2.89 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.854 1.262 . . . . 0.0 112.706 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -81.24 -41.63 21.95 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.656 0.782 . . . . 0.0 111.942 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 72.46 34.1 1.34 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.239 1.016 . . . . 0.0 110.6 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -68.89 -54.8 13.55 Favored 'General case' 0 C--O 1.22 -0.476 0 O-C-N 121.533 -0.729 . . . . 0.0 110.327 -175.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.443 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.94 144.48 15.73 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 125.617 1.58 . . . . 0.0 113.049 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -137.09 -59.89 0.69 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -56.74 171.06 0.35 Allowed 'General case' 0 C--O 1.238 0.484 0 O-C-N 125.215 1.572 . . . . 0.0 110.202 173.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 127' ' ' GLU . 4.7 p90 -48.34 167.9 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 123.656 1.693 . . . . 0.0 113.55 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 50' ' ' ILE . 62.8 m-85 -83.68 114.1 21.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.118 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 125' ' ' PHE . 15.4 mt-10 -89.8 122.02 32.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HG3' ' CG2' ' A' ' 50' ' ' ILE . 26.6 mtmt -50.85 163.34 0.2 Allowed 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.173 -0.954 . . . . 0.0 112.879 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.955 ' SG ' HG21 ' A' ' 19' ' ' VAL . 3.3 t -99.06 163.61 12.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 118.587 -0.721 . . . . 0.0 110.59 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 . . . . . 0 C--O 1.258 1.54 0 O-C-N 125.373 1.671 . . . . 0.0 114.435 -178.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 117.628 -1.177 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' O ' HG12 ' A' ' 21' ' ' VAL . 58.5 Cg_endo -69.65 -16.74 38.19 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.663 2.909 . . . . 0.0 113.382 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 19' ' ' VAL . 7.5 tp -87.46 132.12 33.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.761 1.224 . . . . 0.0 109.709 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 19' ' ' VAL . 2.8 m -124.91 169.49 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.456 1.902 . . . . 0.0 109.921 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -139.94 110.31 6.63 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 119.934 -1.729 . . . . 0.0 113.793 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 27.9 m -55.86 164.89 1.03 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.92 0.488 . . . . 0.0 110.57 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -110.15 36.34 0.11 Allowed Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 72.3 Cg_endo -62.08 165.68 14.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 124.373 3.382 . . . . 0.0 110.744 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.3 ttmm -102.44 118.81 37.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.63 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD22 HG12 ' A' ' 116' ' ' VAL . 0.2 OUTLIER -82.41 -87.95 0.09 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.802 1.314 . . . . 0.0 108.964 173.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -116.22 36.25 4.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 128.268 2.627 . . . . 0.0 111.646 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.59 -36.09 4.51 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 119.664 -1.897 . . . . 0.0 113.474 -177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -90.64 149.48 22.07 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.627 1.171 . . . . 0.0 111.29 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -72.17 124.24 24.61 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.151 . . . . 0.0 108.643 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -114.73 129.49 24.94 Favored Pre-proline 0 N--CA 1.47 0.531 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.412 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -65.23 106.68 0.85 Allowed 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 123.055 2.504 . . . . 0.0 111.326 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -82.18 106.3 13.96 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 121.121 -0.987 . . . . 0.0 110.652 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -45.41 121.65 3.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.05 1.34 . . . . 0.0 112.243 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG23 HG23 ' A' ' 4' ' ' VAL . 1.5 m -154.8 131.65 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 C-N-CA 125.141 1.376 . . . . 0.0 110.442 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -108.22 137.64 45.86 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 122.058 -0.401 . . . . 0.0 110.211 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.8 p -55.32 -50.68 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.253 1.021 . . . . 0.0 110.802 175.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.47 -48.4 65.92 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.346 1.058 . . . . 0.0 110.156 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.688 HG21 HD11 ' A' ' 69' ' ' ILE . 33.2 m -59.03 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.093 0.557 . . . . 0.0 112.052 173.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -47.22 -52.26 16.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.0 112.996 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -59.34 -47.44 85.4 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.62 0.768 . . . . 0.0 111.475 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -46.4 62.5 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.155 0.982 . . . . 0.0 110.658 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -60.51 -56.73 17.89 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.029 0.532 . . . . 0.0 111.806 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 96' ' ' VAL . . . -57.24 -45.95 83.45 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HA ' HG11 ' A' ' 105' ' ' VAL . 5.2 tpm_? -60.84 -51.61 68.59 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.485 174.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -56.05 -55.64 30.42 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.37 1.468 . . . . 0.0 111.52 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.53 -30.42 69.74 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.868 0.73 . . . . 0.0 112.033 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.7 -160.46 37.29 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.291 0.948 . . . . 0.0 112.321 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.747 HD22 HD22 ' A' ' 100' ' ' ASN . 6.4 mp -109.79 41.39 1.7 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.463 1.505 . . . . 0.0 111.845 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.2 m -145.6 102.45 3.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.491 0.663 . . . . 0.0 111.119 -174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.4 t -111.42 164.07 13.34 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.604 1.561 . . . . 0.0 111.016 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.58 -16.22 0.84 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.363 1.459 . . . . 0.0 114.778 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -46.59 88.96 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.658 1.983 . . . . 0.0 110.956 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.413 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 97.7 p -141.71 -56.21 0.47 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.08 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.665 -1.075 . . . . 0.0 112.666 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' OD2' ' CD1' ' A' ' 78' ' ' TRP . 15.7 p-10 -105.39 154.77 38.78 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 118.986 1.393 . . . . 0.0 112.21 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.5 Cg_endo -61.89 176.16 10.42 Favored 'Cis proline' 0 C--N 1.348 0.529 0 CA-C-O 121.204 0.418 . . . . 0.0 112.109 -9.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.38 145.59 49.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 120.14 -1.6 . . . . 0.0 109.15 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 -71.52 125.66 27.64 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.807 0.843 . . . . 0.0 109.36 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -98.7 121.42 40.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.228 1.411 . . . . 0.0 107.397 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -116.09 147.35 41.39 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.55 1.54 . . . . 0.0 108.485 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -46.83 123.57 5.29 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.902 0.881 . . . . 0.0 112.767 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.43 -42.09 0.13 Allowed Glycine 0 CA--C 1.519 0.332 0 CA-C-N 116.472 -0.331 . . . . 0.0 112.717 -175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -71.91 134.0 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.689 0.756 . . . . 0.0 109.829 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.44 79.73 0.1 Allowed 'General case' 0 N--CA 1.472 0.629 0 O-C-N 120.834 -1.166 . . . . 0.0 112.751 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 126' ' ' PHE . 3.1 mt -135.34 167.85 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.519 1.528 . . . . 0.0 110.561 -177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -150.68 112.85 4.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.748 1.619 . . . . 0.0 107.138 177.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.444 ' CZ3' ' HG2' ' A' ' 128' ' ' LYS . 22.3 m95 -87.69 0.92 55.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.881 -1.508 . . . . 0.0 113.442 174.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.5 20.98 19.16 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.995 -0.892 . . . . 0.0 114.371 -170.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 99.3 t -116.79 124.69 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.358 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -50.24 -37.41 35.45 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.15 -53.38 12.88 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.903 1.281 . . . . 0.0 113.984 175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 30.5 m -63.9 -29.12 70.32 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.448 -0.787 . . . . 0.0 112.689 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.15 33.61 0.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.613 2.365 . . . . 0.0 112.279 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 5.8 mmpt? -100.02 167.68 10.33 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.367 -1.458 . . . . 0.0 111.244 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.25 -45.67 5.53 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.194 1.398 . . . . 0.0 111.895 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -99.69 29.92 3.88 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.064 1.745 . . . . 0.0 111.779 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -80.95 167.1 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 123.056 1.407 . . . . 0.0 112.694 175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.9 89.32 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 125.498 1.519 . . . . 0.0 108.091 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD23 HG12 ' A' ' 97' ' ' VAL . 10.7 mp -100.65 -179.18 4.01 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 122.395 1.093 . . . . 0.0 109.561 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.466 ' CD1' HD23 ' A' ' 33' ' ' LEU . 62.5 m95 -145.03 165.83 27.07 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.115 2.166 . . . . 0.0 110.391 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -144.63 136.23 25.6 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.79 1.636 . . . . 0.0 111.671 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.467 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 47.0 t80 -141.57 140.96 21.25 Favored Pre-proline 0 CA--C 1.538 0.514 0 O-C-N 121.753 -0.592 . . . . 0.0 111.124 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 38.2 Cg_endo -68.27 163.58 35.74 Favored 'Trans proline' 0 C--O 1.222 -0.306 0 C-N-CA 124.887 3.725 . . . . 0.0 113.601 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -147.11 156.38 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 O-C-N 121.971 -0.456 . . . . 0.0 112.071 176.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.655 ' N ' HD13 ' A' ' 69' ' ' ILE . 6.3 m-85 -109.19 105.15 14.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.644 1.177 . . . . 0.0 109.607 176.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.444 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 16.5 p90 -54.4 175.56 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 124.145 0.978 . . . . 0.0 111.557 174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -49.55 -56.77 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.64 -47.3 58.2 Favored Glycine 0 CA--C 1.545 1.94 0 N-CA-C 115.88 1.112 . . . . 0.0 115.88 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 19.2 mttm -53.74 156.2 2.85 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 124.426 1.091 . . . . 0.0 111.489 168.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -122.79 -40.4 2.44 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 113.485 -177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.05 -176.97 0.76 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.156 0.582 . . . . 0.0 111.476 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -148.45 156.64 42.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.689 0.796 . . . . 0.0 109.07 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.484 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 1.6 t-105 -68.19 128.02 35.03 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 110.727 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.16 -179.78 6.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.548 0.69 . . . . 0.0 111.769 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -84.18 -56.8 3.46 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.127 -0.983 . . . . 0.0 112.191 172.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' C ' ' HB3' ' A' ' 38' ' ' SER . 14.4 p30 -92.51 40.7 1.06 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.581 -1.324 . . . . 0.0 112.845 -174.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.37 109.99 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 120.767 -1.208 . . . . 0.0 111.351 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.0 158.84 33.96 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 120.955 -1.091 . . . . 0.0 110.057 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.1 p -41.13 -56.07 2.44 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.349 1.859 . . . . 0.0 115.498 173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -49.62 -49.48 46.75 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.23 -39.27 89.44 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.013 0.925 . . . . 0.0 110.378 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 8.5 tp-100 -44.1 110.75 0.23 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.025 1.33 . . . . 0.0 113.091 -175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.73 -36.56 15.12 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.56 -41.79 42.65 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.775 1.179 . . . . 0.0 115.376 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.43 159.35 10.0 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 118.072 -1.405 . . . . 0.0 113.133 161.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.38 15.43 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.806 1 C-N-CA 125.567 4.178 . . . . 0.0 115.25 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.408 ' HB ' ' HE3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -14.49 105.57 0.05 OUTLIER Pre-proline 0 N--CA 1.485 1.304 0 C-N-CA 127.97 2.508 . . . . 0.0 113.315 -178.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.56 -21.9 21.75 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 C-N-CA 121.583 1.522 . . . . 0.0 111.665 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 ' CD2' ' A' ' 17' ' ' PHE . 68.1 mt -70.5 126.08 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.88 1.672 . . . . 0.0 110.875 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -135.13 131.35 36.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.312 1.045 . . . . 0.0 109.321 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.432 ' CG2' ' HB2' ' A' ' 28' ' ' ALA . 7.0 p -70.82 131.33 34.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.216 1.006 . . . . 0.0 109.612 173.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG12 HD23 ' A' ' 64' ' ' LEU . 21.8 t -115.92 137.0 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 124.695 2.188 . . . . 0.0 111.254 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.8 OUTLIER -144.41 161.05 40.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.39 1.476 . . . . 0.0 111.399 -174.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.95 159.12 16.28 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.895 0.878 . . . . 0.0 110.578 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.747 HD22 HD22 ' A' ' 33' ' ' LEU . 20.1 t-20 -86.59 45.06 1.21 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.504 1.922 . . . . 0.0 111.908 173.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 29.8 t -60.38 109.15 0.93 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.117 -1.614 . . . . 0.0 109.846 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.58 36.59 14.1 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.192 0.997 . . . . 0.0 112.539 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 66.57 42.53 93.46 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.283 -0.885 . . . . 0.0 113.527 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -150.76 131.08 13.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.115 1.366 . . . . 0.0 110.104 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.806 HG11 ' HA ' ' A' ' 29' ' ' ARG . 1.1 p -60.62 117.73 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.095 1.358 . . . . 0.0 110.244 170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -89.2 -15.54 33.46 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.1 t80 58.15 63.85 1.65 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 122.138 0.97 . . . . 0.0 111.084 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.3 t -50.34 -38.56 42.69 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.64 174.18 31.2 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 124.994 1.283 . . . . 0.0 110.503 171.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.434 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.4 t -97.07 151.17 4.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 O-C-N 121.824 -0.809 . . . . 0.0 109.594 174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.421 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -129.98 168.07 17.26 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.421 1.889 . . . . 0.0 111.159 173.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 t -148.14 -179.95 7.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.024 1.73 . . . . 0.0 111.977 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.484 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 8.2 m170 -104.94 151.11 24.29 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.549 174.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.9 m -94.44 25.24 4.01 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.358 1.463 . . . . 0.0 112.708 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' NZ ' ' HB3' ' A' ' 117' ' ' ASP . 2.8 tmtt? -129.31 86.08 2.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.052 0.941 . . . . 0.0 111.198 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 116' ' ' VAL . 78.7 t -129.26 59.15 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 124.593 1.157 . . . . 0.0 109.313 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.513 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 20.2 t0 -77.11 -83.25 0.08 Allowed 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.755 -1.215 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt -101.35 -0.4 35.6 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.074 1.349 . . . . 0.0 114.431 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -168.08 125.27 1.11 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.262 1.825 . . . . 0.0 108.198 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 116' ' ' VAL . 0.3 OUTLIER -70.49 61.27 0.23 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.814 2.046 . . . . 0.0 110.561 174.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -90.49 -75.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 123.749 0.819 . . . . 0.0 110.525 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.41 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . 123.24 120.39 2.57 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 126.06 1.791 . . . . 0.0 113.018 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -133.71 -35.97 0.97 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.243 1.022 . . . . 0.0 113.413 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -71.03 177.98 3.45 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 125.089 1.493 . . . . 0.0 111.619 172.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -54.82 163.12 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.355 1.074 . . . . 0.0 111.983 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.54 ' HB3' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -89.11 128.04 35.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.302 177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.35 140.83 49.07 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 124.647 1.179 . . . . 0.0 109.511 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.444 ' HG2' ' CZ3' ' A' ' 52' ' ' TRP . 38.1 mtpt -54.66 164.72 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 112.244 169.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 35.6 m -99.69 136.32 39.8 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 170.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.441 ' C ' ' HB ' ' A' ' 4' ' ' VAL . 28.1 t70 . . . . . 0 C--N 1.314 -0.947 0 C-N-CA 128.535 2.734 . . . . 0.0 104.236 162.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 117.71 -1.138 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' O ' HG23 ' A' ' 21' ' ' VAL . 73.5 Cg_endo -69.82 2.54 3.47 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 124.531 3.488 . . . . 0.0 113.746 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 tp -112.59 124.33 69.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.528 1.531 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 19' ' ' VAL . 26.7 m -114.95 174.74 2.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 125.222 1.409 . . . . 0.0 112.173 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.7 p -148.52 118.11 7.01 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 121.437 -0.79 . . . . 0.0 112.241 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.6 m -64.47 164.65 11.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.939 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -115.12 48.96 0.54 Allowed Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 124.995 1.318 . . . . 0.0 112.923 175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 176.28 6.16 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 124.496 3.464 . . . . 0.0 111.161 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -119.39 128.15 53.79 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.861 0.865 . . . . 0.0 111.73 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -99.35 -82.18 0.44 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 176.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -110.94 44.85 1.22 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 123.956 1.836 . . . . 0.0 109.875 -171.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.52 -30.61 6.33 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 119.891 -1.756 . . . . 0.0 114.1 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -91.87 139.5 30.6 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.782 1.233 . . . . 0.0 110.738 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.24 117.57 9.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.027 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -106.79 128.45 26.12 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.68 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.01 114.81 2.96 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 124.142 3.228 . . . . 0.0 111.422 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.564 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -89.01 107.68 19.17 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 121.417 -0.802 . . . . 0.0 110.624 177.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -54.24 126.59 23.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.539 1.136 . . . . 0.0 112.398 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG23 HG23 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -155.06 129.7 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.634 0 C-N-CA 124.248 1.019 . . . . 0.0 110.494 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -109.65 138.55 45.85 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.046 -1.034 . . . . 0.0 110.8 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 2' ' ' PRO . 17.7 t -61.06 -53.45 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 124.739 1.216 . . . . 0.0 110.983 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -45.21 -47.69 12.62 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.594 1.157 . . . . 0.0 111.227 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 88.7 m -62.5 -60.59 3.32 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.728 -0.653 . . . . 0.0 111.034 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -50.5 -50.63 52.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.806 1.185 . . . . 0.0 113.403 -177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.86 -45.54 92.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 111.269 176.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.74 -47.73 70.33 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 117.936 -1.03 . . . . 0.0 110.388 176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 81.9 mm-40 -63.03 -52.1 64.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.998 0.919 . . . . 0.0 111.429 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.73 -49.75 75.52 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.447 0.699 . . . . 0.0 112.097 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.603 ' HA ' HG11 ' A' ' 105' ' ' VAL . 8.8 tpp85 -62.71 -42.8 99.83 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.268 0.627 . . . . 0.0 112.254 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -59.27 -53.82 53.86 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.551 1.141 . . . . 0.0 111.427 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.728 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -63.5 -32.46 73.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.981 0.801 . . . . 0.0 112.359 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.21 -169.43 53.07 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 122.087 0.826 . . . . 0.0 112.026 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.748 HD13 HD22 ' A' ' 100' ' ' ASN . 4.8 mt -97.96 37.67 1.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.256 -1.143 . . . . 0.0 110.845 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.2 m -151.9 140.66 20.91 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.335 -0.853 . . . . 0.0 110.83 -177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -143.97 166.22 25.58 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.835 0.854 . . . . 0.0 111.202 177.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.07 -28.7 0.35 Allowed Glycine 0 C--O 1.221 -0.711 0 O-C-N 123.524 0.515 . . . . 0.0 112.875 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -38.86 39.97 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.782 1.233 . . . . 0.0 112.967 175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.3 p -139.37 -69.65 0.42 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.677 1.191 . . . . 0.0 112.365 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -174.68 -29.13 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.383 -177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.51 143.41 27.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 118.467 1.133 . . . . 0.0 112.039 -174.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.728 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 72.5 Cg_endo -67.57 179.54 17.18 Favored 'Cis proline' 0 C--O 1.216 -0.6 0 N-CA-C 113.634 0.59 . . . . 0.0 113.634 -1.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.05 145.86 51.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.293 -0.879 . . . . 0.0 108.824 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -66.39 142.02 57.75 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -120.91 114.13 21.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 124.892 1.277 . . . . 0.0 108.063 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -129.73 87.27 2.51 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.282 -0.887 . . . . 0.0 108.951 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.88 28.28 0.05 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.818 1.247 . . . . 0.0 114.338 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.83 -47.82 30.71 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 108.518 -1.833 . . . . 0.0 108.518 -165.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.13 130.04 44.44 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.676 -1.262 . . . . 0.0 108.281 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -64.37 90.47 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.794 0.837 . . . . 0.0 111.54 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 126' ' ' PHE . 4.6 mt -128.39 167.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.434 1.094 . . . . 0.0 110.593 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -141.08 121.48 14.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 125.905 1.682 . . . . 0.0 106.562 176.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.525 ' HB2' HG12 ' A' ' 54' ' ' VAL . 34.2 m95 -100.18 4.29 44.29 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.917 172.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 49.98 33.39 21.14 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.866 0.745 . . . . 0.0 113.915 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG12 ' HB2' ' A' ' 52' ' ' TRP . 8.5 p -133.16 148.41 31.21 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 C-N-CA 124.497 1.119 . . . . 0.0 110.754 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -63.39 -47.31 82.56 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.703 0.763 . . . . 0.0 112.667 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -48.48 -59.86 3.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.634 0.774 . . . . 0.0 112.618 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 64' ' ' LEU . 12.9 m -70.73 -41.21 72.15 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 116.386 -1.768 . . . . 0.0 114.041 174.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -41.19 -40.56 1.6 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.649 1.579 . . . . 0.0 112.36 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -40.84 142.27 0.49 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.573 1.178 . . . . 0.0 112.511 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.6 -58.42 2.56 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.779 -174.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -83.28 36.64 0.53 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.481 1.61 . . . . 0.0 111.609 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.21 162.05 18.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 118.979 -2.326 . . . . 0.0 111.596 175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.47 89.67 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 57' ' ' CYS . 9.4 mp -93.71 -176.96 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.092 0.949 . . . . 0.0 110.98 172.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -144.71 165.16 28.86 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.862 2.065 . . . . 0.0 111.328 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -140.97 135.7 31.45 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.019 1.727 . . . . 0.0 111.053 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.454 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 53.1 t80 -144.4 138.09 14.41 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 47.2 Cg_endo -64.58 156.79 58.93 Favored 'Trans proline' 0 C--O 1.221 -0.354 0 C-N-CA 124.48 3.453 . . . . 0.0 113.011 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 24' ' ' ALA . 11.5 tt -143.59 160.09 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 122.755 1.265 . . . . 0.0 110.966 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 2.3 m-85 -114.32 114.38 25.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -51.62 172.25 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.605 1.193 . . . . 0.0 112.393 169.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.6 t -62.24 114.64 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.566 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.12 57.67 9.15 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 123.82 0.7 . . . . 0.0 111.521 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 38.8 tttp -84.7 -25.86 28.1 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 78.43 40.58 0.12 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.245 1.818 . . . . 0.0 111.342 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 89' ' ' GLY . . . -171.95 -179.33 2.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.479 1.112 . . . . 0.0 111.262 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -157.75 159.82 37.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.152 1.381 . . . . 0.0 110.809 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 8.0 t-105 -87.1 171.94 10.32 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.334 1.054 . . . . 0.0 111.524 174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -134.99 152.69 51.96 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.661 -1.275 . . . . 0.0 111.98 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -64.36 -71.16 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.906 0.882 . . . . 0.0 111.86 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.83 49.11 1.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.609 1.195 . . . . 0.0 109.649 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 84.6 t -139.91 120.87 14.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.212 0 O-C-N 120.49 -1.381 . . . . 0.0 111.105 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -71.93 178.68 3.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.431 1.092 . . . . 0.0 111.272 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.9 p -61.13 -52.67 63.9 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.0 m -62.47 -46.49 88.26 Favored 'General case' 0 C--O 1.22 -0.481 0 O-C-N 121.439 -0.788 . . . . 0.0 111.99 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -65.92 -29.48 69.9 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.64 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 5.5 tp-100 -39.52 124.74 1.67 Allowed 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 126.357 1.863 . . . . 0.0 112.308 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -110.37 92.43 4.04 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.327 -174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 76' ' ' ALA . . . 170.07 -40.5 0.2 Allowed Glycine 0 C--O 1.225 -0.466 0 C-N-CA 119.947 -1.121 . . . . 0.0 114.048 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.82 144.37 4.79 Favored Glycine 0 CA--C 1.521 0.419 0 O-C-N 121.421 -1.047 . . . . 0.0 111.643 176.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.92 144.18 96.27 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.57 2.18 . . . . 0.0 108.986 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.45 122.29 19.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.365 174.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 53.1 Cg_endo -71.43 -28.59 17.74 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.25 1.967 . . . . 0.0 112.472 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.564 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.8 mt -75.94 128.33 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 124.209 1.003 . . . . 0.0 109.443 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -137.83 130.98 30.43 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.626 1.171 . . . . 0.0 110.696 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.38 140.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 123.458 0.703 . . . . 0.0 111.526 172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.613 HG12 HD23 ' A' ' 64' ' ' LEU . 43.1 t -123.46 134.76 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 123.854 1.788 . . . . 0.0 111.349 176.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.737 ' CB ' HG23 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -142.59 155.82 45.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.197 -1.365 . . . . 0.0 110.911 -176.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -94.79 166.19 12.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.638 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.748 HD22 HD13 ' A' ' 33' ' ' LEU . 24.6 t-20 -112.91 22.37 14.51 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 126.149 1.78 . . . . 0.0 111.659 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.1 t -32.58 -60.71 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.605 1.162 . . . . 0.0 113.722 -176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -124.94 44.47 2.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.247 1.419 . . . . 0.0 113.155 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.16 33.2 57.55 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.225 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.85 108.65 5.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.86 1.264 . . . . 0.0 109.188 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.737 HG23 ' CB ' ' A' ' 98' ' ' TYR . 1.8 p -42.14 124.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 124.136 0.898 . . . . 0.0 111.103 171.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -99.89 -14.99 18.52 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CE2' HG13 ' A' ' 21' ' ' VAL . 62.8 t80 59.7 62.38 1.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.849 0.833 . . . . 0.0 110.708 -173.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.402 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -49.54 -37.57 27.56 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 120.794 -1.191 . . . . 0.0 113.3 176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.59 168.17 23.09 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-O 122.543 1.079 . . . . 0.0 111.198 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.86 156.9 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 121.207 -1.172 . . . . 0.0 109.912 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.501 ' HG3' ' CE1' ' A' ' 126' ' ' PHE . 21.6 ptt? -133.88 166.01 23.68 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.032 -1.042 . . . . 0.0 110.663 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.9 t -145.17 -176.78 5.23 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.203 1.401 . . . . 0.0 113.778 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 14.6 m170 -105.29 136.9 43.96 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 119.263 -2.148 . . . . 0.0 110.211 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.7 t -61.44 -43.55 98.67 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 118.316 -0.85 . . . . 0.0 110.944 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.32 111.12 16.41 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 119.316 0.962 . . . . 0.0 109.546 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.602 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.6 m -151.55 108.53 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.313 -0.851 . . . . 0.0 108.856 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -111.9 -76.86 0.59 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.443 1.019 . . . . 0.0 110.88 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -115.81 -45.92 2.86 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.946 1.298 . . . . 0.0 112.249 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -84.39 -0.3 52.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.629 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 39.91 37.44 0.36 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.854 1.261 . . . . 0.0 112.73 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -97.5 149.86 21.72 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 119.853 -1.779 . . . . 0.0 110.3 -171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.13 137.02 15.02 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.284 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -128.0 -71.1 0.67 Allowed 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.839 0.964 . . . . 0.0 110.902 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.66 -70.31 0.09 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.265 1.426 . . . . 0.0 111.279 -176.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -162.46 -179.69 7.14 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.716 1.206 . . . . 0.0 110.329 177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.533 ' HB3' HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -98.23 111.34 23.71 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.073 1.349 . . . . 0.0 108.745 177.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -98.8 123.83 43.29 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 120.282 -1.511 . . . . 0.0 110.538 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HB3' HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -46.45 162.76 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.285 -0.885 . . . . 0.0 113.224 169.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 69.4 m -102.13 178.44 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.633 1.173 . . . . 0.0 110.526 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 C--O 1.264 1.867 0 C-N-CA 124.425 1.09 . . . . 0.0 113.352 -178.346 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 116.679 -1.629 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 21' ' ' VAL . 74.3 Cg_endo -68.79 0.91 4.3 Favored 'Trans proline' 0 CA--C 1.552 1.386 0 C-N-CA 124.417 3.411 . . . . 0.0 113.576 174.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 tp -112.34 104.36 16.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 119.115 -2.241 . . . . 0.0 109.094 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -85.15 169.42 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 122.192 0.996 . . . . 0.0 111.064 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.6 p -144.31 137.41 27.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 122.644 1.212 . . . . 0.0 112.466 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 83.9 m -88.95 167.9 12.82 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -112.49 45.14 0.27 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.77 -173.59 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.992 3.794 . . . . 0.0 111.893 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -117.39 121.21 40.46 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 112.504 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.446 ' HB2' ' CB ' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -95.6 -80.8 0.41 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.209 1.004 . . . . 0.0 109.052 175.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.86 56.51 0.67 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.204 1.802 . . . . 0.0 108.348 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 -18.73 2.09 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 117.953 -1.471 . . . . 0.0 114.868 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -104.23 163.27 12.53 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.868 1.667 . . . . 0.0 110.802 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -72.24 106.97 4.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.355 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' CB ' ' HB2' ' A' ' 10' ' ' LEU . 29.6 tptt -97.13 124.67 48.68 Favored Pre-proline 0 C--O 1.217 -0.613 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.583 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 123.99 11.65 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.418 2.745 . . . . 0.0 112.466 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.534 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -99.73 106.62 18.55 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 122.011 -0.431 . . . . 0.0 111.036 178.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -59.75 136.43 57.99 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.665 0.666 . . . . 0.0 112.502 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 t -149.86 118.43 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 O-C-N 125.931 2.02 . . . . 0.0 109.439 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.0 118.6 24.67 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 124.989 1.316 . . . . 0.0 111.83 170.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 2' ' ' PRO . 8.0 p -51.24 -37.94 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 O-C-N 121.408 -0.808 . . . . 0.0 112.744 173.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.93 -66.82 0.32 Allowed 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.806 1.642 . . . . 0.0 110.117 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.425 HG23 HG13 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -58.32 -45.42 88.07 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.4 -55.0 36.66 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 120.79 -1.194 . . . . 0.0 111.56 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -58.05 -39.23 77.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.79 0.836 . . . . 0.0 112.246 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.0 75.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 117.3 -1.334 . . . . 0.0 110.423 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -63.26 -48.23 79.09 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.986 1.315 . . . . 0.0 111.16 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -47.48 83.03 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.326 0.584 . . . . 0.0 112.072 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -69.0 -40.9 78.43 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.045 0.538 . . . . 0.0 112.277 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -61.93 -39.7 92.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.197 1.399 . . . . 0.0 110.99 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 67' ' ' TYR . . . -74.2 -39.93 62.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 124.437 1.086 . . . . 0.0 112.574 177.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.36 -164.03 54.58 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 121.639 0.577 . . . . 0.0 111.813 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.63 HD13 HD22 ' A' ' 100' ' ' ASN . 6.6 mt -109.17 32.63 4.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.52 1.128 . . . . 0.0 111.207 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.5 p -147.64 125.38 11.87 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.522 0.677 . . . . 0.0 110.99 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.4 t -130.59 168.23 17.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.783 0.833 . . . . 0.0 112.223 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.68 -10.83 0.51 Allowed Glycine 0 C--O 1.222 -0.652 0 C-N-CA 123.811 0.72 . . . . 0.0 113.199 172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -45.87 71.66 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.541 1.536 . . . . 0.0 112.221 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 93.9 p -134.59 -59.56 0.81 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.423 1.089 . . . . 0.0 112.497 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.36 -25.36 0.04 OUTLIER Glycine 0 C--O 1.227 -0.334 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.776 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.97 148.24 40.08 Favored Pre-proline 0 CA--C 1.553 1.096 0 O-C-N 124.942 1.025 . . . . 0.0 110.407 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.82 168.66 62.73 Favored 'Cis proline' 0 C--O 1.213 -0.744 0 N-CA-C 114.98 1.108 . . . . 0.0 114.98 0.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.86 143.12 45.86 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.096 -1.002 . . . . 0.0 108.917 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 26.8 mmm-85 -70.26 130.92 43.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.989 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -108.97 118.78 37.68 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -115.06 143.05 45.8 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.135 -0.978 . . . . 0.0 108.74 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -45.26 102.88 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.685 1.194 . . . . 0.0 112.724 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 -48.31 0.01 OUTLIER Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -77.19 132.27 38.67 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -65.12 79.49 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.595 1.158 . . . . 0.0 111.923 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 126' ' ' PHE . 2.5 mt -126.65 160.82 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.762 1.625 . . . . 0.0 109.305 -176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.44 117.87 9.68 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.369 1.868 . . . . 0.0 107.57 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.413 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.1 m95 -96.06 6.43 48.87 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.801 -1.09 . . . . 0.0 113.001 171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.95 -31.94 0.91 Allowed Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.609 1.099 . . . . 0.0 114.161 -173.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' H ' ' A' ' 57' ' ' CYS . 7.9 p -61.46 146.74 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.117 0.959 . . . . 0.0 110.191 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.438 ' HA ' ' OD2' ' A' ' 58' ' ' ASP . 59.5 m-20 -87.28 6.94 30.83 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 123.109 1.433 . . . . 0.0 114.169 171.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' H ' HG22 ' A' ' 54' ' ' VAL . 32.7 t30 -100.31 -37.39 8.9 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 119.053 -2.279 . . . . 0.0 111.983 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.668 ' H ' HG13 ' A' ' 54' ' ' VAL . 23.5 m -83.18 -33.72 26.13 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 116.197 -1.858 . . . . 0.0 112.434 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -49.99 -29.79 9.27 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.513 1.133 . . . . 0.0 114.05 175.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 23.4 mtpt -45.72 148.43 0.75 Allowed 'General case' 0 C--N 1.347 0.496 0 C-N-CA 126.409 1.884 . . . . 0.0 111.076 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.33 -46.55 8.66 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 122.603 1.192 . . . . 0.0 111.477 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -91.09 33.03 0.97 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.048 1.404 . . . . 0.0 111.06 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -89.41 162.97 15.49 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 119.773 -1.83 . . . . 0.0 112.294 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mp -117.05 97.92 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 97' ' ' VAL . 7.8 mp -107.64 179.83 4.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.772 0.796 . . . . 0.0 109.65 173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.421 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 73.1 m95 -148.02 157.27 43.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.782 1.633 . . . . 0.0 110.742 176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.8 139.53 50.21 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.173 1.789 . . . . 0.0 111.136 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 2.6 t80 -143.64 141.39 18.79 Favored Pre-proline 0 C--O 1.223 -0.32 0 O-C-N 121.887 -0.508 . . . . 0.0 112.033 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 56.5 Cg_endo -64.7 151.9 83.96 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.8 3.0 . . . . 0.0 111.719 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 94' ' ' ILE . 2.2 tt -143.24 148.39 19.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 122.902 1.334 . . . . 0.0 110.205 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 18.4 m-85 -105.16 116.19 31.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CE3' HD12 ' A' ' 94' ' ' ILE . 20.9 p90 -58.14 179.02 0.08 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.24 0.616 . . . . 0.0 112.654 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 HG13 ' N ' ' A' ' 73' ' ' GLY . 14.6 p -51.79 -46.49 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' N ' HG13 ' A' ' 72' ' ' VAL . . . -57.77 -45.19 93.74 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.628 1.108 . . . . 0.0 111.662 -175.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 28.2 mttm -64.29 164.26 11.47 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 122.51 1.148 . . . . 0.0 112.934 170.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -133.71 -35.85 0.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.823 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.65 174.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.424 0.63 . . . . 0.0 111.675 176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -139.71 160.2 40.41 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.481 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 2.6 t-105 -77.73 139.76 39.43 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.24 1.019 . . . . 0.0 111.885 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.63 -178.88 7.17 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.927 1.346 . . . . 0.0 113.312 174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.38 -52.36 5.93 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.806 -1.183 . . . . 0.0 112.167 174.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -105.11 57.05 0.69 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.888 1.675 . . . . 0.0 111.066 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.7 t -138.44 130.71 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 O-C-N 119.717 -1.865 . . . . 0.0 110.623 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -82.19 153.23 26.08 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.811 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -39.87 -54.44 2.15 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 126.715 2.006 . . . . 0.0 114.795 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -53.9 -56.76 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -55.9 -34.69 65.77 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 117.204 -1.379 . . . . 0.0 113.423 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 8.0 tp-100 -42.36 103.33 0.03 OUTLIER 'General case' 0 C--N 1.344 0.332 0 C-N-CA 127.375 2.27 . . . . 0.0 111.606 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -71.23 -43.73 66.75 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.538 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.49 -52.12 6.38 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.456 1.503 . . . . 0.0 113.475 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.25 163.91 9.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.193 -0.782 . . . . 0.0 111.303 169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.81 143.49 61.48 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.248 3.299 . . . . 0.0 111.298 177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 123.26 7.33 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.666 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 113' ' ' HIS . 58.0 Cg_endo -72.56 -35.71 5.84 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.489 2.792 . . . . 0.0 111.74 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.534 HD11 ' CG ' ' A' ' 17' ' ' PHE . 61.5 mt -63.58 130.35 28.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 O-C-N 124.267 0.979 . . . . 0.0 108.897 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 57.7 mtt85 -138.28 122.31 17.9 Favored 'General case' 0 C--N 1.33 -0.283 0 C-N-CA 123.442 0.697 . . . . 0.0 111.102 174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.624 ' HA ' HG13 ' A' ' 110' ' ' VAL . 14.7 p -59.66 136.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.578 -0.701 . . . . 0.0 111.514 172.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 64' ' ' LEU . 13.0 t -117.71 136.91 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 125.75 1.62 . . . . 0.0 110.966 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 0.4 OUTLIER -143.89 145.53 32.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.829 1.252 . . . . 0.0 110.085 -176.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.492 ' HB3' ' HG2' ' A' ' 106' ' ' GLN . . . -98.32 155.46 17.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.677 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.63 HD22 HD13 ' A' ' 33' ' ' LEU . 10.0 t-20 -96.87 63.39 1.96 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.487 1.915 . . . . 0.0 109.968 176.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t -65.92 -61.7 1.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.434 -1.416 . . . . 0.0 111.181 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.5 ptp85 -128.61 56.94 1.62 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.635 1.574 . . . . 0.0 111.988 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.43 26.94 52.79 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 120.369 -0.919 . . . . 0.0 114.067 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.3 174.69 10.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 125.508 1.523 . . . . 0.0 109.724 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.3 120.72 50.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 125.623 1.569 . . . . 0.0 108.846 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.492 ' HG2' ' HB3' ' A' ' 99' ' ' ALA . 11.2 pt20 -88.85 13.03 13.54 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 117.367 -1.301 . . . . 0.0 113.572 174.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.522 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 42.5 t80 40.75 57.59 2.62 Favored 'General case' 0 C--N 1.347 0.483 0 C-N-CA 124.957 1.303 . . . . 0.0 109.824 -172.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 48.9 t -46.89 -36.11 7.18 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.282 -0.886 . . . . 0.0 112.665 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.17 167.4 14.3 Favored Glycine 0 C--O 1.225 -0.464 0 C-N-CA 124.978 1.275 . . . . 0.0 110.152 169.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.8 OUTLIER -97.81 138.86 21.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 O-C-N 120.922 -1.34 . . . . 0.0 109.524 177.762 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.409 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -114.25 175.22 5.57 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.413 1.085 . . . . 0.0 110.774 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -153.75 177.02 11.44 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.945 1.698 . . . . 0.0 112.41 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.506 ' CG ' ' HA3' ' A' ' 122' ' ' GLY . 20.6 m170 -95.14 153.04 17.84 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 171.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.35 -32.79 24.06 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.637 178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -84.01 95.2 8.48 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.041 -1.662 . . . . 0.0 112.699 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.92 108.97 6.91 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 CA-C-N 120.011 1.278 . . . . 0.0 110.17 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -105.21 -70.74 0.77 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.865 0.841 . . . . 0.0 109.974 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -124.79 -59.84 1.41 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.507 1.523 . . . . 0.0 112.056 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.84 -25.75 62.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.269 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 73.25 48.06 0.17 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 122.616 1.198 . . . . 0.0 109.738 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -65.63 -67.27 0.45 Allowed 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.807 -1.183 . . . . 0.0 109.984 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.506 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 95.64 130.03 6.1 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 125.694 1.616 . . . . 0.0 112.946 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -131.94 -57.8 0.97 Allowed 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 116.539 -1.696 . . . . 0.0 113.582 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -51.15 169.92 0.04 OUTLIER 'General case' 0 C--O 1.237 0.441 0 O-C-N 126.852 2.595 . . . . 0.0 110.898 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -46.34 165.79 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 124.135 1.922 . . . . 0.0 113.791 175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.525 ' HB2' HD11 ' A' ' 50' ' ' ILE . 30.5 m-85 -92.75 135.15 34.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.953 -177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.38 125.84 54.31 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.95 147.84 42.7 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.12 -0.362 . . . . 0.0 111.036 173.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 1.7 m -72.88 172.32 11.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.722 0.809 . . . . 0.0 112.78 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.313 1.845 . . . . 0.0 112.691 177.637 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.185 -1.388 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.407 ' HB2' HG12 ' A' ' 21' ' ' VAL . 59.8 Cg_endo -67.03 -22.81 47.28 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.936 3.091 . . . . 0.0 113.266 177.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 tp -84.34 127.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.915 -0.491 . . . . 0.0 110.402 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.642 HG23 HG23 ' A' ' 19' ' ' VAL . 8.3 m -130.44 -176.11 1.6 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.581 177.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.68 ' HA ' HG22 ' A' ' 19' ' ' VAL . 18.2 p -151.61 130.38 12.4 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 123.585 1.659 . . . . 0.0 114.895 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' HG11 ' A' ' 19' ' ' VAL . 17.6 m -63.59 164.82 8.97 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 118.726 -2.484 . . . . 0.0 109.941 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -111.83 44.51 0.24 Allowed Pre-proline 0 N--CA 1.483 1.216 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.3 Cg_endo -67.28 -179.99 2.14 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 124.624 3.549 . . . . 0.0 111.375 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -103.35 112.77 25.81 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.619 1.199 . . . . 0.0 112.205 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -93.51 -76.91 0.46 Allowed 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.891 173.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.92 53.8 0.68 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 124.42 2.057 . . . . 0.0 107.552 -168.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.53 -9.71 5.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 120.002 -1.686 . . . . 0.0 114.586 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -120.7 164.22 16.88 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.094 1.358 . . . . 0.0 110.183 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -71.53 114.05 9.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.97 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -107.64 132.64 20.85 Favored Pre-proline 0 C--O 1.219 -0.511 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.811 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.7 108.78 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 124.082 3.188 . . . . 0.0 112.683 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -89.7 113.84 25.41 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.239 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 5' ' ' THR . 68.9 mmtt -50.55 118.72 3.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 116.625 -1.655 . . . . 0.0 112.392 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' THR . 15.2 m -153.19 109.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.814 0 O-C-N 125.849 1.968 . . . . 0.0 110.627 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.14 145.32 25.09 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 119.432 -2.043 . . . . 0.0 110.936 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 HG23 ' CE2' ' A' ' 107' ' ' TYR . 8.3 p -61.82 -41.73 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.521 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.66 -49.81 71.91 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 123.912 0.885 . . . . 0.0 108.667 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.668 HG22 HD11 ' A' ' 69' ' ' ILE . 59.2 m -64.99 -53.48 45.55 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.86 177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -48.75 -49.1 39.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.552 1.069 . . . . 0.0 113.175 -179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.45 -46.42 83.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.971 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.15 -39.49 60.04 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-O 116.557 -1.687 . . . . 0.0 111.214 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -74.6 -48.34 27.13 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 124.844 1.34 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -56.02 -48.84 75.2 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -65.73 -52.68 49.24 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.508 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp -50.87 -42.95 59.36 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 117.634 -1.174 . . . . 0.0 110.983 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' A' ' 67' ' ' TYR . . . -72.48 -37.89 68.33 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 124.719 1.262 . . . . 0.0 112.362 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.9 -158.18 53.68 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 124.473 1.108 . . . . 0.0 111.244 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 65' ' ' TRP . 7.7 mt -114.71 37.61 3.38 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.505 0.669 . . . . 0.0 110.248 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -141.23 115.21 9.18 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.132 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.6 t -121.07 158.49 27.75 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.59 -16.5 0.65 Allowed Glycine 0 N--CA 1.465 0.588 0 O-C-N 123.472 0.482 . . . . 0.0 112.279 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -66.88 -45.16 78.94 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.131 0.973 . . . . 0.0 111.602 176.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 78.2 p -134.62 -58.88 0.82 Allowed 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.628 0.771 . . . . 0.0 112.316 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.71 -23.56 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.775 -1.57 . . . . 0.0 111.78 -178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.73 149.72 48.94 Favored Pre-proline 0 C--O 1.244 0.806 0 O-C-N 125.373 1.278 . . . . 0.0 108.429 -171.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 74.0 Cg_endo -65.51 179.0 13.47 Favored 'Cis proline' 0 C--O 1.216 -0.581 0 N-CA-C 115.334 1.244 . . . . 0.0 115.334 -5.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -123.57 152.8 41.47 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 120.273 -1.517 . . . . 0.0 108.951 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 18.4 mmm-85 -77.19 110.0 11.53 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.405 0.441 . . . . 0.0 110.355 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.416 ' OH ' HD12 ' A' ' 50' ' ' ILE . 2.1 t80 -88.12 137.88 31.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 122.926 1.345 . . . . 0.0 110.0 173.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -131.61 138.43 48.81 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.644 -1.285 . . . . 0.0 109.77 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -41.53 101.98 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 123.289 1.519 . . . . 0.0 113.978 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -160.01 -32.44 0.02 OUTLIER Glycine 0 N--CA 1.465 0.579 0 O-C-N 120.127 -1.608 . . . . 0.0 111.451 -171.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -77.68 7.75 5.31 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 123.763 1.744 . . . . 0.0 111.608 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.3 m170 60.96 49.58 5.71 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 118.324 -2.735 . . . . 0.0 111.327 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.416 HD12 ' OH ' ' A' ' 44' ' ' TYR . 20.9 mt -120.3 101.18 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -76.96 -24.81 52.31 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.859 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.505 ' CZ2' HG21 ' A' ' 97' ' ' VAL . 91.7 m95 64.59 34.21 10.11 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.673 1.233 . . . . 0.0 113.035 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.52 31.06 3.42 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 123.89 0.744 . . . . 0.0 114.187 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 57' ' ' CYS . 7.4 p -144.15 156.52 15.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -87.23 -44.62 11.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.356 1.062 . . . . 0.0 111.894 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -45.86 -45.77 15.29 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.127 -0.983 . . . . 0.0 113.107 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 64' ' ' LEU . 50.6 m -81.78 -33.36 30.94 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-O 114.466 -2.683 . . . . 0.0 115.727 172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -42.98 -33.19 0.75 Allowed 'General case' 0 N--CA 1.484 1.227 0 O-C-N 126.101 2.126 . . . . 0.0 114.392 174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 62' ' ' ALA . 35.0 mtmt -40.71 158.65 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-O 123.782 1.754 . . . . 0.0 113.709 169.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.8 -45.85 4.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.439 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -92.47 30.64 1.46 Allowed 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 125.678 2.656 . . . . 0.0 111.107 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . . . -80.38 -175.5 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 116.358 -3.964 . . . . 0.0 112.285 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.4 mt -126.08 97.43 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.806 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 57' ' ' CYS . 0.6 OUTLIER -104.09 172.32 6.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.705 0.764 . . . . 0.0 109.8 178.546 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.571 ' CD1' HD22 ' A' ' 33' ' ' LEU . 62.6 m95 -147.44 133.93 19.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.127 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -111.92 142.68 44.01 Favored 'General case' 0 C--O 1.243 0.75 0 O-C-N 125.117 1.511 . . . . 0.0 111.38 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' PRO . 66.4 t80 -149.86 137.33 11.5 Favored Pre-proline 0 C--O 1.219 -0.5 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 46.9 Cg_endo -67.22 162.59 37.82 Favored 'Trans proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.09 3.194 . . . . 0.0 112.517 -176.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.668 HD11 HG22 ' A' ' 23' ' ' THR . 8.3 tt -155.42 159.98 2.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 O-C-N 120.003 -1.686 . . . . 0.0 109.129 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.506 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 17.9 m-85 -107.07 113.81 27.49 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.004 0.922 . . . . 0.0 110.162 175.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.457 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 11.9 p90 -54.63 -179.24 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.442 1.115 . . . . 0.0 113.243 173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 18' ' ' LYS . 9.2 p -60.69 -41.05 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 O-C-N 121.097 -1.002 . . . . 0.0 113.391 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.5 -41.04 95.2 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 23.1 mttm -65.11 172.37 3.04 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.109 0.957 . . . . 0.0 112.82 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -132.3 -45.47 0.92 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.428 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.6 174.74 0.72 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.441 0.639 . . . . 0.0 111.162 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -140.45 151.46 44.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.44 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.465 ' CE3' ' HG2' ' A' ' 87' ' ' GLN . 4.2 t-105 -61.58 157.72 16.76 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.83 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.71 -174.84 2.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 123.552 1.644 . . . . 0.0 112.608 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -92.11 -65.58 0.99 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.254 -1.528 . . . . 0.0 111.294 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.02 53.08 1.52 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 123.927 1.822 . . . . 0.0 112.203 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 51.4 t -140.73 129.45 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 118.961 -2.337 . . . . 0.0 111.149 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -70.38 173.64 6.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.696 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.4 p -58.98 -60.48 3.8 Favored 'General case' 0 C--O 1.211 -0.962 0 CA-C-O 118.053 -0.975 . . . . 0.0 113.13 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -49.97 -54.23 21.29 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.936 1.243 . . . . 0.0 111.936 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -58.01 -42.05 84.42 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 116.009 -1.948 . . . . 0.0 113.045 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 10.0 tp-100 -36.12 117.18 0.44 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.536 1.934 . . . . 0.0 111.667 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -94.66 112.43 24.18 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.04 -55.65 0.37 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.854 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 162.25 9.67 Favored Glycine 0 CA--C 1.522 0.51 0 CA-C-O 118.869 -0.961 . . . . 0.0 111.84 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.09 149.06 70.72 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.959 3.106 . . . . 0.0 112.014 178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 109.12 3.75 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.837 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.52 -27.17 23.18 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 123.185 2.59 . . . . 0.0 112.043 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.474 HD13 ' CG1' ' A' ' 19' ' ' VAL . 69.3 mt -71.72 125.37 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 O-C-N 124.686 1.241 . . . . 0.0 111.072 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 56.0 mtt85 -135.84 128.18 30.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 O-C-N 123.592 0.557 . . . . 0.0 111.79 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.64 HG21 ' HB2' ' A' ' 28' ' ' ALA . 5.6 p -64.47 136.47 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 O-C-N 121.812 -0.555 . . . . 0.0 111.98 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 64' ' ' LEU . 12.1 t -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.942 0.877 . . . . 0.0 112.15 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.449 ' CD1' ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -150.5 139.18 20.7 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.469 0.652 . . . . 0.0 110.045 -174.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -86.63 159.47 19.21 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -87.27 83.29 7.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 123.51 1.624 . . . . 0.0 108.989 177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.6 p -106.22 89.55 3.09 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.102 -1.624 . . . . 0.0 109.927 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 63.82 33.12 12.97 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.473 -0.767 . . . . 0.0 112.74 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.31 -34.66 1.53 Allowed Glycine 0 CA--C 1.54 1.62 0 O-C-N 122.172 -0.33 . . . . 0.0 113.705 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.07 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 121.213 -1.169 . . . . 0.0 110.497 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.72 137.73 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.122 0.487 . . . . 0.0 110.436 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -94.57 7.08 46.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 117.056 -1.45 . . . . 0.0 112.446 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.502 ' CE2' HG23 ' A' ' 21' ' ' VAL . 24.8 t80 41.97 56.83 3.39 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.543 1.137 . . . . 0.0 109.997 -174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.414 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 16.6 t -46.06 -34.49 4.16 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.377 -0.827 . . . . 0.0 112.615 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.6 166.57 12.3 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 122.895 1.275 . . . . 0.0 110.619 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG13 ' HA ' ' A' ' 96' ' ' VAL . 2.4 t -99.57 150.11 5.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 120.264 -1.727 . . . . 0.0 109.581 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -124.33 170.08 11.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 124.35 1.06 . . . . 0.0 109.884 -177.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.0 t -156.99 153.78 28.57 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.827 0.822 . . . . 0.0 110.965 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 126' ' ' PHE . 16.1 m170 -72.11 165.47 24.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 124' ' ' GLU . 5.5 t -84.85 -57.93 2.91 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-O 117.162 -1.399 . . . . 0.0 108.434 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -68.25 104.69 1.9 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 120.94 1.7 . . . . 0.0 111.078 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 4.0 m -145.77 104.0 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 124.508 1.13 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.69 -74.83 0.61 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.739 0.7 . . . . 0.0 110.309 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -120.32 -49.91 2.25 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.665 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -75.38 -38.31 60.05 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.965 -1.017 . . . . 0.0 111.503 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 75.82 46.62 0.1 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.952 1.358 . . . . 0.0 109.745 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.59 -71.43 0.27 Allowed 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.358 -0.839 . . . . 0.0 109.639 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.451 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 100.06 131.53 7.39 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 124.688 1.137 . . . . 0.0 113.371 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -131.69 -53.14 1.0 Allowed 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 125.174 1.161 . . . . 0.0 112.267 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 17.2 mp0 -57.82 174.97 0.21 Allowed 'General case' 0 C--O 1.241 0.633 0 O-C-N 125.659 1.849 . . . . 0.0 111.342 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.0 159.7 2.29 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 122.641 1.21 . . . . 0.0 112.597 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE1' ' NE2' ' A' ' 113' ' ' HIS . 62.9 m-85 -71.54 113.51 8.66 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 124.716 2.198 . . . . 0.0 113.264 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -94.97 108.75 20.81 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.239 -2.163 . . . . 0.0 108.959 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.35 124.14 11.21 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.388 -0.82 . . . . 0.0 109.958 173.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 83.0 m -55.35 171.71 0.17 Allowed 'General case' 0 C--O 1.243 0.719 0 O-C-N 124.417 1.073 . . . . 0.0 111.948 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.2 t70 . . . . . 0 C--O 1.256 1.408 0 CA-C-O 116.641 -1.647 . . . . 0.0 114.291 179.203 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 3.54 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 124.436 3.424 . . . . 0.0 114.025 176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tp -121.12 103.25 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 125.959 1.703 . . . . 0.0 108.575 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 19' ' ' VAL . 32.5 m -94.38 -179.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.757 172.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -144.34 110.23 5.36 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.457 ' SG ' HG21 ' A' ' 19' ' ' VAL . 35.0 m -56.62 164.71 1.36 Allowed 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.863 -0.523 . . . . 0.0 110.553 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -112.8 45.83 0.3 Allowed Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 173.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 57.9 Cg_endo -67.79 178.44 3.38 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.954 3.102 . . . . 0.0 111.197 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -108.68 133.0 53.37 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.924 -1.11 . . . . 0.0 111.947 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -101.92 -79.44 0.52 Allowed 'General case' 0 C--O 1.24 0.568 0 O-C-N 120.89 -1.131 . . . . 0.0 109.502 174.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -120.26 39.3 3.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.704 1.602 . . . . 0.0 109.691 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.21 -27.93 17.02 Favored Glycine 0 C--O 1.222 -0.639 0 CA-C-O 118.484 -1.176 . . . . 0.0 113.698 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -101.01 141.21 34.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.415 1.107 . . . . 0.0 110.57 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -60.33 116.09 4.01 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 124.792 1.308 . . . . 0.0 110.029 177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HD3' HD23 ' A' ' 10' ' ' LEU . 47.6 tttt -106.92 129.53 24.23 Favored Pre-proline 0 C--O 1.224 -0.269 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.757 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.3 118.87 5.87 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 124.056 3.17 . . . . 0.0 112.338 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -104.86 111.26 23.94 Favored 'General case' 0 C--O 1.217 -0.622 0 O-C-N 120.953 -1.092 . . . . 0.0 111.03 178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HD2' HG12 ' A' ' 72' ' ' VAL . 9.1 mtmm -50.94 139.97 16.3 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.448 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.457 HG21 ' SG ' ' A' ' 6' ' ' CYS . 3.4 t -156.07 117.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 125.92 2.012 . . . . 0.0 109.273 -176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' OD1' HD11 ' A' ' 69' ' ' ILE . 1.3 p30 -93.19 115.44 28.07 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 119.985 -1.697 . . . . 0.0 112.689 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.418 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.1 p -57.59 -45.66 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.431 -1.418 . . . . 0.0 112.585 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 -50.21 66.46 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.587 1.155 . . . . 0.0 109.138 -175.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.1 m -63.26 -47.4 82.55 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.666 0.604 . . . . 0.0 111.398 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.63 -48.05 72.73 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -66.19 -40.62 90.54 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.102 -0.999 . . . . 0.0 112.245 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -57.51 11.62 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.661 0.784 . . . . 0.0 110.049 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -64.0 -37.33 87.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.583 -0.722 . . . . 0.0 111.957 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.38 -59.33 4.95 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.979 0.912 . . . . 0.0 110.307 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -65.84 -34.48 78.24 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.039 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -59.71 -59.11 5.95 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.837 0.855 . . . . 0.0 111.395 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -62.31 -36.08 81.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.746 0.818 . . . . 0.0 111.397 177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.74 -158.78 52.59 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' HA ' ' A' ' 100' ' ' ASN . 2.5 mt -113.46 40.12 2.46 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.876 1.271 . . . . 0.0 111.04 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.7 m -151.54 123.44 8.08 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 122.546 1.165 . . . . 0.0 110.278 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 t -127.91 154.93 44.97 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 121.269 -0.894 . . . . 0.0 112.135 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 160.35 31.43 0.02 OUTLIER Glycine 0 C--O 1.221 -0.71 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.66 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -46.31 2.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.064 1.346 . . . . 0.0 111.855 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 p -136.35 -65.4 0.57 Allowed 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.225 0.61 . . . . 0.0 111.909 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.84 23.57 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.309 0 CA-C-O 115.64 -2.756 . . . . 0.0 112.008 -177.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.7 p30 -160.98 148.48 12.29 Favored Pre-proline 0 CA--C 1.556 1.196 0 CA-C-N 119.326 1.563 . . . . 0.0 112.216 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.541 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 65.2 Cg_endo -64.31 179.9 9.72 Favored 'Cis proline' 0 C--O 1.215 -0.637 0 N-CA-C 114.457 0.906 . . . . 0.0 114.457 -5.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -121.18 151.92 39.38 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 119.77 -1.831 . . . . 0.0 109.481 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 25.5 mmm-85 -78.54 109.29 12.6 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.321 0.648 . . . . 0.0 110.304 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -87.06 126.79 34.98 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.39 43.54 2.77 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.427 1.091 . . . . 0.0 112.573 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.04 42.98 30.48 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.489 -0.757 . . . . 0.0 112.698 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.56 -29.39 52.72 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.015 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.93 12.8 20.48 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.966 -0.726 . . . . 0.0 111.811 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 50.75 50.53 18.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.125 1.37 . . . . 0.0 112.282 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 126' ' ' PHE . 4.6 mt -96.34 163.68 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 121.756 -0.59 . . . . 0.0 109.862 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' O ' ' HE3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -140.47 116.67 10.57 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 126.296 1.839 . . . . 0.0 107.846 176.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -94.49 0.95 55.7 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.807 172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.21 -16.77 2.03 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.706 0.669 . . . . 0.0 114.078 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.736 HG12 ' H ' ' A' ' 56' ' ' ASN . 67.5 t -70.55 133.96 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 O-C-N 121.546 -0.973 . . . . 0.0 108.47 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 -61.67 -26.4 68.0 Favored 'General case' 0 C--O 1.214 -0.773 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.736 ' H ' HG12 ' A' ' 54' ' ' VAL . 36.1 t30 -79.69 -44.84 20.09 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-N 118.699 0.682 . . . . 0.0 111.758 177.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 64.1 m -74.0 -51.36 16.17 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-O 116.424 -1.75 . . . . 0.0 113.227 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -40.7 -44.6 2.21 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.211 1.804 . . . . 0.0 111.933 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -51.46 146.6 7.06 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 122.794 1.283 . . . . 0.0 112.101 174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.51 -52.05 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.52 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -58.6 -17.4 21.71 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.808 0.843 . . . . 0.0 113.126 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -48.62 173.69 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 125.179 2.419 . . . . 0.0 113.652 169.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.4 mp -128.93 95.84 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 119.647 -1.908 . . . . 0.0 108.569 -173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -102.95 173.1 6.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 66.3 m95 -144.82 140.01 28.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.18 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -119.39 139.63 51.7 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.622 1.169 . . . . 0.0 111.154 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 46.9 t80 -140.04 140.96 25.3 Favored Pre-proline 0 C--O 1.219 -0.518 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.694 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.538 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 53.5 Cg_endo -70.16 147.61 60.67 Favored 'Trans proline' 0 C--O 1.224 -0.199 0 C-N-CA 124.422 3.415 . . . . 0.0 112.804 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' OD1' ' A' ' 20' ' ' ASP . 15.4 tt -134.28 160.6 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.345 1.058 . . . . 0.0 111.299 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 29.0 m-85 -115.6 115.13 25.9 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.284 1.034 . . . . 0.0 110.267 174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.613 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.0 p90 -60.29 -178.75 0.09 Allowed 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.783 0.677 . . . . 0.0 112.628 173.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.414 HG12 ' HD2' ' A' ' 18' ' ' LYS . 11.9 p -66.76 -36.24 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 122.71 1.243 . . . . 0.0 112.697 178.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.66 -25.69 71.73 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.47 -1.394 . . . . 0.0 112.167 -178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.556 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.3 mttm -79.76 163.81 24.17 Favored 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.747 0.819 . . . . 0.0 110.839 174.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -133.77 30.54 3.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.323 1.049 . . . . 0.0 111.591 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -135.29 179.68 6.17 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.391 -1.443 . . . . 0.0 110.494 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 1.3 tt0 -143.46 159.98 41.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.573 0.749 . . . . 0.0 111.315 174.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.456 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 5.3 t-105 -83.24 145.79 28.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.515 0.674 . . . . 0.0 109.901 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.669 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -94.44 179.08 5.4 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 121.846 -0.534 . . . . 0.0 112.26 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -91.51 -46.75 7.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -107.27 45.89 0.97 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.274 1.829 . . . . 0.0 111.425 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 52.9 t -133.01 122.99 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 O-C-N 120.255 -1.528 . . . . 0.0 111.625 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -68.95 166.91 16.91 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 121.338 -0.851 . . . . 0.0 111.736 175.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -58.92 -59.79 4.89 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -53.48 -42.19 67.0 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.48 0.712 . . . . 0.0 112.083 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -71.31 -28.44 64.1 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -50.24 125.43 12.42 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 127.122 2.169 . . . . 0.0 110.158 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -101.61 72.61 1.4 Allowed 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.847 0.832 . . . . 0.0 109.486 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.19 -49.55 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 119.508 -1.329 . . . . 0.0 112.9 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.4 152.18 5.88 Favored Glycine 0 C--O 1.227 -0.301 0 CA-C-O 117.044 -1.976 . . . . 0.0 110.552 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.88 24.25 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.242 1 C-N-CA 126.147 4.565 . . . . 0.0 114.268 177.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -15.83 108.62 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 126.593 1.957 . . . . 0.0 112.568 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 33.3 Cg_endo -69.42 -37.62 9.72 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 C-N-CA 121.383 1.389 . . . . 0.0 111.115 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.613 HD12 ' CE3' ' A' ' 71' ' ' TRP . 17.3 mt -60.72 129.98 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.268 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 90.5 mtt180 -138.39 131.97 30.72 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.454 0.471 . . . . 0.0 110.998 176.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HA ' HG13 ' A' ' 110' ' ' VAL . 10.3 p -66.32 130.71 31.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 121.295 -0.878 . . . . 0.0 111.416 174.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG23 ' HG3' ' A' ' 111' ' ' MET . 18.7 t -112.84 136.66 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 122.714 1.245 . . . . 0.0 110.099 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 2.2 p90 -149.62 136.49 19.53 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.36 1.076 . . . . 0.0 110.737 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.599 ' HA ' HD13 ' A' ' 64' ' ' LEU . . . -75.4 147.11 40.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.613 ' HA ' HD22 ' A' ' 33' ' ' LEU . 2.4 t30 -52.99 -21.3 4.25 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 116.468 -1.729 . . . . 0.0 112.305 175.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 t 38.75 35.37 0.11 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.684 1.993 . . . . 0.0 111.318 178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 50.88 56.16 8.42 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 102.7 -31.56 8.58 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.436 1.493 . . . . 0.0 114.646 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.51 -175.87 3.59 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 119.506 1.653 . . . . 0.0 113.037 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.83 133.24 69.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 119.591 -1.943 . . . . 0.0 109.001 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.659 HE22 HG11 ' A' ' 54' ' ' VAL . 9.8 pt20 -97.08 7.88 45.69 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.375 -1.298 . . . . 0.0 112.748 174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 40.4 t80 40.05 59.31 1.99 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.27 1.028 . . . . 0.0 109.547 -174.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.436 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 11.4 t -44.9 -34.1 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.321 -0.862 . . . . 0.0 112.86 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.02 166.47 11.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-O 122.668 1.149 . . . . 0.0 110.38 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.55 HG13 ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -90.2 150.78 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.154 -1.203 . . . . 0.0 108.726 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.49 ' HG3' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -128.05 170.98 12.3 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.492 1.117 . . . . 0.0 110.611 177.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 t -152.58 147.45 26.19 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 123.69 1.709 . . . . 0.0 112.406 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 12.1 m170 -67.85 139.55 56.54 Favored 'General case' 0 C--N 1.32 -0.681 0 O-C-N 120.254 -1.529 . . . . 0.0 110.023 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.9 t -63.53 -52.17 62.33 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-O 119.369 -0.348 . . . . 0.0 110.564 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 118.86 18.3 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.134 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.62 ' O ' HD22 ' A' ' 10' ' ' LEU . 2.6 m -155.26 107.27 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.366 0 CA-C-O 117.823 -1.084 . . . . 0.0 109.809 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 53.1 t0 -112.73 -73.59 0.66 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.122 0.874 . . . . 0.0 111.337 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -118.08 -46.22 2.63 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.419 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -78.43 -35.45 46.92 Favored 'General case' 0 C--O 1.216 -0.683 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.077 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.526 ' HA ' HG12 ' A' ' 116' ' ' VAL . 2.3 m-20 70.34 42.84 0.88 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 122.048 0.928 . . . . 0.0 108.953 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.63 179.55 4.64 Favored 'General case' 0 C--O 1.215 -0.723 0 O-C-N 119.923 -1.736 . . . . 0.0 110.627 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -101.15 126.47 8.92 Favored Glycine 0 N--CA 1.465 0.578 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -127.54 -72.11 0.64 Allowed 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.544 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 125' ' ' PHE . 54.9 mm-40 -62.17 -73.4 0.1 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 125.312 1.632 . . . . 0.0 109.842 -178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 124' ' ' GLU . 23.0 p90 -165.32 -175.76 3.75 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 124.576 1.15 . . . . 0.0 110.305 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.0 m-85 -109.75 116.68 32.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.844 1.307 . . . . 0.0 108.449 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -102.36 129.72 48.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HE3' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -50.93 168.77 0.05 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.807 1.243 . . . . 0.0 111.829 174.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.4 t -104.67 174.37 5.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.115 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -30.81 28.76 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.707 2.938 . . . . 0.0 112.768 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 tp -81.76 120.59 33.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 123.248 0.619 . . . . 0.0 109.493 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 19' ' ' VAL . 12.1 m -119.03 -179.45 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 124.351 1.06 . . . . 0.0 111.355 176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 19' ' ' VAL . 25.0 p -150.85 125.78 9.8 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' A' ' 8' ' ' PRO . 13.5 m -62.81 168.83 3.57 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.506 -1.371 . . . . 0.0 110.43 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -115.17 49.11 0.56 Allowed Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.564 1.145 . . . . 0.0 112.69 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 6' ' ' CYS . 63.6 Cg_endo -73.75 171.05 18.61 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.433 2.756 . . . . 0.0 111.216 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp -108.16 121.95 45.91 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.932 0.893 . . . . 0.0 111.892 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.08 -79.74 0.49 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.616 0.722 . . . . 0.0 109.591 177.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.75 57.08 0.61 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.129 2.171 . . . . 0.0 109.738 -172.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.51 -24.96 1.73 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.517 -1.157 . . . . 0.0 114.06 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -103.35 161.94 13.42 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.404 1.481 . . . . 0.0 110.558 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -86.81 120.06 27.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.621 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -109.82 139.56 21.38 Favored Pre-proline 0 C--O 1.22 -0.464 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.249 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.54 117.1 4.46 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 124.047 3.165 . . . . 0.0 111.638 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.599 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -91.43 107.7 19.39 Favored 'General case' 0 C--O 1.214 -0.808 0 O-C-N 121.557 -0.714 . . . . 0.0 109.654 177.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -40.96 112.29 0.28 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.164 0.986 . . . . 0.0 113.573 175.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.738 HG23 HG23 ' A' ' 4' ' ' VAL . 7.4 m -149.13 110.07 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.723 0 CA-C-N 119.34 0.973 . . . . 0.0 110.157 -178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -93.12 140.07 29.89 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.086 -1.634 . . . . 0.0 110.943 176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 22' ' ' ALA . 11.2 p -55.48 -50.02 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 123.177 0.591 . . . . 0.0 111.43 175.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -50.87 -45.39 59.94 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.643 1.177 . . . . 0.0 110.38 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.638 HG21 HD11 ' A' ' 69' ' ' ILE . 58.9 m -63.13 -61.15 2.57 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.56 176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.97 -48.68 43.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.157 0.889 . . . . 0.0 112.53 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -61.13 -47.85 84.34 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.436 1.094 . . . . 0.0 112.005 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.35 -45.9 55.37 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.299 0.64 . . . . 0.0 111.124 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 67' ' ' TYR . 93.9 mm-40 -66.16 -51.31 59.06 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.302 0.641 . . . . 0.0 112.149 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.06 -49.9 67.94 Favored 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 123.136 0.574 . . . . 0.0 112.394 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -65.18 -39.18 92.54 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.765 -0.584 . . . . 0.0 111.374 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.76 -47.76 84.86 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.911 0.885 . . . . 0.0 112.195 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -76.4 -31.33 57.88 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 123.937 0.773 . . . . 0.0 112.132 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.38 -155.03 40.72 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.191 0.901 . . . . 0.0 111.492 -177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.995 HD13 HD22 ' A' ' 100' ' ' ASN . 2.9 mt -111.22 40.41 2.07 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.626 -0.926 . . . . 0.0 111.566 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.0 m -150.34 110.06 4.06 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.409 0.623 . . . . 0.0 110.215 -174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.0 t -112.59 171.64 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.962 0.905 . . . . 0.0 111.76 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 142.82 -16.07 2.4 Favored Glycine 0 C--O 1.222 -0.628 0 C-N-CA 124.956 1.265 . . . . 0.0 113.313 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -63.7 -49.03 74.73 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 124.786 1.234 . . . . 0.0 111.9 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.412 ' HB2' ' N ' ' A' ' 83' ' ' LYS . 90.0 p -136.04 -70.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.877 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.18 15.22 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 116.914 -2.048 . . . . 0.0 112.369 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.99 150.12 29.19 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 119.167 1.484 . . . . 0.0 110.165 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.748 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.7 Cg_endo -66.07 -179.51 12.03 Favored 'Cis proline' 0 C--N 1.345 0.385 0 C-N-CA 125.15 -0.771 . . . . 0.0 113.278 -6.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -119.83 148.36 43.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.202 -0.936 . . . . 0.0 109.78 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' HG2' ' CH2' ' A' ' 65' ' ' TRP . 23.1 mmm-85 -73.71 113.85 11.31 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 123.473 0.709 . . . . 0.0 109.909 177.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -91.08 119.86 31.57 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.7 48.88 2.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.329 1.452 . . . . 0.0 111.66 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.34 39.28 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.6 0.714 . . . . 0.0 112.249 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.99 -21.69 32.51 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.429 -0.795 . . . . 0.0 113.459 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.54 5.23 48.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.854 -0.791 . . . . 0.0 111.979 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 58.5 41.74 22.13 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 120.653 -1.279 . . . . 0.0 112.03 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 126' ' ' PHE . 5.8 mt -118.94 135.56 58.97 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 121.742 0.782 . . . . 0.0 109.924 -178.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -104.12 -31.72 9.52 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.601 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' O ' HG23 ' A' ' 54' ' ' VAL . 37.7 m95 71.86 19.05 4.92 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 113.027 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.3 24.98 2.63 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.235 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 52' ' ' TRP . 70.8 t -124.88 129.08 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -54.59 -36.84 64.84 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' HG12 ' A' ' 54' ' ' VAL . 5.8 m-20 -66.43 -59.87 3.27 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 123.692 0.797 . . . . 0.0 112.44 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 58.8 m -65.56 -27.61 68.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.12 -34.56 77.87 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.328 1.451 . . . . 0.0 111.781 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 23.0 mttm -42.25 144.0 0.54 Allowed 'General case' 0 C--N 1.346 0.433 0 C-N-CA 124.273 1.029 . . . . 0.0 111.351 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.59 -52.07 7.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.433 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -84.46 25.36 0.89 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.545 1.164 . . . . 0.0 112.188 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -75.92 172.68 12.3 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.152 -1.593 . . . . 0.0 111.869 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.2 mt -127.23 93.16 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 O-C-N 120.983 -1.073 . . . . 0.0 110.348 -178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.578 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.89 174.64 5.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.089 0.947 . . . . 0.0 108.59 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.435 ' CH2' ' HG2' ' A' ' 43' ' ' ARG . 69.8 m95 -145.12 132.9 21.09 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.926 0.89 . . . . 0.0 109.423 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.91 144.73 36.45 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.962 0.905 . . . . 0.0 112.153 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 27' ' ' GLN . 64.1 t80 -152.39 136.89 10.5 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 121.436 -0.79 . . . . 0.0 112.788 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 67' ' ' TYR . 43.2 Cg_endo -66.71 160.93 44.05 Favored 'Trans proline' 0 C--O 1.218 -0.505 0 C-N-CA 124.249 3.299 . . . . 0.0 112.643 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -153.71 134.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 6.6 m-85 -89.66 104.73 17.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.547 ' CE3' HD12 ' A' ' 94' ' ' ILE . 13.9 p90 -50.13 176.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.73 0.812 . . . . 0.0 112.842 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 18' ' ' LYS . 4.3 p -62.66 -30.03 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 121.037 -1.04 . . . . 0.0 113.379 -178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.38 -40.08 87.17 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.805 0.716 . . . . 0.0 113.131 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 32.8 mttm -64.86 -179.62 0.55 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.961 0.904 . . . . 0.0 111.238 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -130.29 -55.33 1.1 Allowed 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.246 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.63 -179.76 0.1 Allowed 'General case' 0 CA--C 1.534 0.344 0 O-C-N 123.625 0.578 . . . . 0.0 111.926 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -151.13 150.92 31.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.307 0.575 . . . . 0.0 110.179 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.39 154.16 41.06 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 122.019 0.914 . . . . 0.0 111.565 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.48 151.23 49.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.341 1.067 . . . . 0.0 111.181 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -51.23 -62.28 1.71 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.264 1.026 . . . . 0.0 112.903 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.67 49.47 1.79 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.718 1.207 . . . . 0.0 111.096 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 86' ' ' GLN . 68.8 t -149.41 104.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 124.939 1.296 . . . . 0.0 110.684 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' N ' ' HB2' ' A' ' 38' ' ' SER . 0.0 OUTLIER -71.03 166.86 20.45 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.461 176.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.6 p -41.66 -66.1 0.38 Allowed 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.6 t -44.37 -55.14 5.2 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.844 0.858 . . . . 0.0 112.82 177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' CG ' HG13 ' A' ' 82' ' ' VAL . 4.1 tp-100 -55.24 -43.97 75.06 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.975 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -36.97 116.57 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.524 1.53 . . . . 0.0 112.73 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -108.01 87.4 2.49 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.308 0.643 . . . . 0.0 109.632 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.13 -52.21 0.1 OUTLIER Glycine 0 C--O 1.226 -0.381 0 C-N-CA 120.232 -0.985 . . . . 0.0 114.802 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.64 157.48 7.81 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-O 119.462 -0.632 . . . . 0.0 112.871 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.96 145.78 62.96 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.771 2.981 . . . . 0.0 111.481 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.29 119.17 10.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 124.338 1.055 . . . . 0.0 110.495 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.466 ' HB3' ' ND1' ' A' ' 113' ' ' HIS . 57.0 Cg_endo -71.88 -34.28 8.89 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.339 2.692 . . . . 0.0 112.816 177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.599 HD11 ' CD2' ' A' ' 17' ' ' PHE . 75.2 mt -65.21 120.57 12.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.06 1.344 . . . . 0.0 110.348 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HB2' ' SD ' ' A' ' 111' ' ' MET . 0.1 OUTLIER -131.54 125.83 33.35 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.154 0.981 . . . . 0.0 109.962 179.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.58 135.2 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 121.536 -0.727 . . . . 0.0 110.509 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.578 HG12 HD12 ' A' ' 64' ' ' LEU . 46.7 t -115.78 136.7 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 124.761 1.224 . . . . 0.0 110.861 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 0.3 OUTLIER -145.33 141.19 28.3 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.775 1.23 . . . . 0.0 110.793 -177.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.42 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -88.91 156.96 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.995 HD22 HD13 ' A' ' 33' ' ' LEU . 18.0 t-20 -82.38 52.97 2.16 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.569 1.148 . . . . 0.0 111.435 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.9 t -74.6 88.71 2.18 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.353 -1.467 . . . . 0.0 111.047 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 54.83 39.45 31.45 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.113 -0.992 . . . . 0.0 112.251 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.18 -39.47 1.42 Allowed Glycine 0 CA--C 1.536 1.368 0 O-C-N 121.282 -0.886 . . . . 0.0 114.221 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.57 105.49 1.53 Allowed 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 120.97 -1.312 . . . . 0.0 110.506 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -51.88 135.94 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.925 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.42 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.0 pt20 -96.18 11.83 33.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 118.514 -0.755 . . . . 0.0 112.713 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 33.0 t80 39.97 57.85 2.25 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 123.747 0.819 . . . . 0.0 110.831 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.456 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 42.1 t -41.55 -40.4 1.85 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.9 168.23 14.49 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 124.602 1.096 . . . . 0.0 110.704 170.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.45 138.83 19.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.25 -1.147 . . . . 0.0 109.978 175.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.434 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -118.03 159.52 23.05 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 123.544 0.737 . . . . 0.0 110.574 176.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 t -148.57 165.39 31.38 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 122.291 1.043 . . . . 0.0 112.157 175.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.504 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 6.8 m170 -81.87 157.2 24.47 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 120.862 -1.149 . . . . 0.0 111.288 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -83.1 -46.26 13.0 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.843 -0.599 . . . . 0.0 111.254 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' HE2' ' C ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.78 96.21 4.21 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.178 0.899 . . . . 0.0 112.087 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.593 ' O ' HD22 ' A' ' 10' ' ' LEU . 3.8 m -135.99 114.42 15.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 O-C-N 120.494 -1.379 . . . . 0.0 109.941 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -111.25 -71.91 0.74 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.078 0.942 . . . . 0.0 110.338 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.19 -45.66 1.38 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.717 1.207 . . . . 0.0 113.4 -175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -82.48 -13.7 56.27 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.618 174.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.79 30.67 12.17 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.242 0.617 . . . . 0.0 110.853 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -56.24 169.32 0.42 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.93 0.871 . . . . 0.0 110.879 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -118.57 83.19 0.34 Allowed Glycine 0 CA--C 1.5 -0.89 0 O-C-N 119.765 -1.834 . . . . 0.0 112.068 176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -83.49 -55.04 4.52 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 125.039 1.082 . . . . 0.0 112.203 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 178.85 6.82 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.019 0.824 . . . . 0.0 110.5 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -58.41 173.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.509 1.147 . . . . 0.0 112.28 175.242 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.504 ' CE2' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -97.65 96.4 8.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.542 1.163 . . . . 0.0 109.898 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 125' ' ' PHE . 1.5 pp20? -74.82 128.81 36.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.07 0.938 . . . . 0.0 111.143 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -61.64 149.77 38.36 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.278 -0.889 . . . . 0.0 111.268 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 98.7 m -75.14 162.66 28.32 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.378 0.424 . . . . 0.0 111.638 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 C--O 1.252 1.237 0 C-N-CA 125.984 1.713 . . . . 0.0 111.515 -179.651 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.69 0.97 3.58 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.601 2.867 . . . . 0.0 113.819 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 3' ' ' ILE . 10.9 tp -118.44 107.27 21.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.807 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 19' ' ' VAL . 33.5 m -115.37 -175.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 O-C-N 121.867 -0.521 . . . . 0.0 111.444 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.558 ' HA ' HG22 ' A' ' 19' ' ' VAL . 40.1 p -151.88 131.9 13.44 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-O 122.145 0.974 . . . . 0.0 113.428 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 8' ' ' PRO . 63.0 m -69.11 168.1 14.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.717 -1.239 . . . . 0.0 110.232 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -112.64 46.43 0.31 Allowed Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 6' ' ' CYS . 59.1 Cg_endo -65.94 160.25 45.13 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 123.137 2.558 . . . . 0.0 111.532 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -108.59 101.04 10.23 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.321 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.432 HD22 ' CG1' ' A' ' 116' ' ' VAL . 0.2 OUTLIER -56.37 -79.41 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 123.728 1.728 . . . . 0.0 110.467 178.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.57 32.17 4.45 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 120.041 -1.662 . . . . 0.0 110.322 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.06 -19.23 7.79 Favored Glycine 0 C--O 1.222 -0.61 0 O-C-N 120.782 -1.199 . . . . 0.0 113.236 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mpp_? -105.22 159.41 15.89 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 123.195 0.598 . . . . 0.0 110.547 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -91.47 113.74 26.09 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.793 0.683 . . . . 0.0 110.375 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -111.78 128.95 24.69 Favored Pre-proline 0 C--O 1.213 -0.857 0 CA-C-O 118.984 -0.532 . . . . 0.0 111.473 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.87 112.49 2.93 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.598 2.865 . . . . 0.0 112.385 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.576 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -83.5 105.7 14.64 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 119.575 -0.25 . . . . 0.0 111.259 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.431 ' HA ' HG22 ' A' ' 5' ' ' THR . 28.3 mmtm -48.95 112.98 0.69 Allowed 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.104 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.85 HG23 HG23 ' A' ' 4' ' ' VAL . 4.6 m -145.81 134.64 16.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 122.815 1.293 . . . . 0.0 110.335 -177.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' OD2' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -119.24 134.65 55.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 120.09 -1.631 . . . . 0.0 107.573 -174.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.515 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 9.7 p -60.33 -43.98 94.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.936 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.66 70.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 99.3 m -67.59 -55.78 12.05 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.667 0.604 . . . . 0.0 109.856 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HA ' HG21 ' A' ' 69' ' ' ILE . . . -50.05 -52.32 35.34 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.131 0.491 . . . . 0.0 111.507 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -62.4 -44.67 95.89 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.807 -0.558 . . . . 0.0 111.522 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.67 63.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-O 118.864 -0.589 . . . . 0.0 110.49 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HG3' HG22 ' A' ' 69' ' ' ILE . 51.0 mm-40 -71.49 -47.35 56.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.963 0.505 . . . . 0.0 111.143 -179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.63 -54.46 32.89 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.8 mmm-85 -65.44 -46.83 78.37 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.774 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -50.86 -44.36 59.52 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.775 0.43 . . . . 0.0 111.875 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -71.57 -41.12 69.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.28 -166.55 48.13 Favored Glycine 0 N--CA 1.447 -0.602 0 O-C-N 124.123 0.89 . . . . 0.0 111.674 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 100' ' ' ASN . 4.0 mt -104.48 38.7 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.435 -0.45 . . . . 0.0 111.145 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.3 m -150.46 141.32 22.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.176 0.989 . . . . 0.0 110.565 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.429 HG21 ' O ' ' A' ' 41' ' ' PRO . 14.7 t -152.04 169.87 21.31 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.112 -0.993 . . . . 0.0 111.325 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.97 32.34 0.07 OUTLIER Glycine 0 C--O 1.221 -0.698 0 O-C-N 123.5 0.5 . . . . 0.0 113.048 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.1 -41.08 2.55 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 112.235 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.3 p -136.19 -43.92 0.63 Allowed 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.912 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.87 -40.16 0.32 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 118.481 -1.177 . . . . 0.0 112.385 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.54 ' HB3' ' CE1' ' A' ' 42' ' ' HIS . 1.6 p30 -102.27 151.06 38.06 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 121.786 0.803 . . . . 0.0 112.994 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 59.8 Cg_endo -67.16 175.48 27.28 Favored 'Cis proline' 0 C--O 1.219 -0.456 0 C-N-CA 124.736 -0.943 . . . . 0.0 113.659 -3.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.54 ' CE1' ' HB3' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -129.67 146.13 51.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.072 -0.392 . . . . 0.0 110.334 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 31.2 mmm-85 -75.54 135.73 40.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.3 0.24 . . . . 0.0 110.388 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -111.87 140.52 46.46 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.965 0.791 . . . . 0.0 109.984 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -140.16 119.37 12.85 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.817 175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -31.88 100.11 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 O-C-N 125.505 1.753 . . . . 0.0 112.015 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.29 -27.68 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.259 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.405 -174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.55 25.06 0.34 Allowed 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 122.25 1.024 . . . . 0.0 111.146 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.6 m170 57.49 53.83 7.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 119.717 -1.864 . . . . 0.0 110.927 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -139.76 110.17 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.436 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -91.75 -26.18 18.7 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.34 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' VAL . 63.9 m95 66.85 34.65 5.32 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.414 0.685 . . . . 0.0 112.137 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 45.18 24.46 0.89 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.393 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 57' ' ' CYS . 9.0 p -135.17 147.69 29.1 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.89 0 C-N-CA 123.659 0.784 . . . . 0.0 109.22 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -81.93 -41.13 21.27 Favored 'General case' 0 C--O 1.216 -0.691 0 O-C-N 121.406 -0.809 . . . . 0.0 112.074 175.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -48.72 -45.91 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.349 0.522 . . . . 0.0 111.029 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.504 ' H ' HG13 ' A' ' 54' ' ' VAL . 63.8 m -83.08 -30.73 27.76 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.95 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -82.45 28.7 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 122.169 0.985 . . . . 0.0 112.73 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 2.6 mtpm? -86.26 -177.98 6.37 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 120.875 -1.141 . . . . 0.0 111.147 178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 -48.73 5.85 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.066 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -105.62 39.43 1.76 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.647 0.737 . . . . 0.0 110.097 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -76.55 164.53 25.85 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 120.351 -1.468 . . . . 0.0 111.923 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.28 90.57 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.612 HD23 ' CG1' ' A' ' 97' ' ' VAL . 9.8 mp -102.23 -174.51 2.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.573 0.701 . . . . 0.0 111.455 176.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 61.1 m95 -142.91 -179.54 6.41 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 123.99 0.916 . . . . 0.0 113.029 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 7.8 pt-20 -157.09 133.57 9.91 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 123.898 0.879 . . . . 0.0 110.867 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 35.5 t80 -144.92 135.38 12.02 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.666 -0.646 . . . . 0.0 111.812 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.49 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 53.5 Cg_endo -69.5 146.67 62.5 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.52 2.813 . . . . 0.0 112.888 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.788 HD11 HG22 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -146.17 154.52 12.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.52 -0.737 . . . . 0.0 110.567 -176.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.861 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 6.8 m-85 -101.07 136.55 40.74 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 120.837 -1.164 . . . . 0.0 109.663 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CE3' HD12 ' A' ' 94' ' ' ILE . 6.0 p90 -78.41 -175.79 4.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.168 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.04 -59.1 4.27 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 C-N-CA 123.257 0.623 . . . . 0.0 110.904 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -47.6 -33.12 8.47 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HE2' ' CZ2' ' A' ' 71' ' ' TRP . 40.7 mttm -80.26 156.23 26.94 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-O 122.634 1.207 . . . . 0.0 112.593 174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -135.44 35.98 2.96 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 121.314 -0.866 . . . . 0.0 111.37 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.861 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -122.04 175.64 6.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.911 0.386 . . . . 0.0 111.658 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -137.48 157.98 45.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.488 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.51 ' HZ2' HG22 ' A' ' 84' ' ' THR . 3.5 t-105 -95.83 131.18 42.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.23 0.538 . . . . 0.0 111.089 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.54 171.58 13.22 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-O 121.128 0.489 . . . . 0.0 112.001 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -91.08 -45.58 8.61 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 122.057 -0.402 . . . . 0.0 111.306 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -99.31 47.71 0.96 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.682 1.23 . . . . 0.0 111.519 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.9 t -139.09 133.66 40.64 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.216 -1.552 . . . . 0.0 111.718 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -70.09 166.51 19.68 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 121.721 -0.612 . . . . 0.0 111.615 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.51 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 29.3 p -66.94 -41.72 86.5 Favored 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.6 t -65.74 -44.19 86.71 Favored 'General case' 0 C--O 1.224 -0.284 0 O-C-N 123.354 0.409 . . . . 0.0 111.315 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -71.78 -37.49 70.45 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 117.711 -1.138 . . . . 0.0 111.331 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.476 ' HG2' ' CE2' ' A' ' 78' ' ' TRP . 4.1 tp-100 -36.3 110.53 0.11 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.62 1.168 . . . . 0.0 111.666 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -92.23 79.74 5.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 -52.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.785 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' HA3' ' NZ ' ' A' ' 74' ' ' LYS . . . 163.89 147.24 5.01 Favored Glycine 0 C--O 1.219 -0.833 0 CA-C-O 118.595 -1.114 . . . . 0.0 112.467 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.98 14.87 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.026 3.151 . . . . 0.0 113.5 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 t -18.52 103.48 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.088 1.355 . . . . 0.0 112.79 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.547 ' HB3' ' CE1' ' A' ' 113' ' ' HIS . 43.3 Cg_endo -68.45 -38.51 11.22 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 C-N-CA 121.788 1.659 . . . . 0.0 111.868 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.788 HG22 HD11 ' A' ' 69' ' ' ILE . 17.3 mt -53.84 129.27 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.471 0.709 . . . . 0.0 109.752 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -138.5 132.59 31.46 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 122.775 0.43 . . . . 0.0 110.923 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 110' ' ' VAL . 7.5 p -70.89 131.88 33.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 123.203 0.601 . . . . 0.0 110.739 177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 64' ' ' LEU . 50.3 t -113.1 127.36 70.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.919 1.343 . . . . 0.0 111.543 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.706 ' CB ' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -126.24 168.79 13.6 Favored 'General case' 0 C--O 1.214 -0.811 0 O-C-N 120.707 -1.246 . . . . 0.0 110.443 -177.568 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -103.59 165.37 11.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.16 0.505 . . . . 0.0 111.499 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.684 HD22 HD13 ' A' ' 33' ' ' LEU . 17.8 t-20 -111.39 29.83 7.47 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.63 0.772 . . . . 0.0 110.541 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.1 t -48.71 91.77 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.581 0 C-N-CA 123.275 0.63 . . . . 0.0 111.642 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 45.44 44.94 10.03 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -174.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.37 39.34 70.28 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.979 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 105.17 5.83 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.724 0.773 . . . . 0.0 110.305 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 98' ' ' TYR . 76.8 t -61.17 132.63 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.989 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.44 -9.67 14.22 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.248 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.515 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 25.4 t80 57.55 57.99 4.02 Favored 'General case' 0 C--O 1.221 -0.409 0 O-C-N 123.689 0.618 . . . . 0.0 109.999 -176.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.8 t -42.46 -30.24 0.33 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 141.18 175.4 14.8 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 96' ' ' VAL . 1.5 t -102.16 146.83 9.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 O-C-N 121.293 -1.121 . . . . 0.0 110.457 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.444 ' HB3' ' CH2' ' A' ' 52' ' ' TRP . 21.5 ptt? -119.76 162.46 19.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 123.147 0.579 . . . . 0.0 111.443 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 6' ' ' CYS . 5.9 t -157.03 157.45 34.68 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-O 121.923 0.868 . . . . 0.0 111.609 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.561 ' NE2' ' CZ ' ' A' ' 126' ' ' PHE . 4.1 m170 -72.08 -178.7 2.5 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 121.105 -0.997 . . . . 0.0 112.295 176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.8 p -126.7 -31.99 2.64 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.775 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -79.91 59.17 3.09 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.424 1.011 . . . . 0.0 111.58 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.56 HG13 ' HA ' ' A' ' 120' ' ' ASN . 52.9 t -72.71 107.91 3.73 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.577 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.957 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.437 ' HB3' ' NE2' ' A' ' 121' ' ' GLN . 2.4 t0 -85.19 -70.56 0.58 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.945 0.878 . . . . 0.0 111.258 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -128.45 -66.1 0.86 Allowed 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 123.89 0.876 . . . . 0.0 110.404 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -92.75 17.93 9.65 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.85 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.56 ' HA ' HG13 ' A' ' 116' ' ' VAL . 0.6 OUTLIER 71.07 54.01 0.24 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 122.015 0.912 . . . . 0.0 109.429 177.198 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 117' ' ' ASP . 2.1 mp0 -58.91 -73.67 0.08 Allowed 'General case' 0 C--O 1.218 -0.604 0 O-C-N 121.371 -0.831 . . . . 0.0 110.722 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 93.62 124.81 3.9 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 123.462 0.553 . . . . 0.0 113.46 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.48 -51.27 0.8 Allowed 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 117.4 -1.286 . . . . 0.0 111.841 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -42.21 -74.04 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 126.466 2.354 . . . . 0.0 110.889 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -172.06 -176.88 1.76 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.029 0.532 . . . . 0.0 110.688 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.561 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 2.8 m-85 -106.72 88.27 2.72 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-O 123.299 1.523 . . . . 0.0 109.438 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -75.3 125.1 28.28 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 119.946 -1.721 . . . . 0.0 111.924 176.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 126.08 19.9 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.804 -1.185 . . . . 0.0 110.574 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.761 ' SG ' HG21 ' A' ' 19' ' ' VAL . 2.0 t -58.72 177.12 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.161 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' O ' HG12 ' A' ' 21' ' ' VAL . 61.8 Cg_endo -71.85 -0.01 7.77 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.564 2.843 . . . . 0.0 113.904 177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 tp -95.83 128.71 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.781 1.232 . . . . 0.0 110.063 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.834 HG23 HG23 ' A' ' 19' ' ' VAL . 3.4 m -131.47 -177.93 2.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 124.697 1.199 . . . . 0.0 110.67 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 ' HA ' HG22 ' A' ' 19' ' ' VAL . 3.2 p -157.39 118.59 3.63 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.202 1.001 . . . . 0.0 112.643 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.7 m -62.88 171.04 2.33 Favored 'General case' 0 C--O 1.238 0.491 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.53 46.68 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.426 1.09 . . . . 0.0 113.793 176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.52 175.84 4.75 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.504 2.803 . . . . 0.0 112.103 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 8.1 tttp -125.03 96.79 4.99 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.355 1.062 . . . . 0.0 110.743 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.705 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -84.05 -86.02 0.12 Allowed 'General case' 0 C--O 1.219 -0.538 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -84.37 53.52 2.67 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.463 1.125 . . . . 0.0 110.794 -168.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 57.61 12.89 10.53 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.401 -1.437 . . . . 0.0 113.889 -172.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -133.39 160.48 37.25 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 126.327 1.851 . . . . 0.0 110.434 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -76.26 105.68 7.45 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.093 -177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -109.27 127.66 26.82 Favored Pre-proline 0 C--O 1.214 -0.776 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.899 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.29 120.81 7.99 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 123.672 2.914 . . . . 0.0 113.092 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.603 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -91.2 107.61 19.32 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 119.37 -0.347 . . . . 0.0 110.963 178.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -46.04 115.72 1.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 117.951 -1.023 . . . . 0.0 111.347 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 ' SG ' ' A' ' 129' ' ' CYS . 4.0 m -148.51 165.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 124.203 1.001 . . . . 0.0 110.273 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.77 124.2 10.31 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.546 1.165 . . . . 0.0 109.193 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 4.0 p -55.5 -40.87 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.466 177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.02 -52.15 66.43 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.173 0.989 . . . . 0.0 110.808 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.6 m -59.47 -56.44 22.0 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 123.939 0.775 . . . . 0.0 109.663 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.33 -53.26 18.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.694 0.679 . . . . 0.0 111.772 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -56.27 -45.52 80.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.682 0.793 . . . . 0.0 112.073 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.8 -49.62 58.06 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.569 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.562 ' HB3' ' CD1' ' A' ' 67' ' ' TYR . 12.8 mt-30 -61.45 -54.9 37.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.31 -47.05 47.32 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.651 0.78 . . . . 0.0 112.223 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 69.6 mtm180 -65.05 -49.42 70.19 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.41 -60.43 3.8 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.972 1.309 . . . . 0.0 112.717 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -56.47 -39.72 73.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.34 1.056 . . . . 0.0 111.818 176.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.11 -160.93 52.38 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 123.988 0.805 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' A' ' 103' ' ' GLY . 3.5 mt -107.22 38.19 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.102 0.961 . . . . 0.0 111.181 -177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.4 m -144.81 106.79 4.3 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.373 1.083 . . . . 0.0 110.73 -174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.9 t -123.59 163.13 21.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 123.473 0.709 . . . . 0.0 112.268 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 159.59 -31.09 0.42 Allowed Glycine 0 C--O 1.223 -0.589 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.267 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -39.62 52.33 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.679 1.191 . . . . 0.0 112.636 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.7 p -138.47 -65.26 0.51 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.21 1.004 . . . . 0.0 112.488 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 177.94 -29.77 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.847 0 CA-C-O 117.944 -1.476 . . . . 0.0 112.385 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 7.7 p-10 -105.01 146.31 32.42 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-N 118.921 1.36 . . . . 0.0 113.259 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 62.2 Cg_endo -64.56 166.29 48.07 Favored 'Cis proline' 0 C--O 1.215 -0.636 0 C-N-CA 126.255 -0.311 . . . . 0.0 112.326 -3.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.45 149.98 33.45 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.613 -1.304 . . . . 0.0 109.376 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -76.52 116.1 16.88 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.359 0.664 . . . . 0.0 110.191 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -87.56 134.23 33.66 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.301 1.001 . . . . 0.0 109.031 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -116.25 162.78 16.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.198 1.799 . . . . 0.0 110.714 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 60' ' ' ALA . . . -74.05 46.21 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.6 1.191 . . . . 0.0 113.312 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.13 -30.94 7.53 Favored Glycine 0 CA--C 1.521 0.434 0 O-C-N 120.805 -1.184 . . . . 0.0 112.424 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -83.0 135.03 35.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.701 0.762 . . . . 0.0 109.775 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -49.82 -31.88 12.85 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.126 1.371 . . . . 0.0 113.638 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.438 HG23 ' HE2' ' A' ' 128' ' ' LYS . 2.1 mt -34.3 119.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 C-N-CA 126.168 1.787 . . . . 0.0 111.863 173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -103.83 -23.86 13.36 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 114.761 -1.109 . . . . 0.0 113.326 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.551 ' HB2' HG12 ' A' ' 54' ' ' VAL . 68.8 m95 66.99 23.37 9.82 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.571 1.148 . . . . 0.0 113.541 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 41.8 32.62 0.95 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.076 -0.847 . . . . 0.0 113.757 -172.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 52' ' ' TRP . 9.1 p -137.38 152.01 27.12 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 C-N-CA 124.406 1.082 . . . . 0.0 108.932 -174.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -80.08 -43.09 22.39 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.685 0.794 . . . . 0.0 112.665 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -50.37 -64.7 0.73 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.779 -1.201 . . . . 0.0 112.472 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 66.1 m -63.07 -38.44 91.19 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-O 117.299 -1.334 . . . . 0.0 112.783 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -48.9 -34.3 12.45 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.855 0.862 . . . . 0.0 112.953 175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -40.74 143.86 0.31 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.848 0.833 . . . . 0.0 112.607 176.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . . . -88.19 -45.66 9.92 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.753 1.263 . . . . 0.0 111.587 -176.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -90.35 30.49 1.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.951 -1.093 . . . . 0.0 111.646 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.27 176.45 6.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.241 -1.537 . . . . 0.0 112.336 176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 53.1 mt -129.53 109.71 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mp -113.93 -178.47 3.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.071 0.939 . . . . 0.0 110.001 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -143.78 165.77 26.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.056 1.743 . . . . 0.0 111.238 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -147.64 132.3 17.84 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.052 1.341 . . . . 0.0 111.179 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.562 ' CD1' ' HB3' ' A' ' 27' ' ' GLN . 43.9 t80 -136.12 135.52 21.38 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 112.335 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HG3' ' CE2' ' A' ' 78' ' ' TRP . 48.2 Cg_endo -65.73 144.79 79.24 Favored 'Trans proline' 0 C--O 1.213 -0.738 1 C-N-CA 125.549 4.166 . . . . 0.0 113.647 -176.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 94' ' ' ILE . 17.2 tt -124.73 165.91 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.935 0.789 . . . . 0.0 112.995 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 14.1 m-85 -122.0 114.63 21.23 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 121.486 -0.758 . . . . 0.0 109.125 177.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CZ3' ' HD2' ' A' ' 93' ' ' PRO . 26.6 p90 -66.83 175.36 2.48 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.925 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.0 t -46.71 -69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.379 1.072 . . . . 0.0 112.068 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -49.73 -55.17 14.89 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.682 0.658 . . . . 0.0 113.12 -176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 19.3 tttp -37.92 113.32 0.27 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.844 1.658 . . . . 0.0 111.501 174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -107.58 75.39 1.01 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . . . -170.64 -179.0 2.77 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.367 0.667 . . . . 0.0 110.776 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -145.9 149.72 34.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.765 0.826 . . . . 0.0 109.875 177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.515 ' CE2' ' HG3' ' A' ' 68' ' ' PRO . 5.1 t-105 -76.19 146.47 39.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.801 0.81 . . . . 0.0 111.257 176.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.771 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -100.1 155.62 17.63 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.589 -0.695 . . . . 0.0 111.956 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -66.61 -58.59 4.86 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 119.117 -0.468 . . . . 0.0 110.626 175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -96.07 42.92 1.08 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.205 1.402 . . . . 0.0 112.372 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 58.1 t -133.28 122.54 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.195 -1.566 . . . . 0.0 111.555 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -69.46 163.45 25.27 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 121.582 -0.699 . . . . 0.0 110.983 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.6 p -54.25 -52.6 60.85 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 m -54.46 -46.12 73.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.875 0.87 . . . . 0.0 112.274 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -67.73 -33.26 74.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.17 0.588 . . . . 0.0 112.223 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.512 ' HG2' ' CE3' ' A' ' 78' ' ' TRP . 4.8 tp-100 -50.0 106.64 0.12 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.967 1.707 . . . . 0.0 111.129 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 62.1 mmtt -65.77 -47.93 73.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.045 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.22 -41.15 3.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.875 1.226 . . . . 0.0 115.289 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.13 158.13 9.81 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 124.289 0.947 . . . . 0.0 110.825 167.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.02 79.74 1.0 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 124.665 3.577 . . . . 0.0 110.064 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.07 127.9 91.51 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 123.918 0.887 . . . . 0.0 110.729 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.636 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 59.2 Cg_endo -71.56 -37.14 5.75 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 123.32 2.68 . . . . 0.0 112.379 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.76 HD13 ' CG1' ' A' ' 19' ' ' VAL . 24.4 mt -70.8 125.51 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -138.12 131.36 30.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.47 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 27' ' ' GLN . 4.0 p -69.23 133.3 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 122.817 0.447 . . . . 0.0 110.352 173.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.3 t -116.37 138.86 45.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 122.555 1.169 . . . . 0.0 110.342 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 108' ' ' CYS . 1.2 p90 -150.24 139.76 21.52 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.613 0.765 . . . . 0.0 110.944 -176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.02 158.77 23.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.478 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.67 65.3 5.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.521 1.128 . . . . 0.0 110.776 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -82.54 88.7 6.64 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.769 -1.207 . . . . 0.0 111.048 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 55.48 37.43 28.88 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.451 -0.78 . . . . 0.0 113.079 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' A' ' 33' ' ' LEU . . . 82.95 -28.49 3.62 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 114.297 0.479 . . . . 0.0 114.297 -175.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.1 128.55 35.22 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.502 1.144 . . . . 0.0 110.98 174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.45 141.82 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.938 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -104.44 11.05 34.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 118.265 -0.874 . . . . 0.0 112.906 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 38.2 t80 41.35 60.37 2.1 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.661 0.784 . . . . 0.0 110.302 -173.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 98' ' ' TYR . 29.1 t -42.86 -37.47 1.84 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 149.95 173.02 19.93 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 124.792 1.187 . . . . 0.0 110.853 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.8 t -97.95 136.12 29.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 O-C-N 120.828 -1.395 . . . . 0.0 108.296 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -117.31 166.22 12.54 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 123.285 0.634 . . . . 0.0 110.981 174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -156.29 148.4 23.24 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.68 1.592 . . . . 0.0 112.312 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.636 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 3.7 m170 -67.48 148.52 51.4 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 121.379 -0.825 . . . . 0.0 110.944 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 79.0 p -92.59 -38.94 11.62 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.969 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -88.51 89.2 7.89 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.549 1.14 . . . . 0.0 111.021 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.705 ' O ' HD22 ' A' ' 10' ' ' LEU . 11.7 m -137.79 109.88 6.6 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.236 0 C-N-CA 124.378 1.071 . . . . 0.0 109.468 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 10' ' ' LEU . 1.2 m-20 -131.86 -83.39 0.5 Allowed 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 122.337 1.065 . . . . 0.0 110.188 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -70.41 -21.82 62.8 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.266 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -158.01 123.28 4.44 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.84 1.656 . . . . 0.0 108.603 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.583 ' HA ' HG12 ' A' ' 116' ' ' VAL . 15.7 m-80 -71.71 40.09 0.07 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.419 ' O ' ' CE1' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -82.98 -30.86 27.88 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 119.831 -1.793 . . . . 0.0 112.236 -176.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 93.34 131.55 5.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.613 0.625 . . . . 0.0 111.992 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.66 -50.84 1.26 Allowed 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 118.384 -0.817 . . . . 0.0 112.581 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -60.74 -80.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.711 1.257 . . . . 0.0 110.264 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -172.64 178.48 2.67 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.789 1.236 . . . . 0.0 109.931 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.48 ' CZ ' ' NE2' ' A' ' 113' ' ' HIS . 3.4 m-85 -94.83 88.63 5.39 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-O 122.999 1.38 . . . . 0.0 108.789 -177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -68.56 134.83 50.59 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 118.95 -2.344 . . . . 0.0 111.569 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HE2' HG23 ' A' ' 50' ' ' ILE . 27.7 mtmt -55.25 157.59 3.51 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.1 -1.0 . . . . 0.0 110.733 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.918 ' SG ' HG21 ' A' ' 19' ' ' VAL . 1.3 t -100.63 177.47 4.99 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.263 175.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 . . . . . 0 C--O 1.25 1.128 0 C-N-CA 125.318 1.447 . . . . 0.0 114.4 -174.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 21' ' ' VAL . 60.0 Cg_endo -69.85 -2.49 10.32 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.481 2.787 . . . . 0.0 113.731 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.16 131.6 59.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 120.587 -1.321 . . . . 0.0 109.09 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -129.32 171.32 17.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 C-N-CA 124.325 1.05 . . . . 0.0 110.909 176.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 p -147.41 124.71 11.55 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 48.5 m -72.02 166.37 22.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.413 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -112.41 45.02 0.26 Allowed Pre-proline 0 N--CA 1.481 1.096 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.3 174.87 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.904 3.069 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -112.25 138.23 49.24 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.873 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.49 -84.94 0.42 Allowed 'General case' 0 CA--C 1.532 0.261 0 O-C-N 125.832 1.957 . . . . 0.0 108.959 174.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -120.74 38.43 4.03 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.596 1.558 . . . . 0.0 110.661 -172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -22.8 34.89 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 119.904 -1.747 . . . . 0.0 114.373 -178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -94.79 160.33 14.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.559 1.144 . . . . 0.0 112.203 173.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -76.09 117.44 17.79 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.067 0.947 . . . . 0.0 109.711 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -107.92 118.91 51.7 Favored Pre-proline 0 C--O 1.219 -0.528 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.273 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.7 126.57 14.9 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.975 2.45 . . . . 0.0 113.344 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.48 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -105.13 109.05 20.89 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.29 -0.881 . . . . 0.0 112.051 178.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -56.63 133.18 53.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.763 0.825 . . . . 0.0 111.71 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 t -149.28 120.79 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 O-C-N 125.078 1.486 . . . . 0.0 108.697 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -95.04 139.06 31.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.686 -0.634 . . . . 0.0 111.109 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 22' ' ' ALA . 14.6 p -60.08 -51.55 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 C-N-CA 124.66 1.184 . . . . 0.0 111.659 173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -52.0 -48.66 64.36 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.602 1.161 . . . . 0.0 109.005 -175.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.0 m -59.34 -61.78 2.37 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.204 1.002 . . . . 0.0 110.56 173.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.12 -49.6 31.51 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 118.995 0.816 . . . . 0.0 112.208 -175.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -61.06 -47.51 86.02 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.224 1.41 . . . . 0.0 111.831 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.06 -50.07 49.15 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.743 177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.457 ' HG3' HG22 ' A' ' 69' ' ' ILE . 26.6 mm100 -63.78 -49.85 71.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.319 1.047 . . . . 0.0 112.017 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB2' HG21 ' A' ' 96' ' ' VAL . . . -51.7 -52.54 47.49 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.853 0.861 . . . . 0.0 111.316 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -65.95 -48.23 72.02 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.509 177.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -51.05 -43.01 60.87 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.642 1.177 . . . . 0.0 111.842 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.97 57.16 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 124.888 1.367 . . . . 0.0 112.949 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.59 -158.64 53.31 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 103' ' ' GLY . 6.9 mt -109.12 34.01 3.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.758 0.823 . . . . 0.0 112.236 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.8 m -148.85 110.36 4.46 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 122.326 1.06 . . . . 0.0 110.779 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -118.01 158.13 25.52 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.684 1.194 . . . . 0.0 111.504 176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.04 41.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.21 0.91 . . . . 0.0 113.162 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.07 -43.95 1.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.826 1.251 . . . . 0.0 112.792 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.433 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 31.9 p -137.59 -61.71 0.63 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 124.006 0.922 . . . . 0.0 111.625 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 173.39 26.43 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.494 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' C ' ' A' ' 41' ' ' PRO . 1.4 p30 -164.53 154.31 12.18 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 119.091 1.445 . . . . 0.0 113.065 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 40' ' ' ASP . 63.4 Cg_endo -63.82 174.4 18.69 Favored 'Cis proline' 0 C--N 1.351 0.688 0 N-CA-C 114.607 0.964 . . . . 0.0 114.607 -5.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 143.44 47.08 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.578 -1.326 . . . . 0.0 109.216 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -69.3 117.62 11.15 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.673 0.789 . . . . 0.0 109.559 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -94.4 140.35 29.93 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.758 1.286 . . . . 0.0 108.613 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -125.1 163.58 22.08 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.788 1.635 . . . . 0.0 110.775 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 61' ' ' ASP . . . -72.7 38.81 0.08 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.854 1.262 . . . . 0.0 113.696 177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.02 -32.44 17.59 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 124.853 1.216 . . . . 0.0 112.656 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -84.26 135.7 34.23 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -43.51 -32.61 0.94 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.793 1.637 . . . . 0.0 114.988 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.4 mt -36.71 124.68 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 C-N-CA 125.829 1.651 . . . . 0.0 111.741 172.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 -27.09 7.59 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.597 1.159 . . . . 0.0 113.229 -176.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.414 ' CH2' ' HB3' ' A' ' 111' ' ' MET . 53.3 m95 67.62 16.1 9.82 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 125.075 1.35 . . . . 0.0 113.143 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 46.92 31.18 5.45 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.579 -170.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 52' ' ' TRP . 53.6 t -128.3 141.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.183 0.991 . . . . 0.0 108.954 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -66.62 -46.97 74.11 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -61.83 -44.09 97.53 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.188 0.995 . . . . 0.0 113.247 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.2 m -69.86 -43.91 70.92 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.668 -0.682 . . . . 0.0 111.949 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -82.36 33.34 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.399 1.479 . . . . 0.0 112.756 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.6 mtpp -74.06 177.85 5.41 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 120.277 -1.514 . . . . 0.0 112.099 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.23 79.0 9.68 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.266 1.026 . . . . 0.0 108.546 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ALA . 28.0 t0 64.47 40.67 6.11 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 123.497 1.617 . . . . 0.0 111.793 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.04 170.53 0.31 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 123.874 1.797 . . . . 0.0 113.664 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.9 mt -91.6 93.27 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 178.86 4.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 123.007 1.384 . . . . 0.0 109.894 171.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -145.26 163.58 34.02 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.918 1.687 . . . . 0.0 111.022 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -142.35 138.18 31.04 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.959 1.304 . . . . 0.0 112.083 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.43 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 38.7 t80 -145.23 137.63 13.45 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 61.4 Cg_endo -71.01 151.3 61.83 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.54 2.826 . . . . 0.0 112.769 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -141.1 172.26 11.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 122.574 1.178 . . . . 0.0 110.64 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' CD2' ' HD3' ' A' ' 74' ' ' LYS . 21.3 m-85 -121.07 111.17 17.12 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.476 ' CE3' HD12 ' A' ' 94' ' ' ILE . 16.1 p90 -54.47 175.52 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.654 -0.654 . . . . 0.0 112.476 172.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -57.25 -35.4 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.94 -40.9 97.52 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.957 0.789 . . . . 0.0 113.261 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 16.2 mttm -63.45 162.34 12.74 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.753 0.787 . . . . 0.0 111.213 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -134.97 36.6 3.05 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.263 1.025 . . . . 0.0 111.056 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -147.13 177.33 9.25 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.816 -1.178 . . . . 0.0 110.839 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -135.43 147.02 48.82 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.295 1.038 . . . . 0.0 109.918 178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.469 ' CG ' ' HG2' ' A' ' 68' ' ' PRO . 6.7 t-105 -68.38 127.2 32.09 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -72.5 -179.01 2.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.192 0.996 . . . . 0.0 111.76 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 -44.64 6.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.612 -0.68 . . . . 0.0 111.066 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 38' ' ' SER . 8.8 p-10 -104.89 40.94 1.41 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.781 1.232 . . . . 0.0 111.776 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 90.4 t -138.12 119.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.132 -1.605 . . . . 0.0 111.812 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -74.1 170.76 14.83 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.991 0.916 . . . . 0.0 111.314 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -53.45 -50.49 65.18 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.98 1.312 . . . . 0.0 113.653 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -55.72 -54.43 44.46 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.018 0.927 . . . . 0.0 112.391 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 82' ' ' VAL . 5.0 tp-100 -59.92 -42.91 94.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.735 174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -38.86 103.38 0.03 OUTLIER 'General case' 0 C--N 1.341 0.209 0 C-N-CA 126.314 1.846 . . . . 0.0 112.469 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -74.76 -41.52 59.92 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.294 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.38 -41.72 8.97 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.934 1.254 . . . . 0.0 114.133 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.74 165.35 11.01 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.62 1.105 . . . . 0.0 112.39 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.18 154.58 73.58 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.415 2.744 . . . . 0.0 111.546 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.43 118.57 3.87 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 123.702 0.801 . . . . 0.0 110.517 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 57.5 Cg_endo -73.08 -30.62 10.55 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.391 2.06 . . . . 0.0 112.323 176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.516 ' HB ' HD11 ' A' ' 69' ' ' ILE . 19.8 mt -73.25 137.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -140.19 136.32 33.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.97 1.308 . . . . 0.0 109.887 174.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 28' ' ' ALA . 9.5 p -74.34 132.39 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 C-N-CA 123.559 0.744 . . . . 0.0 110.594 173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.1 138.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 125.39 1.476 . . . . 0.0 108.966 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.64 143.61 28.92 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.406 1.082 . . . . 0.0 110.741 -176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -85.58 160.55 19.6 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.327 0.584 . . . . 0.0 111.633 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -115.37 73.28 0.83 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.052 1.341 . . . . 0.0 110.115 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 t -88.55 -64.22 1.18 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.746 -0.596 . . . . 0.0 110.678 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -125.27 35.59 4.73 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.21 1.404 . . . . 0.0 113.121 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.417 ' O ' HD11 ' A' ' 33' ' ' LEU . . . 76.48 -40.66 1.56 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 122.37 0.983 . . . . 0.0 114.335 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.53 120.78 16.67 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.932 -1.922 . . . . 0.0 110.614 172.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.4 m -61.25 147.21 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.542 173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -108.23 14.64 24.8 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.769 -1.11 . . . . 0.0 112.931 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.7 t80 40.12 61.3 1.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.701 0.8 . . . . 0.0 110.832 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.9 t -44.69 -38.41 4.36 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.673 -0.642 . . . . 0.0 112.191 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.85 174.46 24.07 Favored Glycine 0 C--O 1.22 -0.764 0 C-N-CA 124.605 1.098 . . . . 0.0 110.487 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -103.44 128.34 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 120.087 -1.831 . . . . 0.0 109.934 176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 21.8 ptt? -105.46 157.69 17.18 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 123.356 0.662 . . . . 0.0 109.529 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -139.01 160.65 39.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 122.139 0.971 . . . . 0.0 110.969 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 5.6 m170 -85.62 151.03 24.22 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.725 -0.609 . . . . 0.0 110.75 172.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.4 t -99.66 27.56 5.27 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.921 0.889 . . . . 0.0 112.575 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -137.49 62.7 1.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.129 -1.607 . . . . 0.0 113.336 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 120' ' ' ASN . 6.2 m -107.17 116.12 50.12 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.273 0 CA-C-O 118.465 -0.779 . . . . 0.0 110.94 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -111.82 -71.71 0.75 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.344 0.974 . . . . 0.0 110.945 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -118.14 -48.31 2.54 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 125.864 1.666 . . . . 0.0 113.067 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -96.05 12.06 31.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 123.65 0.78 . . . . 0.0 112.803 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 116' ' ' VAL . 0.5 OUTLIER 44.25 41.46 4.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.893 0.854 . . . . 0.0 112.057 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -71.17 174.38 6.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.14 0.971 . . . . 0.0 110.378 -173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.68 111.09 2.7 Favored Glycine 0 CA--C 1.5 -0.889 0 O-C-N 120.015 -1.678 . . . . 0.0 111.715 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -116.46 -43.21 2.94 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.07 1.1 . . . . 0.0 113.034 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -80.08 178.63 8.11 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.934 0.771 . . . . 0.0 111.409 174.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -55.5 174.63 0.09 Allowed 'General case' 0 C--O 1.243 0.726 0 CA-C-O 123.05 1.405 . . . . 0.0 112.776 172.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.583 ' HB2' HD11 ' A' ' 50' ' ' ILE . 2.8 m-85 -105.75 125.57 51.14 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 122.731 1.253 . . . . 0.0 107.833 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.57 125.12 53.59 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.45 145.22 11.79 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -75.61 178.75 5.79 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.858 1.263 . . . . 0.0 110.904 172.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.577 2.351 . . . . 0.0 113.03 -176.409 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.364 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.66 -20.63 30.35 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.795 2.997 . . . . 0.0 113.176 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tp -69.15 135.11 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 123.617 0.767 . . . . 0.0 109.917 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 19' ' ' VAL . 3.8 m -133.52 178.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.021 1.328 . . . . 0.0 111.744 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.8 p -147.89 120.12 8.36 Favored 'General case' 0 C--O 1.224 -0.267 0 O-C-N 121.176 -0.952 . . . . 0.0 113.48 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.0 m -61.16 165.6 4.26 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.318 -0.864 . . . . 0.0 110.51 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.85 43.56 0.21 Allowed Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 125.84 1.656 . . . . 0.0 114.253 176.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.21 169.81 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.003 2.469 . . . . 0.0 112.185 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -105.02 109.91 22.1 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.759 1.224 . . . . 0.0 111.287 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD23 ' HE2' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -76.01 -81.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -120.03 40.62 3.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 123.782 1.753 . . . . 0.0 111.329 -171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.54 24.01 Favored Glycine 0 CA--C 1.524 0.628 0 O-C-N 120.483 -1.386 . . . . 0.0 113.779 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -94.49 154.32 17.48 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.714 1.205 . . . . 0.0 111.771 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -72.54 113.2 9.32 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.417 1.087 . . . . 0.0 108.597 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HE2' HD23 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -104.73 128.73 26.24 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-O 118.112 -0.947 . . . . 0.0 109.76 177.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.19 113.46 3.08 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 123.289 2.659 . . . . 0.0 112.224 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -87.15 109.13 19.24 Favored 'General case' 0 C--O 1.218 -0.597 0 O-C-N 120.453 -1.405 . . . . 0.0 110.754 177.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -47.48 113.45 0.7 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 111.072 177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.013 HG23 HG23 ' A' ' 4' ' ' VAL . 5.7 m -144.09 162.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 119.47 1.032 . . . . 0.0 110.227 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -139.32 135.17 33.5 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 121.542 -0.723 . . . . 0.0 109.606 176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 10.0 p -57.36 -43.76 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 123.176 0.59 . . . . 0.0 110.759 175.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.1 74.01 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 123.725 0.81 . . . . 0.0 110.686 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.683 HG21 HD11 ' A' ' 69' ' ' ILE . 40.6 m -67.32 -50.81 58.6 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.787 0.835 . . . . 0.0 112.141 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.07 -43.6 74.02 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -68.61 -45.91 70.68 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.934 0.894 . . . . 0.0 112.168 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.74 -60.94 2.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.428 1.091 . . . . 0.0 111.066 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.578 HE21 ' HB ' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.47 -41.09 72.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.432 0.293 . . . . 0.0 110.934 177.164 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -58.81 -54.37 47.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.209 1.005 . . . . 0.0 110.439 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -62.01 -36.47 81.63 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.343 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -59.27 -48.15 82.68 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 112.21 176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.26 84.41 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 118.55 -0.738 . . . . 0.0 111.132 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.58 -162.28 52.25 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.755 1.169 . . . . 0.0 111.357 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 100' ' ' ASN . 5.8 mt -104.62 35.85 2.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.438 1.095 . . . . 0.0 110.913 -175.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 m -140.62 119.47 12.59 Favored 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 120.901 -1.124 . . . . 0.0 110.081 -173.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -132.4 172.49 12.39 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.93 1.692 . . . . 0.0 111.259 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.34 -19.82 3.01 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.865 1.698 . . . . 0.0 112.985 175.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -43.2 93.77 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.027 1.331 . . . . 0.0 112.713 175.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 61.4 p -138.0 -64.49 0.54 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.542 0.737 . . . . 0.0 111.905 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -30.08 0.04 OUTLIER Glycine 0 C--O 1.225 -0.448 0 C-N-CA 124.826 1.203 . . . . 0.0 113.021 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -107.32 154.44 40.58 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 118.133 0.967 . . . . 0.0 113.262 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.87 173.03 15.45 Favored 'Cis proline' 0 C--N 1.346 0.437 0 N-CA-C 113.587 0.572 . . . . 0.0 113.587 -9.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -120.91 147.12 45.86 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.019 -1.051 . . . . 0.0 108.974 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD3' ' CZ2' ' A' ' 65' ' ' TRP . 32.2 mmm-85 -70.4 128.34 35.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 46' ' ' ALA . 39.1 t80 -106.79 118.36 36.48 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.217 1.007 . . . . 0.0 108.971 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -98.61 26.36 5.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.034 0.934 . . . . 0.0 113.167 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 44' ' ' TYR . . . 44.13 31.52 0.55 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.33 21.12 8.8 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.603 1.573 . . . . 0.0 113.009 -167.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -98.32 29.61 3.51 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.073 1.349 . . . . 0.0 111.527 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 57.4 43.53 23.02 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.11 -1.619 . . . . 0.0 112.988 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.714 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.0 mt -117.25 167.92 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.681 0.753 . . . . 0.0 110.084 -177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -148.18 124.03 10.6 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 174.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.646 ' HB2' HG12 ' A' ' 54' ' ' VAL . 21.3 m95 -103.35 11.01 37.17 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 125.247 1.419 . . . . 0.0 112.811 174.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 51.16 25.17 10.53 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.686 1.136 . . . . 0.0 114.608 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.646 HG12 ' HB2' ' A' ' 52' ' ' TRP . 12.3 p -131.31 127.28 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.909 1.683 . . . . 0.0 109.428 -173.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -48.66 -52.29 24.04 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -46.33 -58.19 3.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.938 1.295 . . . . 0.0 113.643 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.0 m -72.77 -28.23 62.48 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 118.099 -0.953 . . . . 0.0 112.59 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.83 25.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.597 1.959 . . . . 0.0 112.584 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 34.3 mttt -95.9 168.63 10.52 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.286 -1.509 . . . . 0.0 111.507 175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.97 -53.04 3.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.245 1.018 . . . . 0.0 111.152 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.28 25.38 1.92 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.135 1.374 . . . . 0.0 113.625 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -78.73 169.87 17.55 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 123.746 1.736 . . . . 0.0 113.393 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.1 mt -132.76 88.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.019 -178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 97' ' ' VAL . 8.5 mp -101.28 179.48 4.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 122.05 0.929 . . . . 0.0 109.821 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.48 ' CZ2' ' HD3' ' A' ' 43' ' ' ARG . 73.6 m95 -145.46 152.69 40.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.089 1.756 . . . . 0.0 110.586 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.52 141.45 50.99 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.283 1.433 . . . . 0.0 112.178 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 31.6 t80 -149.01 137.07 11.51 Favored Pre-proline 0 CA--C 1.535 0.382 0 O-C-N 121.606 -0.684 . . . . 0.0 112.506 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 55.5 Cg_endo -68.36 152.81 75.25 Favored 'Trans proline' 0 C--O 1.219 -0.432 0 C-N-CA 124.878 3.719 . . . . 0.0 113.854 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.711 HD13 ' N ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -136.27 152.96 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.909 -1.119 . . . . 0.0 111.294 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.711 ' N ' HD13 ' A' ' 69' ' ' ILE . 29.0 m-85 -99.18 100.86 12.04 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.394 1.077 . . . . 0.0 111.318 174.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.524 ' CE3' HD12 ' A' ' 94' ' ' ILE . 19.4 p90 -51.43 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.5 t -55.59 -49.39 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 121.478 -0.764 . . . . 0.0 113.01 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.92 -30.02 62.76 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 114.239 0.456 . . . . 0.0 114.239 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 33.3 mttm -71.63 167.7 19.24 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.626 1.171 . . . . 0.0 111.57 170.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.51 -35.5 0.9 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.48 172.74 2.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.564 0.346 . . . . 0.0 111.364 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -138.23 156.33 47.79 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.265 1.026 . . . . 0.0 109.903 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.528 ' HZ2' HG22 ' A' ' 84' ' ' THR . 5.6 t-105 -75.7 145.93 40.54 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -96.87 167.86 10.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.644 0.735 . . . . 0.0 112.049 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.8 mmmt -78.35 -63.34 1.42 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.949 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -96.49 44.85 1.06 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.173 0.989 . . . . 0.0 110.567 -171.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.681 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 60.4 t -138.05 120.64 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.708 1.203 . . . . 0.0 111.09 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -66.89 165.9 14.5 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.096 0.558 . . . . 0.0 111.452 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.528 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 32.0 p -58.04 -55.27 37.14 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.161 0.985 . . . . 0.0 113.419 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -56.89 -39.57 74.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.729 0.811 . . . . 0.0 113.073 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 82' ' ' VAL . 31.7 tt0 -69.79 -34.21 73.42 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.142 174.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -42.81 109.29 0.13 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.199 2.2 . . . . 0.0 112.821 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -90.95 85.5 5.99 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 109.747 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 175.65 -23.4 0.06 OUTLIER Glycine 0 N--CA 1.469 0.884 0 N-CA-C 115.637 1.015 . . . . 0.0 115.637 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.37 148.98 8.02 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.23 0.919 . . . . 0.0 112.198 172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.42 150.21 88.66 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.438 2.759 . . . . 0.0 110.969 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.77 124.2 13.22 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 124.525 1.13 . . . . 0.0 110.277 176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 60.7 Cg_endo -74.74 -36.9 2.49 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.992 2.461 . . . . 0.0 112.103 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.549 HD11 ' CD2' ' A' ' 17' ' ' PHE . 55.3 mt -62.71 118.81 5.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 125.597 1.559 . . . . 0.0 110.213 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.7 mtt85 -129.22 127.71 41.82 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.942 0.897 . . . . 0.0 109.854 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 28' ' ' ALA . 9.8 p -71.21 140.6 18.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 121.713 -0.617 . . . . 0.0 109.395 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG12 HD23 ' A' ' 64' ' ' LEU . 60.0 t -116.09 130.93 69.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 125.266 1.427 . . . . 0.0 109.428 175.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -140.74 137.64 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.968 1.307 . . . . 0.0 110.105 -176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.501 ' HB3' ' CD ' ' A' ' 106' ' ' GLN . . . -87.39 154.28 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.13 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.438 HD22 ' CD1' ' A' ' 33' ' ' LEU . 4.9 t-20 -77.64 79.55 4.13 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.487 1.115 . . . . 0.0 110.52 172.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -97.32 92.94 6.23 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.916 -1.115 . . . . 0.0 110.668 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 53.71 40.05 30.99 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.239 0.616 . . . . 0.0 112.047 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.65 -38.16 2.65 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.605 -0.684 . . . . 0.0 114.023 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.59 161.21 20.81 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.505 1.145 . . . . 0.0 111.484 171.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.7 m -96.69 141.37 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.108 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.501 ' CD ' ' HB3' ' A' ' 99' ' ' ALA . 13.1 pt20 -100.52 8.6 43.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 118.175 -0.917 . . . . 0.0 113.092 175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 69.1 t80 41.56 61.22 1.91 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 122.207 1.003 . . . . 0.0 110.905 -173.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -46.12 -38.44 8.14 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 120.85 -1.156 . . . . 0.0 113.008 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 153.33 166.19 14.32 Favored Glycine 0 C--O 1.223 -0.584 0 C-N-CA 124.78 1.181 . . . . 0.0 110.32 168.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.4 t -93.92 145.69 7.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 120.643 -1.504 . . . . 0.0 109.461 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 18.4 ptt? -124.84 170.41 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.577 1.151 . . . . 0.0 110.69 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 t -151.34 150.93 31.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.609 1.964 . . . . 0.0 111.836 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 11.8 m170 -69.08 145.04 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 121.382 -0.824 . . . . 0.0 109.508 174.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.7 p -73.02 -45.81 55.61 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.553 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -77.27 89.47 3.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.064 1.302 . . . . 0.0 112.335 -174.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.1 63.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.783 0.833 . . . . 0.0 113.003 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -52.06 -73.6 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.698 1.599 . . . . 0.0 112.474 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -135.95 -42.96 0.65 Allowed 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 120.573 -1.33 . . . . 0.0 111.414 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -81.93 5.27 19.61 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.921 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 44.46 42.96 5.92 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.166 0.987 . . . . 0.0 111.76 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -69.01 -172.73 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 122.129 0.966 . . . . 0.0 111.215 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -133.13 110.54 0.91 Allowed Glycine 0 CA--C 1.499 -0.923 0 O-C-N 120.352 -1.468 . . . . 0.0 111.181 173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -116.58 -70.5 0.79 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 125.478 1.34 . . . . 0.0 112.326 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.48 173.1 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 124.869 1.356 . . . . 0.0 110.485 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -49.85 163.58 0.13 Allowed 'General case' 0 C--O 1.242 0.677 0 CA-C-O 123.402 1.572 . . . . 0.0 113.484 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.714 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.6 m-85 -91.07 114.15 26.6 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.26 1.505 . . . . 0.0 108.773 -175.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -86.18 127.29 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 120.448 -1.407 . . . . 0.0 109.544 176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -51.67 165.35 0.18 Allowed 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.753 -1.217 . . . . 0.0 111.335 174.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.852 ' SG ' HG21 ' A' ' 19' ' ' VAL . 5.0 t -105.97 149.15 26.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 118.222 -0.894 . . . . 0.0 109.23 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.959 1.412 . . . . 0.0 111.592 178.29 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 CA-C-O 116.571 -1.68 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.3 -29.57 3.87 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.813 2.342 . . . . 0.0 113.689 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 tp -71.13 135.08 28.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 19' ' ' VAL . 2.4 m -135.14 177.21 7.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 C-N-CA 126.136 1.775 . . . . 0.0 110.592 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HA ' HG22 ' A' ' 19' ' ' VAL . 24.5 p -148.77 126.32 11.68 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.992 -1.068 . . . . 0.0 112.311 171.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 129' ' ' CYS . 19.0 m -60.71 160.93 8.54 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.039 -1.038 . . . . 0.0 110.733 174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -106.97 33.81 0.06 OUTLIER Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 116.488 2.032 . . . . 0.0 116.488 175.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -65.77 174.07 6.05 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 124.984 3.79 . . . . 0.0 112.144 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HE3' ' O ' ' A' ' 12' ' ' GLY . 23.9 tttt -102.04 111.56 23.88 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.0 1.32 . . . . 0.0 111.927 -176.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -90.62 -94.21 0.12 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 172.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.46 49.81 1.86 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 128.553 2.741 . . . . 0.0 111.463 -169.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' HE3' ' A' ' 9' ' ' LYS . . . 72.29 -6.5 10.72 Favored Glycine 0 CA--C 1.537 1.462 0 O-C-N 120.551 -1.343 . . . . 0.0 114.608 -173.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -116.16 163.62 15.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.853 2.061 . . . . 0.0 111.872 176.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -68.33 123.2 20.11 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HD3' HD23 ' A' ' 10' ' ' LEU . 25.0 tttp -117.85 122.79 30.23 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.05 1.34 . . . . 0.0 111.749 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.13 104.19 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.24 2.627 . . . . 0.0 111.703 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 114.68 21.44 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.393 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -48.75 110.99 0.4 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.674 1.989 . . . . 0.0 111.958 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 4' ' ' VAL . 11.9 m -142.5 121.65 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.487 1.039 . . . . 0.0 111.449 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.23 130.76 52.0 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 120.828 -1.17 . . . . 0.0 110.769 -175.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.6 -42.64 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.741 -1.224 . . . . 0.0 113.488 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.99 -46.82 78.59 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.527 1.531 . . . . 0.0 111.1 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.2 m -61.46 -56.89 15.12 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.115 0.966 . . . . 0.0 110.347 170.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -55.46 -48.93 73.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.506 1.048 . . . . 0.0 113.04 -172.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -59.88 -48.15 82.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.441 1.496 . . . . 0.0 112.698 171.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.31 -51.44 45.21 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.182 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -60.44 -54.02 50.54 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.106 1.362 . . . . 0.0 113.331 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.76 -53.39 15.4 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.856 1.662 . . . . 0.0 112.396 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -67.55 -42.89 81.91 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.785 0.834 . . . . 0.0 113.193 176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt -61.17 -41.55 96.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.745 1.218 . . . . 0.0 112.488 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.69 -43.28 72.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.172 1.389 . . . . 0.0 112.005 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.5 -166.46 52.89 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.344 0.973 . . . . 0.0 111.62 -176.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.84 HD13 HD22 ' A' ' 100' ' ' ASN . 9.0 mt -102.66 33.12 3.31 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.114 1.766 . . . . 0.0 110.181 -177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.6 m -146.82 120.82 9.38 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 120.906 -1.121 . . . . 0.0 111.674 -176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -130.81 166.07 21.63 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.909 1.684 . . . . 0.0 111.223 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 154.34 -30.81 0.71 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-O 118.485 -1.175 . . . . 0.0 113.39 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.55 -52.79 2.16 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 127.233 2.213 . . . . 0.0 110.964 171.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 p -132.29 -65.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.165 1.386 . . . . 0.0 113.738 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.09 -28.15 0.06 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 127.357 2.408 . . . . 0.0 112.449 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.74 141.07 22.06 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 119.281 1.54 . . . . 0.0 112.245 -173.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.79 175.52 22.4 Favored 'Cis proline' 0 C--N 1.357 0.98 0 CA-C-N 120.094 1.069 . . . . 0.0 113.571 -3.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.82 147.6 49.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.678 1.581 . . . . 0.0 109.908 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.3 mmm-85 -69.07 127.23 32.39 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.677 0.791 . . . . 0.0 109.72 175.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -104.09 120.19 40.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.248 1.419 . . . . 0.0 107.936 170.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -128.56 81.63 2.04 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.714 2.006 . . . . 0.0 107.581 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.04 25.97 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.181 2.192 . . . . 0.0 116.346 177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.71 6.17 Favored Glycine 0 N--CA 1.467 0.767 0 CA-C-O 122.903 1.28 . . . . 0.0 110.768 -157.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -76.11 134.32 40.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 113.24 -1.48 . . . . 0.0 109.78 167.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -67.88 86.42 0.23 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.941 1.296 . . . . 0.0 111.651 175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.536 HD11 ' HB2' ' A' ' 126' ' ' PHE . 3.6 mt -132.9 167.58 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.687 1.195 . . . . 0.0 110.089 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -152.89 106.88 3.09 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.937 2.495 . . . . 0.0 107.327 177.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.88 -12.37 59.75 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 127.524 2.329 . . . . 0.0 110.529 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.87 10.83 84.98 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.613 1.101 . . . . 0.0 112.742 -174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.73 112.85 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -174.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -41.03 -37.22 0.79 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -63.76 -48.51 76.65 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.419 1.488 . . . . 0.0 113.363 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.3 m -81.37 -16.29 52.7 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -105.21 24.24 12.37 Favored 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 131.035 3.734 . . . . 0.0 110.71 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 33.3 mttt -81.59 170.6 15.66 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 127.008 2.123 . . . . 0.0 113.008 169.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.48 -59.54 2.22 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.516 1.526 . . . . 0.0 111.44 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -106.14 33.68 3.71 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 127.436 2.294 . . . . 0.0 112.98 -177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -70.94 168.11 17.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.741 1.734 . . . . 0.0 113.732 171.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mt -129.53 91.07 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.27 177.57 5.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.773 1.273 . . . . 0.0 108.557 168.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -142.95 160.78 39.7 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.671 2.388 . . . . 0.0 109.721 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -136.89 142.29 42.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.863 1.665 . . . . 0.0 111.538 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.437 ' CG ' ' HD2' ' A' ' 68' ' ' PRO . 45.7 t80 -145.6 142.22 17.81 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 121.71 -0.619 . . . . 0.0 112.41 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 67' ' ' TYR . 57.9 Cg_endo -68.99 147.08 67.03 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.755 3.636 . . . . 0.0 113.844 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 24' ' ' ALA . 9.0 tt -129.71 155.69 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 122.164 0.983 . . . . 0.0 112.576 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -112.51 111.01 21.53 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.376 1.87 . . . . 0.0 106.355 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.448 ' CE2' ' HD2' ' A' ' 74' ' ' LYS . 28.4 p90 -59.46 166.98 2.1 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.124 0.969 . . . . 0.0 112.666 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.45 131.24 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.71 0.804 . . . . 0.0 109.666 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.58 -18.09 53.83 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.469 1.509 . . . . 0.0 115.093 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 71' ' ' TRP . 32.5 tttm -59.1 105.08 0.29 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.658 1.583 . . . . 0.0 111.242 173.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.438 ' H ' ' ND2' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -78.28 71.88 4.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.714 2.006 . . . . 0.0 111.384 -177.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.443 ' HB1' ' HA2' ' A' ' 89' ' ' GLY . . . -175.24 173.67 2.53 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.227 1.411 . . . . 0.0 111.863 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -150.64 154.49 37.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.836 1.654 . . . . 0.0 110.258 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.524 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -87.59 113.28 23.14 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.948 1.299 . . . . 0.0 111.532 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -179.24 0.39 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.767 1.227 . . . . 0.0 113.326 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -75.73 0.24 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 120.035 -1.666 . . . . 0.0 112.229 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -85.13 69.42 10.77 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 123.588 1.661 . . . . 0.0 109.773 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.12 114.94 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.972 2.109 . . . . 0.0 112.172 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.88 144.82 38.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -42.72 -46.2 5.02 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.698 1.999 . . . . 0.0 115.443 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.7 t -57.36 -42.45 82.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.041 1.336 . . . . 0.0 114.021 174.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -73.18 -34.98 66.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.86 173.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HG2' ' CZ3' ' A' ' 78' ' ' TRP . 9.7 tp-100 -41.82 99.88 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.32 1.848 . . . . 0.0 114.221 -172.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -80.55 5.11 16.28 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.106 -0.996 . . . . 0.0 112.908 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.443 ' HA2' ' HB1' ' A' ' 76' ' ' ALA . . . -91.22 -47.16 3.63 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 123.827 0.727 . . . . 0.0 114.289 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.25 154.04 6.84 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.116 -1.38 . . . . 0.0 111.603 167.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.24 26.37 0.22 Allowed 'Trans proline' 0 CA--C 1.548 1.185 1 C-N-CA 126.342 4.695 . . . . 0.0 114.049 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -26.42 111.23 0.22 Allowed Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 127.526 2.33 . . . . 0.0 113.153 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.45 -21.69 19.35 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.077 2.518 . . . . 0.0 111.951 -174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' MET . 64.3 mt -73.8 125.59 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 126.276 1.83 . . . . 0.0 109.294 177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -130.93 125.29 33.08 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.45 1.1 . . . . 0.0 108.749 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 24' ' ' ALA . 13.7 p -69.48 138.46 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.485 ' CG2' ' SD ' ' A' ' 111' ' ' MET . 10.3 t -119.12 145.4 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 127.007 2.123 . . . . 0.0 109.708 176.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -154.37 144.77 22.16 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.952 -1.476 . . . . 0.0 109.056 -173.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -83.76 160.9 21.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.58 0.752 . . . . 0.0 109.849 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.84 HD22 HD13 ' A' ' 33' ' ' LEU . 26.2 t-20 -89.27 83.74 6.47 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.928 1.691 . . . . 0.0 110.71 167.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.7 p -99.7 92.93 5.57 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.089 -1.632 . . . . 0.0 110.934 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 56.05 39.95 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.513 1.125 . . . . 0.0 113.223 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.84 23.91 75.41 Favored Glycine 0 CA--C 1.538 1.495 0 O-C-N 120.627 -1.296 . . . . 0.0 114.005 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.88 165.35 18.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.02 1.728 . . . . 0.0 110.763 176.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.6 m -109.1 126.66 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 126.647 1.979 . . . . 0.0 108.275 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -94.48 8.75 41.06 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 29.4 t80 47.75 58.7 4.75 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.628 1.171 . . . . 0.0 112.429 -170.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.0 t -47.31 -44.42 23.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.354 1.062 . . . . 0.0 113.674 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.86 168.77 20.69 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 125.826 1.679 . . . . 0.0 109.832 165.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.7 t -98.25 142.92 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.686 -1.479 . . . . 0.0 108.125 176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.485 ' SD ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -115.11 171.97 7.35 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 120.405 1.457 . . . . 0.0 110.237 169.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.2 t -144.59 160.54 40.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.251 1.82 . . . . 0.0 111.471 173.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.434 ' NE2' ' CE2' ' A' ' 126' ' ' PHE . 37.7 m170 -77.42 136.93 38.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.977 170.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -44.3 86.83 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 170.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.642 ' HE2' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -83.28 97.14 8.73 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 121.149 1.795 . . . . 0.0 112.391 -178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.561 ' O ' HD22 ' A' ' 10' ' ' LEU . 5.5 m -134.99 110.91 13.11 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 CA-C-N 119.319 0.963 . . . . 0.0 111.157 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.642 ' OD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 m-20 -109.66 -72.56 0.72 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.612 1.096 . . . . 0.0 112.307 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -127.54 -52.7 1.36 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.766 2.026 . . . . 0.0 113.413 -177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.13 -31.64 62.84 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.19 0.996 . . . . 0.0 112.152 175.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 74.24 40.57 0.42 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.285 2.234 . . . . 0.0 112.872 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -57.99 -64.58 0.86 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.438 1.095 . . . . 0.0 111.738 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . 91.29 150.05 24.56 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 126.353 1.93 . . . . 0.0 114.896 -170.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -145.18 -63.02 0.35 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -55.16 168.66 0.31 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.984 1.314 . . . . 0.0 111.902 168.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -49.52 163.98 0.1 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 124.887 2.279 . . . . 0.0 114.547 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 50' ' ' ILE . 9.7 m-85 -91.73 112.84 24.93 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 113.319 -1.764 . . . . 0.0 109.089 -171.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 109.82 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.24 153.47 26.19 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.75 -1.219 . . . . 0.0 111.486 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 73.5 m -85.79 148.17 25.96 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.598 -0.715 . . . . 0.0 109.395 173.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 7' ' ' ARG . 14.8 t0 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 117.569 -1.205 . . . . 0.0 111.127 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 117.577 -1.201 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.07 5.36 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.731 3.621 . . . . 0.0 114.108 175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.0 tp -126.87 95.91 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.67 1.988 . . . . 0.0 109.157 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.3 m -84.54 171.65 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.759 0 CA-C-O 122.12 0.962 . . . . 0.0 110.347 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 p -142.99 131.24 22.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 123.029 1.395 . . . . 0.0 110.068 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.0 m -83.46 169.68 15.26 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.08 -1.013 . . . . 0.0 109.089 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.6 mtm105 -117.02 45.16 0.49 Allowed Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.212 1.405 . . . . 0.0 113.647 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.63 177.97 3.03 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.437 3.424 . . . . 0.0 111.774 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -112.42 120.83 43.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.098 0.959 . . . . 0.0 110.887 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -94.48 -86.13 0.29 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -106.81 51.2 0.75 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.57 2.348 . . . . 0.0 109.187 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 -20.67 3.71 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.321 -1.487 . . . . 0.0 114.81 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -99.87 142.19 31.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.429 1.492 . . . . 0.0 110.336 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.6 111.48 1.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.523 1.129 . . . . 0.0 109.786 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -103.75 124.5 37.61 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.516 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.16 119.13 6.12 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.062 2.508 . . . . 0.0 112.207 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.637 ' CD1' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -98.76 108.69 21.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.53 0.604 . . . . 0.0 110.871 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -57.06 135.75 56.33 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 124.201 1.0 . . . . 0.0 111.944 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 94' ' ' ILE . 11.1 t -151.41 119.29 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 125.522 1.764 . . . . 0.0 109.346 -178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.18 120.44 30.56 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 126.09 1.756 . . . . 0.0 112.299 172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' CZ ' ' A' ' 107' ' ' TYR . 7.4 p -56.76 -42.03 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.488 -0.757 . . . . 0.0 112.437 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.26 -53.89 50.43 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.3 m -61.23 -54.92 38.1 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.277 1.031 . . . . 0.0 110.096 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.15 -46.16 44.82 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -61.34 -49.32 77.47 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.094 1.358 . . . . 0.0 111.932 174.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.04 -47.2 61.76 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.56 176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -64.03 -51.28 64.9 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.107 0.963 . . . . 0.0 112.651 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' CD1' ' A' ' 98' ' ' TYR . . . -52.46 -51.23 60.38 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.341 0.657 . . . . 0.0 111.819 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -65.46 -39.61 92.22 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -63.04 -43.75 97.82 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.741 1.216 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HD3' ' A' ' 41' ' ' PRO . . . -69.44 -40.51 77.18 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.032 1.333 . . . . 0.0 112.391 173.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.0 -162.88 54.04 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 121.949 0.749 . . . . 0.0 111.509 -178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.537 HD13 ' ND2' ' A' ' 100' ' ' ASN . 3.9 mt -105.61 27.12 8.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.228 1.411 . . . . 0.0 111.257 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -141.26 121.31 13.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.683 -1.261 . . . . 0.0 110.226 -176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -122.9 162.07 22.93 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.958 0.903 . . . . 0.0 111.266 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 162.26 -38.35 0.37 Allowed Glycine 0 C--O 1.223 -0.566 0 C-N-CA 121.784 -0.246 . . . . 0.0 112.708 165.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.97 -35.8 0.57 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.216 2.207 . . . . 0.0 114.234 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.2 p -137.57 -65.04 0.54 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.85 2.06 . . . . 0.0 111.459 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.58 -23.03 0.08 OUTLIER Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.078 1.799 . . . . 0.0 113.986 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.95 153.34 40.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 119.645 1.722 . . . . 0.0 113.884 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' ' HB1' ' A' ' 31' ' ' ALA . 73.3 Cg_endo -64.38 179.81 9.97 Favored 'Cis proline' 0 C--O 1.209 -0.931 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 -8.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.407 ' CE1' HH21 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -126.7 143.19 51.31 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 119.859 -1.775 . . . . 0.0 108.408 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 mmm-85 -63.77 134.48 55.38 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 119.098 -0.477 . . . . 0.0 109.806 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -114.22 137.01 52.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.141 0.9 . . . . 0.0 108.852 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -139.42 48.67 1.84 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.605 1.562 . . . . 0.0 110.596 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.51 34.75 20.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 112.512 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -51.9 -41.48 51.89 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.801 1.191 . . . . 0.0 112.044 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -96.6 17.35 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.846 1.258 . . . . 0.0 113.857 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.7 t60 49.82 46.24 24.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.662 1.585 . . . . 0.0 113.298 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.3 mt -92.98 130.88 41.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.989 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' HD3' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -89.57 -28.66 19.42 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 176.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CG ' ' SG ' ' A' ' 108' ' ' CYS . 69.0 m95 66.58 14.9 9.95 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.0 22.41 34.92 Favored Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.954 -0.914 . . . . 0.0 114.112 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.9 t -129.37 131.94 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.812 1.306 . . . . 0.0 109.088 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -58.26 -40.23 81.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.19 0.996 . . . . 0.0 112.189 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -66.35 -54.59 22.74 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.769 0.827 . . . . 0.0 111.683 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.71 -32.86 73.11 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.38 -29.32 67.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.206 1.402 . . . . 0.0 113.69 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 25.2 mmtp -48.54 140.12 8.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.347 1.059 . . . . 0.0 112.149 173.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.67 -52.78 5.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.929 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -83.47 36.08 0.52 Allowed 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.999 1.381 . . . . 0.0 111.848 175.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -88.6 177.81 6.67 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 119.801 -1.812 . . . . 0.0 112.098 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.06 92.89 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.935 -178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.456 HD12 HG12 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -107.16 179.45 4.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 122.497 1.142 . . . . 0.0 109.134 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.548 ' O ' HG13 ' A' ' 97' ' ' VAL . 69.2 m95 -147.98 172.67 13.84 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 126.498 1.919 . . . . 0.0 111.83 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -152.19 134.13 14.9 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.45 1.1 . . . . 0.0 111.29 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -147.96 130.8 7.93 Favored Pre-proline 0 CA--C 1.54 0.578 0 O-C-N 121.276 -0.89 . . . . 0.0 112.219 -176.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HG2' ' CG ' ' A' ' 78' ' ' TRP . 56.5 Cg_endo -60.9 154.16 58.18 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 124.725 3.616 . . . . 0.0 113.87 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.465 HD13 ' C ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -151.24 157.05 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.997 0.903 . . . . 0.0 111.156 178.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 29.3 m-85 -101.22 104.5 15.56 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.123 1.369 . . . . 0.0 109.208 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 94' ' ' ILE . 26.8 p90 -51.53 173.98 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 173.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.21 -50.81 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.268 1.027 . . . . 0.0 113.663 -172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.13 -42.5 81.84 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.656 -0.652 . . . . 0.0 113.613 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.428 ' HD3' ' CD2' ' A' ' 70' ' ' TYR . 43.5 mttm -70.44 163.95 25.67 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.002 0.906 . . . . 0.0 111.295 171.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -132.69 -32.83 1.25 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.761 1.224 . . . . 0.0 114.183 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . . . -55.01 167.03 0.44 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.67 0.788 . . . . 0.0 111.977 175.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -136.79 143.31 43.11 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 122.021 -0.424 . . . . 0.0 110.088 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 87' ' ' GLN . 3.6 t-105 -77.48 140.89 39.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -177.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.86 173.37 6.89 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-O 121.549 0.69 . . . . 0.0 111.345 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -83.11 -64.88 1.09 Allowed 'General case' 0 C--O 1.217 -0.65 0 O-C-N 121.348 -0.845 . . . . 0.0 111.677 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -87.78 48.68 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.536 1.534 . . . . 0.0 112.846 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.778 HG11 HE22 ' A' ' 87' ' ' GLN . 12.6 p -121.22 155.07 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 O-C-N 120.692 -1.255 . . . . 0.0 111.143 -175.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 144.46 38.22 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.1 p -39.49 -48.29 1.97 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.9 p -56.83 -52.14 66.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.879 1.272 . . . . 0.0 113.286 173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -80.67 22.23 0.6 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.581 1.952 . . . . 0.0 113.611 174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.778 HE22 HG11 ' A' ' 82' ' ' VAL . 7.9 tp-100 -90.39 106.11 18.27 Favored 'General case' 0 N--CA 1.439 -1.023 0 O-C-N 120.159 -1.588 . . . . 0.0 110.678 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -41.71 140.39 0.99 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.826 1.65 . . . . 0.0 111.917 177.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.03 -64.23 3.12 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.395 -0.816 . . . . 0.0 113.029 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.63 -175.77 28.64 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.086 0.943 . . . . 0.0 114.552 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -65.01 166.3 19.01 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.878 3.052 . . . . 0.0 112.056 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.68 127.13 4.56 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.559 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . 65.4 Cg_endo -74.46 -24.48 14.0 Favored 'Trans proline' 0 N--CA 1.443 -1.441 0 C-N-CA 123.094 2.53 . . . . 0.0 112.535 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.734 HD12 ' CE3' ' A' ' 71' ' ' TRP . 87.4 mt -78.21 125.41 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 124.885 1.274 . . . . 0.0 110.893 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 HH21 ' CE1' ' A' ' 42' ' ' HIS . 9.8 mtp180 -139.07 140.24 37.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.19 143.97 11.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 123.828 0.851 . . . . 0.0 110.315 173.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 65' ' ' TRP . 98.9 t -122.02 133.27 68.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 126.98 2.112 . . . . 0.0 109.524 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.481 ' CD2' ' HB2' ' A' ' 65' ' ' TRP . 1.3 p90 -133.57 174.72 10.12 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 126.46 1.904 . . . . 0.0 110.193 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.17 170.48 8.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.878 0.871 . . . . 0.0 110.192 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.537 ' ND2' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -122.31 19.69 10.57 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.342 1.457 . . . . 0.0 112.268 177.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.4 p -39.86 -57.76 1.52 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.022 1.329 . . . . 0.0 113.939 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.53 34.66 4.97 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.191 1.796 . . . . 0.0 112.836 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.92 21.96 59.52 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.37 108.04 10.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.07 1.748 . . . . 0.0 107.614 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.447 HG22 ' CD2' ' A' ' 98' ' ' TYR . 4.4 t -46.4 126.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.825 0.85 . . . . 0.0 109.999 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -103.75 -7.52 20.54 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.688 ' CZ ' HG23 ' A' ' 21' ' ' VAL . 51.6 t80 53.16 66.69 1.16 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.877 1.322 . . . . 0.0 110.356 -171.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . 0.441 ' SG ' ' CG ' ' A' ' 52' ' ' TRP . 50.8 t -44.65 -39.85 5.39 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.318 -0.864 . . . . 0.0 113.217 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 156.42 177.61 29.75 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 124.891 1.234 . . . . 0.0 110.844 167.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -103.69 143.39 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.146 1.778 . . . . 0.0 110.853 175.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -125.36 168.6 13.32 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.294 1.438 . . . . 0.0 110.804 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -149.43 150.98 33.24 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.207 1.403 . . . . 0.0 111.421 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 93' ' ' PRO . 7.9 m170 -68.63 152.81 44.85 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.738 -0.601 . . . . 0.0 111.588 172.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 m -83.39 -24.75 31.84 Favored 'General case' 0 C--O 1.212 -0.897 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.55 97.91 11.34 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.628 1.558 . . . . 0.0 110.895 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.751 HG23 ' HA ' ' A' ' 120' ' ' ASN . 1.5 p -140.07 112.21 5.0 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.207 0 CA-C-N 119.291 0.951 . . . . 0.0 110.161 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.35 -74.98 0.62 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 122.04 0.924 . . . . 0.0 110.912 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -119.82 -49.06 2.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.804 1.642 . . . . 0.0 112.552 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -85.82 6.61 27.36 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.743 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.751 ' HA ' HG23 ' A' ' 116' ' ' VAL . 3.4 m-80 46.1 49.31 12.44 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.164 0.986 . . . . 0.0 112.126 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -61.97 -168.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 124.214 1.959 . . . . 0.0 112.269 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.468 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -165.19 118.41 0.81 Allowed Glycine 0 CA--C 1.495 -1.18 0 O-C-N 118.762 -2.461 . . . . 0.0 111.121 174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -134.64 -38.23 0.82 Allowed 'General case' 0 C--O 1.216 -0.672 0 O-C-N 125.545 1.379 . . . . 0.0 113.88 176.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -77.77 165.12 24.59 Favored 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.225 0.953 . . . . 0.0 110.047 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -47.52 152.73 0.62 Allowed 'General case' 0 C--O 1.239 0.538 0 O-C-N 125.958 2.036 . . . . 0.0 111.909 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -85.11 115.38 22.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 122.707 1.241 . . . . 0.0 109.128 -177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.28 115.78 22.13 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.156 -0.965 . . . . 0.0 108.842 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 133.65 56.1 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.985 -0.447 . . . . 0.0 110.216 167.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.3 m -62.36 167.43 4.21 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.645 1.178 . . . . 0.0 111.833 167.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 126.809 2.044 . . . . 0.0 111.272 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.374 -1.298 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' VAL . 90.9 Cg_endo -73.53 3.23 4.98 Favored 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.823 3.016 . . . . 0.0 114.891 175.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.04 96.45 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 128.484 2.714 . . . . 0.0 107.785 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -84.09 169.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.989 1.716 . . . . 0.0 109.537 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.5 p -145.03 113.19 6.5 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.025 -1.047 . . . . 0.0 113.543 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 m -62.24 166.17 5.18 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.47 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -112.49 34.94 0.13 Allowed Pre-proline 0 N--CA 1.486 1.337 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.01 172.44 6.11 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 123.768 2.978 . . . . 0.0 111.318 -177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -110.01 142.65 41.13 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 124.754 1.221 . . . . 0.0 108.535 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 116' ' ' VAL . 0.1 OUTLIER -100.72 -92.69 0.29 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.466 -1.243 . . . . 0.0 107.693 167.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -108.55 47.43 0.91 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.11 2.564 . . . . 0.0 109.908 -170.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.81 -26.41 8.41 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 119.808 -1.808 . . . . 0.0 114.971 -176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -84.91 156.21 21.33 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 119.243 1.521 . . . . 0.0 111.813 171.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.33 130.19 39.65 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 126.108 1.763 . . . . 0.0 108.794 172.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.85 116.88 27.49 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.594 1.158 . . . . 0.0 110.579 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -63.07 128.78 23.8 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 CA-C-N 120.963 1.38 . . . . 0.0 111.11 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.566 ' CG ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -103.6 107.14 17.86 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.235 0.925 . . . . 0.0 111.257 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -55.51 127.58 30.4 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.924 1.29 . . . . 0.0 112.608 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.5 t -145.52 125.87 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 127.098 2.159 . . . . 0.0 108.507 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -88.83 117.95 28.19 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 128.289 2.636 . . . . 0.0 111.849 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' CE2' ' A' ' 107' ' ' TYR . 9.0 p -57.46 -42.64 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.68 -0.638 . . . . 0.0 112.206 175.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.85 -53.59 50.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.971 0.908 . . . . 0.0 109.733 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.6 m -63.71 -58.44 6.87 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.852 1.261 . . . . 0.0 110.672 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' HG22 ' A' ' 110' ' ' VAL . . . -45.4 -60.58 2.08 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.577 0.703 . . . . 0.0 111.853 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.48 -50.72 72.13 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.274 -0.87 . . . . 0.0 112.194 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.13 -59.51 4.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.128 1.371 . . . . 0.0 111.486 -174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -42.81 71.47 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.695 1.198 . . . . 0.0 110.856 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.434 ' HB2' HG11 ' A' ' 96' ' ' VAL . . . -55.77 -52.07 65.22 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.584 1.538 . . . . 0.0 111.816 178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -58.21 -39.4 78.92 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.85 0.86 . . . . 0.0 110.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -67.44 -38.48 84.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.075 1.35 . . . . 0.0 114.354 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.83 79.38 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.515 1.926 . . . . 0.0 111.819 171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.16 -161.88 53.12 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD13 ' ND2' ' A' ' 100' ' ' ASN . 10.1 mt -110.82 33.71 4.42 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.008 1.723 . . . . 0.0 109.904 -174.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -152.54 117.61 5.17 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.904 -1.123 . . . . 0.0 112.226 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -110.42 148.04 32.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.146 1.778 . . . . 0.0 110.859 175.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.74 43.46 0.03 OUTLIER Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.16 0.886 . . . . 0.0 113.131 170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 -49.02 1.16 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.942 2.097 . . . . 0.0 110.333 -174.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' HB3' ' C ' ' A' ' 81' ' ' ASP . 60.7 p -140.38 -50.8 0.47 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 113.319 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.26 33.63 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 117.35 -1.806 . . . . 0.0 111.703 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -156.82 155.6 28.67 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 119.359 1.579 . . . . 0.0 113.477 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -63.85 173.36 21.19 Favored 'Cis proline' 0 C--N 1.357 0.986 0 N-CA-C 114.21 0.812 . . . . 0.0 114.21 -8.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -113.13 142.93 45.19 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 120.197 -1.564 . . . . 0.0 109.346 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -66.42 122.38 17.41 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.165 0.986 . . . . 0.0 109.538 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -96.86 134.42 40.2 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.018 1.327 . . . . 0.0 107.887 168.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -114.16 155.39 26.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.206 2.202 . . . . 0.0 108.729 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.47 36.95 0.06 Allowed 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.438 1.895 . . . . 0.0 114.652 176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.39 -38.32 9.08 Favored Glycine 0 N--CA 1.469 0.836 0 O-C-N 120.565 -1.335 . . . . 0.0 111.526 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -80.15 131.57 35.75 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.387 0.675 . . . . 0.0 109.697 176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -52.63 -12.11 0.26 Allowed 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.624 HD11 ' HB2' ' A' ' 126' ' ' PHE . 1.5 mt -47.85 96.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 128.204 2.602 . . . . 0.0 111.357 169.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -99.28 -13.76 19.53 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 115.567 1.691 . . . . 0.0 115.567 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 52.4 m95 64.0 13.88 8.02 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 125.991 1.717 . . . . 0.0 114.931 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.48 21.3 33.9 Favored Glycine 0 CA--C 1.541 1.701 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.959 -164.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.46 135.82 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.847 1.824 . . . . 0.0 110.314 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -58.87 -44.99 91.21 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.44 -37.06 84.33 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 176.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.2 m -76.39 -31.02 57.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 117.512 -1.233 . . . . 0.0 112.99 174.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -82.82 21.07 1.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 128.534 2.734 . . . . 0.0 113.964 170.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 62' ' ' ALA . 14.5 mmtp -74.61 165.17 25.65 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.708 -1.87 . . . . 0.0 111.164 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.35 -51.49 5.4 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.896 0.879 . . . . 0.0 113.104 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -106.25 40.8 1.53 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 123.468 1.604 . . . . 0.0 111.52 177.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.61 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . . . -77.32 163.95 25.99 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 119.764 -1.835 . . . . 0.0 112.867 173.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 63.1 mt -125.03 102.8 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 97' ' ' VAL . 9.5 mp -112.38 -179.93 3.81 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.059 1.344 . . . . 0.0 109.478 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -140.79 161.4 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.173 2.189 . . . . 0.0 110.072 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -133.8 143.04 48.14 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.212 1.805 . . . . 0.0 111.657 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -149.43 126.75 5.54 Favored Pre-proline 0 CA--C 1.549 0.927 0 O-C-N 121.274 -0.891 . . . . 0.0 112.898 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 78' ' ' TRP . 73.9 Cg_endo -70.59 136.45 30.83 Favored 'Trans proline' 0 C--N 1.351 0.693 1 C-N-CA 125.871 4.381 . . . . 0.0 115.095 -177.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.4 pt -132.82 162.9 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.697 1.199 . . . . 0.0 112.671 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CD1' ' HA ' ' A' ' 77' ' ' GLU . 10.1 m-85 -105.09 120.37 41.33 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.659 ' CE3' HD12 ' A' ' 94' ' ' ILE . 27.9 p90 -65.88 169.34 6.74 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.534 0.683 . . . . 0.0 111.464 170.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.9 t -50.68 121.17 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.774 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.21 -26.94 12.75 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.542 2.02 . . . . 0.0 114.999 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 tttp -64.24 102.03 0.48 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -81.95 174.06 11.63 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 121.711 -0.618 . . . . 0.0 110.697 169.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.5 37.06 0.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 128.638 2.775 . . . . 0.0 112.566 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 11.1 tt0 -31.99 130.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.334 2.254 . . . . 0.0 112.473 173.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.491 ' CD2' ' HG2' ' A' ' 68' ' ' PRO . 6.9 t-105 -52.13 132.52 33.27 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -169.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . . . -83.73 172.25 12.41 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.908 -175.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -87.47 -51.9 5.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 120.875 -1.14 . . . . 0.0 113.787 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 38' ' ' SER . 13.8 p-10 -100.93 37.18 1.79 Allowed 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.897 -1.127 . . . . 0.0 111.284 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 79' ' ' ALA . 61.3 t -130.67 116.54 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.985 -1.072 . . . . 0.0 112.048 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -64.22 156.32 29.1 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.57 -0.706 . . . . 0.0 110.948 176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.453 HG22 ' HZ2' ' A' ' 78' ' ' TRP . 68.6 p -45.98 -47.35 16.65 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 m -64.84 -45.06 87.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.244 1.818 . . . . 0.0 114.385 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 tp60 -62.6 -37.01 84.57 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.951 172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -43.45 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 128.43 2.692 . . . . 0.0 115.364 -173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -88.18 65.22 8.03 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.261 -0.899 . . . . 0.0 111.24 -170.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.21 -40.91 0.02 OUTLIER Glycine 0 N--CA 1.464 0.562 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.04 147.84 4.9 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.501 -0.999 . . . . 0.0 113.173 169.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.3 27.29 0.27 Allowed 'Trans proline' 0 CA--C 1.547 1.169 1 C-N-CA 125.911 4.407 . . . . 0.0 114.37 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.1 t -23.64 110.28 0.17 Allowed Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 127.925 2.49 . . . . 0.0 112.633 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.19 -15.87 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.322 1.348 . . . . 0.0 111.879 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.659 HD12 ' CE3' ' A' ' 71' ' ' TRP . 86.9 mt -74.47 125.91 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.619 1.567 . . . . 0.0 109.416 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -139.61 131.17 27.13 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.257 1.023 . . . . 0.0 109.249 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 28' ' ' ALA . 7.3 p -62.32 146.11 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 121.612 -0.68 . . . . 0.0 109.742 170.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 64' ' ' LEU . 11.4 t -127.17 130.18 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 127.926 2.49 . . . . 0.0 111.142 173.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB2' HG13 ' A' ' 105' ' ' VAL . 1.0 OUTLIER -139.66 159.91 41.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 126.116 1.766 . . . . 0.0 110.22 -174.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.3 160.19 14.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' ND2' HD13 ' A' ' 33' ' ' LEU . 16.0 t-20 -83.93 -36.31 23.4 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 117.516 -1.231 . . . . 0.0 112.665 167.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . 0.318 93.3 p 36.57 30.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 73.94 53.14 0.11 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 129.753 3.221 . . . . 0.0 113.672 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.73 50.25 7.25 Favored Glycine 0 CA--C 1.547 2.081 0 C-N-CA 126.326 1.917 . . . . 0.0 115.776 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -157.04 103.13 2.01 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 128.966 2.906 . . . . 0.0 110.33 -174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 98' ' ' TYR . 53.9 t -65.03 125.61 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.988 0.915 . . . . 0.0 111.345 170.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.88 -12.15 18.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.398 -1.274 . . . . 0.0 114.163 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.452 ' CE2' HG23 ' A' ' 21' ' ' VAL . 40.8 t80 49.72 71.48 0.39 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.747 1.158 . . . . 0.0 110.947 -168.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.5 t -52.32 -30.79 30.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.608 1.163 . . . . 0.0 114.022 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 148.14 -174.4 27.85 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 127.077 2.275 . . . . 0.0 109.925 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.5 HG22 ' HB1' ' A' ' 24' ' ' ALA . 2.1 t -106.46 144.68 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 119.239 1.519 . . . . 0.0 109.257 176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -114.51 167.07 11.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 120.951 1.705 . . . . 0.0 110.313 176.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.0 t -151.11 169.14 22.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.857 1.663 . . . . 0.0 112.622 168.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.486 ' CB ' ' HA3' ' A' ' 122' ' ' GLY . 8.1 m170 -84.43 155.61 22.17 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.42 -13.12 32.9 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' NZ ' ' OD1' ' A' ' 117' ' ' ASP . 5.7 tmtm? -98.09 83.52 3.13 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.933 1.242 . . . . 0.0 109.446 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 120' ' ' ASN . 1.4 p -116.87 113.83 44.06 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 CA-C-N 119.228 0.922 . . . . 0.0 109.434 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 12.0 m-20 -112.97 -87.33 0.56 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 174.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -102.69 -54.09 2.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.723 1.609 . . . . 0.0 112.932 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -95.63 10.6 36.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.652 2.781 . . . . 0.0 111.962 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL 0.342 0.2 OUTLIER 49.45 36.39 9.9 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.452 1.101 . . . . 0.0 113.104 173.734 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -57.83 -64.49 0.88 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.468 1.107 . . . . 0.0 111.923 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 113' ' ' HIS . . . 82.69 123.39 0.79 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.91 175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -134.41 -30.28 1.16 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -63.1 167.46 4.94 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.184 0.994 . . . . 0.0 110.289 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -48.68 145.57 3.6 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.405 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.624 ' HB2' HD11 ' A' ' 50' ' ' ILE . 3.5 m-30 -70.99 118.11 13.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.767 1.27 . . . . 0.0 109.869 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -88.52 126.92 35.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 120.615 -1.303 . . . . 0.0 110.125 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -67.0 116.78 8.21 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.735 -0.603 . . . . 0.0 109.676 163.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -56.78 150.6 15.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.706 2.002 . . . . 0.0 109.904 164.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.26 1.648 0 C-N-CA 130.006 3.322 . . . . 0.0 108.211 -175.903 . . . . . . . . 0 0 . 1 stop_ save_